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Clathrin-mediated endocytosis is the major process by which cells internalize nutrients, 
extracellular macromolecules, and membrane constituents to regulate such diverse processes as 
cell polarity, development, and motility. Over twenty proteins comprise a large protein 
interaction web that is pertinent to this process. This work investigates proteins that act as 
clathrin-associated sorting proteins (CLASPs), and their interactions with other endocytic 
components. Epsin 1 is shown to be a CLASP that engages components of the endocytic clathrin 
coat and selects for polyubiquitinated cargo. The interaction with polyubiquitin is enabled 
through epsin 1’s UIM domains. I show that polyubiquitin is an efficient endocytic signal, which 
is relevant for physiological mammalian substrates such as the epithelial sodium channel 
(ENaC). Stonin 2 behaves as an unconventional CLASP, as it doesn’t directly engage clathrin or 
the plasma membrane. My work uses this protein to biochemically characterize the WXXF motif 
and identify a privileged binding site located on the sandwich subdomain of the AP-2 α 
appendage. This work supports a model in which arrays of binding motifs and multiple 
engagement sites on the α appendage allow for an increase in binding affinity, which affects the 
temporal ordering of endocytic accessory protein interactions during clathrin-mediated 
endocytosis. These studies have defined important protein interactions that have improved our 
understanding of the molecular mechanism of clathrin-mediated endocytosis. 
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1.0  INTRODUCTION 
1.1 OVERVIEW OF ENDOCYTOSIS 
1.1.1 Mechanisms of Endocytosis 
The plasma membrane provides the critical interface between the intracellular and extracellular 
environments. This membrane is not static, but rather is a truly dynamic feature of the cell. The 
barrier is crucial in various physiologic functions including cell motility, regulation of growth, 
establishment of polarity, nutrient absorption, defense against pathogens, and ion balance [1]. 
One of its main functions is to regulate and coordinate the entry and exit of small and large 
molecules. Small molecules such as amino acids, sugars, and ions can be transported across the 
plasma membrane via transmembrane pumps or channels. In contrast, invagination and scission 
of the plasma membrane creates membrane-bound vesicles that deliver macromolecules to the 
cell interior in the process known as endocytosis [2]. Endocytosis is involved in all of the 
physiologic functions associated with the plasma membrane because it controls the protein and 
lipid composition at the surface, regulates signaling pathways, modulates the cell surface area, 
and enables the uptake of nutrients and pathogens [3]. 
Endocytosis is classified into two major types: phagocytosis, the uptake of large particles, 
and pinocytosis, the uptake of fluid and solutes [4]. The process of phagocytosis occurs in a few 
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specialized mammalian cell types including macrophages, monocytes, and neutrophils [5], which 
utilize phagocytosis to destroy large pathogens such as invading bacteria or yeast cells [6]. The 
process of pinocytosis occurs in all cell types [7]. The molecular mechanisms by which cells 
internalize fluid and solutes through pinocytosis can be subdivided into additional classes: 
macropinocytosis, caveolae-mediated endocytosis, clathrin-mediated endocytosis, and clathrin- 
and caveolae-independent endocytosis [3]. Each of these pathways utilizes distinct mechanisms 
and is highly regulated. They are important in the physiology of signal transduction [8], immune 
surveillance [9], antigen presentation [10], and homeostasis [8].  
Macropinocytosis is the endocytic process that involves the internalization of sizeable 
areas of plasma membrane with a large volume of fluid [11]. This occurs when membrane 
protrusions extend and then fuse back with the plasma membrane to create irregularly shaped 
vesicles (>1 μm) which are called macropinosomes [12]. There is currently little known about 
the mechanism by which the membrane protrusions and the plasma membrane fuse.  
Caveolae-mediated endocytosis has been well studied in endothelial cells, although 
caveolae are also found in other mammalian cell types including adipocytes, smooth muscles 
cells, and fibroblasts [13]. Caveolae are flask-shaped invaginations of the plasma membrane that 
are thought to define cholesterol- and sphingolipid-rich microdomains on the plasma membrane 
where many transporters and signaling molecules are located [14]. The shape of caveolae is 
defined by the protein caveolin [15]. These structures are involved in intracellular cholesterol 
trafficking and cholesterol homeostasis [16-18]. There is also evidence that caveolae have a role 
in the recycling of glycosyl-phosphatidylinositol (GPI) -anchored proteins, transport of 
glycosphingolipids, and transcytosis of serum components [19]. This type of endocytosis is 
important in the internalization of Simian Virus 40 (SV40) [20, 21]. 
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The most well studied type of endocytosis is clathrin-mediated endocytosis (CME). This 
process occurs constitutively in most mammalian cells and will be described in detail below. The 
clathrin- and caveolin-independent molecular mechanisms are poorly understood and are often 
described according to endocytic components that are not involved. For example, in 
neuroendocrine cells, endocytosis occurs even when a dynamin mutant is used [22]. Dynamin is 
a GTPase required for budding and release in both CME and caveolae-mediated endocytosis [23, 
24]. The independence of dynamin in this endocytic process suggests that this pathway is a 
primordial endocytic pathway; it is independent of clathrin, dynamin, and caveolae, and is 
simply described as such [12].  
Clathrin-mediated vesicle budding is important for the internalization of receptors and 
extracellular ligands, recycling of plasma membrane components, and retrieval of surface 
proteins destined for degradation [25]. CME is critical in many aspects of development as well as 
in synaptic transmission, where CME provides the recycling of synaptic vesicle proteins and 
maintains the plasma membrane architecture at the synapse [26]. Some of the essential nutrients 
that CME is responsible for internalizing are iron-containing transferrin that binds to transferrin 
receptors, and cholesterol-rich low-density lipoprotein (LDL) particles that bind to LDL 
receptors [27]. In addition to these nutrients that are internalized, CME can downregulate and 
clear signaling receptors from the surface, thus modulating signaling cascades that are vital for 
cellular physiology [28]. 
1.1.2 Brief History of CME 
Thomas Roth and Keith Porter were the first to describe the basic aspects of clathrin-coated pit 
formation over thirty years ago using electron microscopy [29]. This technique requires 
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extensive fixation that inherently sacrifices a sense for the dynamics of a process [30]. To 
circumvent this problem, they utilized a staged system so that the timing of cellular events could 
be elucidated. According to their protocol, mosquito ovaries were fixed at various durations after 
a blood meal to visualize the entry of yolk proteins into the oocyte [29]. Electron microscopy 
was then used to image the cellular events at each time point. They showed “bristle-coated pits” 
at the plasma membrane and observed the formation and budding of a clathrin-coated vesicle, 
which enabled them to propose a chronology for the cellular events of CME [29]. 
The study of CME was accelerated in the 1970s by several morphological studies that 
were performed on coated vesicles. In 1975 and 1976, two major studies conducted by Barbara 
Pearse described the purification of coated vesicles and the identification of clathrin as the most 
abundant protein in these vesicles [31, 32]. It was shown that clathrin is able to self assemble 
into a honeycomb-shaped lattice to form the clathrin coat at low pH [33-36]. Additional work led 
to the discovery of a clathrin assembly factor, a heterotetrameric protein complex found in the 
coated vesicles, which possessed the ability to bind clathrin and assist in the assembly of coats at 
physiological pH [37]. The pool of this complex that is distributed to the plasma membrane was 
later named adaptor protein 2 (AP-2), and it was initially suggested that the AP-2 complex is 
responsible for cargo sorting. It is now clear that the AP-2 complex is able to interact with short 
peptide sequences within cargo transmembrane proteins that define their localization inside the 
cell (Table 1.1) [38]. There are several sorting signals that have been identified to date [39] and 
these will be discussed in the following sections (Table 1.1). 
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 Table  1.1: Internalization Signals 
Signal Type Recognition Domain or Protein
NPXY PTB domain of Dab2 or ARH 
YXXØ μ2 subunit of AP-2 
[DE]XXXL[LI] μ2 and/or β2 subunits of AP-2 
Ubiquitin UIM, UBA, and UBC domains 
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1.1.3 Clathrin-Mediated Endocytosis Components 
Clathrin-coated vesicles are assembled at the plasma membrane surface to select cargo molecules 
and shuttle them between the plasma membrane and underlying membrane-bound intracellular 
compartments. This process occurs very quickly (within minutes) and involves the deformation 
of the plasma membrane with the synchronous capture of cargo to create a round transport 
vesicle. There are four major components of CME: clathrin, heterotetrameric adaptor complexes 
(AP-2), transmembrane cargo receptors, and dynamin [1].  
Clathrin is assembled into functional units known as triskelia, a three-legged structure 
that has three heavy chains and three light chains (Figure 1.1) [40]. Each heavy chain has several 
functional domains, a globular N-terminal region, a “knee” which segments the distal and 
proximal legs, and a C-terminus that allows for its trimerization [41, 42]. Three separate C-
termini of individual clathrin molecule bind together to form the clathrin hub [43]. Further 
assembly occurs as each proximal leg of the clathrin heavy chain associate with a clathrin light 
chain [41, 44, 45]. The molecule is able to assemble into polyhedral lattices by packing the distal 
and proximal legs in an anti-parallel fashion [46]. The N-terminal region of the heavy chain has a 
β-propeller conformation which has binding sites for several endocytic proteins, most notably 
AP-2 [47]. The clathrin molecules are responsible for creating the structural part of the coat, but 
do not possess the ability to interact with the phospholipid membrane or cargo molecules 
directly. Instead, the interaction with the cargo and membrane is carried out by adaptors and 
accessory proteins [27, 38, 48]. 
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 Figure  1.1: Clathrin schematic. 
A schematic depiction of the clathrin triskelion modeled on the known molecular structure with the clathrin heavy 
chains in blue and the clathrin light chains in red. The proximal, distal, and terminal domains of the clathrin heavy 
chains can also be seen in this schematic. 
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AP-2, as introduced above, is a heterotetrameric protein complex composed of two large 
subunits (α and β2), a medium sized subunit (μ2), and a small subunit (σ2) (Figure 1.2) [49, 50]. 
The two large subunits, α and β2, are approximately 100 kDa and have an N-terminal domain 
(referred to as the trunk) and a globular C-terminal domain (known as the appendage) that are 
connected to each other via a flexible linker [49]. AP-2 has the two appendages just described 
and a core. The core comprises two N-terminal domains (“trunks”) of the large subunits (α and 
β2), the μ subunit and the σ subunit [51]. The AP-2 complex has the ability to bind to clathrin 
via its β2 subunit [52]. In order for the transmembrane receptors to be incorporated into a newly 
forming clathrin coated pit, these proteins require an appropriate sorting signal. The μ2 subunit 
of AP-2 has the ability to bind to YXXØ sequences (where single letters designate the amino 
acids, with X as any amino acid, and Ø as any bulky hydrophobic amino acid) (Table 1.1) [25]. 
Another sorting signal is the [DE]XXXL[LI] sequence (Table 1.1) [38]. This motif acts as a 
strong endocytic signal, and although the precise interaction surface on the AP-2 complex has 
not been mapped, there is some data to support the possible engagement of the motif by a 
hemcomplex of α/σ2 as well as cross-linking studies showing a β2 interaction [38]. 
1.1.4 The Traditional Model 
According to the traditional or “textbook” model of CME, the assembly of the clathrin bud is 
intiated by interactions between cargo and AP-2. Next, the clathrin triskelia are polymerized into 
a lattice, and following recruitment of additional endocytic proteins (to be discussed below), the 
bud invaginates. Dynamin is recruited to the necks of coated pits, where it assembles into a spiral  
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Figure  1.2: AP-2 schematic. 
Schematic illustration of the AP-2 adaptor modeled on the known molecular structure. The independently-folded 
globular appendages project off the heterotetrameric adaptor core. The appendages are flexible due to the 
unstructured hinge region that connects each appendage to the core. The inset illustrates the subdomains on the α 
appendage with the FXDXF and DP[FW] binding sites existing on the platform subdomain and the WXXF binding 
site existing on the sandwich subdomain.  
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structure that is involved in the membrane fission and subsequent release of clathrin-coated 
vesicles. After successful budding has occurred, an uncoating reaction allows recycling of the 
components for subsequent rounds of endocytosis [11, 53]. 
1.1.5 Shortcomings of the Traditional Model 
Although this traditional model has been generally accepted and is consistent with much data, 
many studies have yielded a more detailed understanding of this process. There are several 
important inconsistencies with the textbook model that piqued my interest to further study CME. 
It is now known that AP-2 does not bind cargo spontaneously; rather, a phosphorylation event is 
necessary for this interaction to occur [54]. The AP-2 core structures are normally in a closed 
state that requires a conformational change in order to engage the cargo’s YXXØ motif via the 
μ2 subunit carboxy-terminus [51, 55]. The change in conformation occurs upon a 
phosphorylation event in the μ2 subunit, specifically by phosphorylation of Thr156 by adaptor-
associated kinase 1 (AAK1), a member of the Ark/Prk family of kinases [54, 56, 57]. AAK1 is 
colocalized with clathrin-coated pits, and interestingly, the activity of this kinase is enhanced by 
polymerized clathrin, thus promoting cargo engagement where a clathrin lattice is assembled [58, 
59]. Additional data that supports the biochemical interaction of AAK1 with AP-2 will be 
discussed in chapter 3. 
The textbook model also does not acknowledge the role that phosphoinosides play in 
adaptor targeting and coat assembly. It was once believed that adaptors were recruited to the 
membrane via protein interactions with the cargo, but it was found that adaptors were always 
enriched at the plasma membrane even when cargo was not concentrated there. The structure of 
AP-2 also revealed the molecular mechanism by which AP-2 is able to engage membranes and 
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localize to specific membranes. Different cellular membranes have distinct lipid compositions; 
for example the plasma membrane is enriched with a specific phosphoinositide lipid, 
phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) relative to other intracellular membranes. 
The PtdIns(4,5)P2 lipid is concentrated at the surface by the action of PtdIns-4 and PtdIns-5 
kinases, which are located at the plasma membrane [60]. AP-2 is targeted to the plasma 
membrane through an interaction of the α subunit N-terminus with PtdIns(4,5)P2 by coordinating 
the phosphorylated inositol headgroup [61]. A second PtdIns(4,5)P2 binding site exists on the 
AP-2 μ2 subunit, which allows for simultaneous lipid association and cargo binding (after 
phosphorylation by AAK1) by stabilizing the interaction [55, 62]. Mutation of either of these 
lipid-binding sites results in mislocalized AP-2 complexes [55, 61, 62]. Altering the amount of 
PtdIns(4,5)P2 via overexpression or depletion systems also impacts the localization of AP-2. 
Increased levels of PtdIns(4,5)P2 cause increased rates of endocytosis (with concordant increases 
in the amounts of AP-2 and clathrin structures at the surface) [63]. Thus, these lipids are clearly 
important binding partners for the subunits of AP-2 and may even provide a mechanism for 
regulation of recruitment to the membrane. 
The importance of PtdIns(4,5)P2 in CME is further illustrated by the studies of 
synaptojanin, a phosphoinositide phosphatase. Disruption of the synaptojanin gene in mice 
causes a phenotype that suggests a retardation of vesicle release [64-66]. PtdIns(4,5)P2 acts as a 
target for the docking of clathrin coat components and its dephosphorylation is important for 
vesicle release. The role of synaptojanin and lipid metabolism in CME will be explored further in 
chapter 3.  
The past several years have shown a significant increase in the identification of endocytic 
accessory proteins, with more than twenty recognized to date [48, 67, 68]. Biochemical and 
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structural studies have revealed accessory proteins that are capable of binding to the appendage 
domains of AP-2 via various binding motifs organized as short linear binding sequences (Figure 
1.2) [48, 67, 68]. Accessory proteins contain several of these motifs embedded within 
unstructured regions, oftentimes linking two folded domains. The structures of the AP-2 
appendages (α and β2) have been solved, and have yielded insight into how they are able to 
interact with these motifs [69, 70]. The appendages, despite primary sequence differences, adopt 
a similar structure with an N-terminal β-sandwich domain and a C-terminal “platform” domain 
[69, 70]. Some interacting sequences have been determined, and many of these interactions are 
achieved by utilizing hydrophobic residues, which have corresponding structural binding 
“pockets” on the appendage. Most of the peptide motifs that interact with the appendages have 
weak affinities, but the apparent strength of the interaction is increased by the presence of 
multiple repeats or motifs, as described above [71]. Examples of these AP-2 interaction motifs 
are the DP[FW] and FXDXF motifs (sequences are in single amino acid notation), which interact 
with the α-appendage through an overlapping binding site on the “platform” domain (Figure 1.2) 
[72]. Details about these “platform” binding sequences, as well as evidence for a novel 
interaction motif with a corresponding binding site on the β-sandwich domain will be discussed 
in chapter 3. 
In addition to the AP-2 binding motifs, accessory proteins also contain binding sites for 
clathrin. The first identified clathrin binding motif was the clathrin box [73], a linear sequence of 
five amino acids, LØXØ[DE]. This clathrin box is able to bind to the N-terminus 7-bladed β-
propeller domain within clathrin [52]. Another clathrin binding motif is the PWDLW amino acid 
sequence (termed the W-box or type II clathrin box), which also binds to the β-propeller at a 
distinct site [74]. In addition to the short peptide interaction motifs that bind clathrin, AP-2, and 
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cargo, some accessory proteins utilize a folded binding domain that can engage PtdIns(4,5)P2 as 
described above [75, 76]. The traditional model does not account for these proteins satisfactorily, 
but it is clear that these accessory proteins use all of these functional features to cooperate with 
AP-2 to make buds efficiently. 
Probably the largest oversimplification of the traditional model of CME is that it does not 
account for additional endocytic signals that are now known to exist. It is becoming more clear 
that different receptors utilize distinct molecular mechanisms for uptake. The most well-
characterized internalization signal is YXXØ, found in the cytoplasmic tail of such proteins as 
the transferrin receptor and the asialoglycoprotein receptor (Table 1.1) (ASGPR) [38]. As 
described above, this signal sequence is recognized by the μ2 subunit of AP-2 (Table 1.1). 
Even though the YXXØ motif is the best-understood internalization motif, it was not the 
first to be discovered. The FXNPXY sorting motif found primarily in LDL receptor family 
members (including LDL receptor, ApoER2, and megalin), was discovered in 1986 when the 
Brown and Goldstein laboratories determined that the mutation of a tyrosine to a cysteine residue 
in the tail of the LDL receptor prevented its internalization [77]. Additional studies confirmed 
that this tyrosine residue was part of the motif, NPXY (later expanded to FXNPXY). 
Historically, the YXXØ and the FXNPXY signals were grouped together as they are tyrosine 
based; there was even a study that suggested that AP-2 can bind FXNPXY signals in addition to 
YXXØ [78]. However, it is now known that the endocytic proteins Dab2 and ARH are the 
interacting partners for the FXNPXY motif found in these receptors [75, 79]. In summary, many 
recent studies have advanced our understanding of CME beyond the classic “textbook” models, 
and have provided additional details that have allowed detailed study of the chronology of CME.  
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1.2 PROTEIN-PROTEIN INTERACTIONS IN CME 
1.2.1 Chronology of Clathrin Coat Assembly 
The above inconsistencies and inadequacies of the textbook model have led to the development 
of a new, more detailed model to describe a molecular chronology of events for CME. The 
plasma membrane contains PtdIns(4,5)P2 and cargo molecules. The presence of PtdIns-4 and -5 
kinases generates increased local concentrations of the PtdIns(4,5)P2 lipids at the surface, which 
enables the recruitment of accessory proteins and AP-2 [80]. Clathrin trimers are recruited to this 
site by both accessory proteins and AP-2 [71]. These trimers assemble into a lattice, which drive 
the recruitment of more clathrin molecules to increase the kinetics of coat formation [71, 81]. 
Next, the AAK1 phosphorylation event occurs within μ2 at Thr156 which allows for YXXØ 
cargo capture and exposes another AP-2 PtdIns(4,5)P2 binding site that was sequestered in the 
unphosphorylated state [71]. Additional accessory proteins that have structural or regulatory 
functions are recruited, and may be involved in processes such as membrane remodeling or 
membrane curvature and scission to form a clathrin-coated vesicle [27]. The creation of the 
clathrin coat is a continuous, dynamic process, which includes an extensive network of protein-
protein interactions occurring simultaneously. Late in the process, dynamin is recruited to the 
neck of the coated pit, and following a GTPase-dependent vesicle release, disassembly of the 
coat begins [1]. The enzymatic activity of the phosphoinositide phosphatase synaptojanin 
hydrolyzes the phosphoinositide head groups (converting PtdIns(4,5)P2 into PtdIns), and thereby 
weakens the binding affinity of AP-2 and possibly other accessory proteins for the PtdIns(4,5)P2 
containing membrane [82]. Hsc70 and auxilin drive coat disassembly through an ATP-dependent 
reaction in which clathrin molecules are disrupted [71, 83, 84]. The uncoated
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 vesicle containing the cargo is able to tether and fuse with the acceptor membrane. This entire 
cycle is regulated by phosphorylation and dephosphorylation events on many of the coat 
components [71, 80, 81, 85]. 
1.3 ACCESORY PROTEINS AND SORTING SIGNALS IN CME 
1.3.1 Early Research on Sorting Proteins 
The role of accessory proteins in CME has only recently become appreciated. Some of these 
proteins have the ability to recognize protein cargo, or even a family of cargo [48]. One of the 
first accessory proteins studied was β-arrestin, but it was not appreciated as a sorting adaptor 
because it was initially studied with respect to G protein-coupled receptor (GPCR) signal 
termination, as opposed to protein and membrane trafficking. This is because visual arrestin 
terminates rhodopsin signaling without removal of the GPCR from the membrane. Currently, 
there are more than 1000 GPCRs that have been identified in the human genome, designating 
them as the most abundant pathway by which signals from the outside of the cell are transduced 
to the cell interior [86]. Many signaling receptors are rapidly internalized by CME when 
stimulated by their ligand to attenuate the signal. There is evidence that suggests that this 
pathway utilizes distinct components from the constitutive internalization pathway [87-89]. For 
example, the internalization of GPCRs does not rely on an amino acid sequence motif; rather, the 
signal that directs the endocytosis of these receptors is a phosphorylation event of the GPCR by a 
G protein-coupled receptor kinase (GRK) [87, 88]. The phosphorylated GPCR cytoplasmic tail is 
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recognized by soluble proteins, namely the β-arrestins, that link the phosphorylated GPCR to the 
clathrin endocytic machinery [90, 91]. 
The β-arrestins are responsible for controlling the magnitude and the extent of the GPCR 
signaling by two mechanisms. First, the β-arrestins bind to the phosphorylated cytoplasmic tail 
of a ligand-activated receptor and inhibit the receptor from interacting with its cognate G-protein, 
thereby preventing additional signaling [90, 91]. Another mechanism by which the signal 
transduction is attenuated is by sorting of the GPCR into a clathrin-coated pit destined for 
endocytosis [87, 88]. β-arrestin has a C-terminal folded domain that is able to bind to 
PtdIns(4,5)P2, and an unstructured region housing a clathrin box motif able to interact with 
clathrin, and an AP-2 β2 appendage binding sequence [87, 88]. Upon binding of β-arrestins to 
activated GPCRs, a conformational change occurs that releases the disordered C-terminus from a 
sequestered state to allow its interaction with clathrin and AP-2, effectively targeting the GPCR-
β-arrestin complex to a coated pit [87, 88]. 
In a mechanistically analogous manner, Dab2 and ARH are clathrin accessory proteins 
that promote the endocytosis of LDL receptor family members [75, 79]. These two proteins are 
well studied because of a hypercholesterolemia phenotype associated with LDL internalization 
defects. Dab2 and ARH possess an N-terminal phosphotyrosine binding (PTB) domain capable 
of interacting with PtdIns(4,5)P2 as well as FXNPXY peptides (preferentially to non-
phosphorylated sequences) [75, 79]. The FXNPXY motif is embedded in the cytoplasmic 
domain of LDL receptor family members [75, 79]. Similar to β-arrestin, Dab2 and ARH possess 
the ability to interact with clathrin as well as the AP-2 appendage [75, 79]. These proteins (β-
arrestin, Dab2, and ARH) are the founding members of a growing family of proteins known as 
clathrin associated sorting proteins (CLASPs) (Figure 1.3) [27]. Thus, members of this family
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 Figure  1.3: Founding members of the CLASP family of proteins. 
Interactions between AP-2, clathrin and the founding members of the CLASP family are denoted by the lines. A 




possess four functional attributes: the ability to bind the membrane (specifically PtdIns(4,5)P2), 
clathrin, AP-2 (through the appendage domains), and cargo.  
1.3.2 CLASPs 
The data supporting a role for dedicated sorting proteins in CME is now incontrovertible. Much 
of the traditional model relied upon AP-2 acting as the sole protein responsible for sorting cargo. 
If this were true, then depletion or knocking-out AP-2 would have a devastating effect. It turns 
out that deletion mutants of AP-2 in S. cerevisiae have no effect on CME or any other pathway 
[92]. Even though yeast are viable when AP-2 is deleted, when deletion mutants and 
temperature-sensitive alleles of a homolog of another CLASP, epsin, are utilized, these were 
shown to be critical for CME [93]. Although yeast can survive independently of AP-2, transgenic 
experiments show that multicellular organisms such as D. melanogaster, C. elegans, and M. 
musculus require AP-2 to survive [27, 94]. In support of the CLASP family of proteins, siRNA-
mediated silencing of AP-2 in cultured cells caused the transferrin receptor (containing a YXXØ 
motif) to remain at the surface while internalization of the epidermal growth factor (EGF) 
receptor and LDL receptor (which contain NPXY motifs) was unaffected [95]. In addition to 
silencing AP-2, clathrin has also been silenced, which strongly decreases the internalization of 
all of the above cargo [95-97]. These data suggest the importance of other proteins beyond the 
traditional endocytic components in CME. 
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1.4 UBIQUITIN AS AN ENDOCYTIC SIGNAL AND EPSIN 
1.4.1 Alternate Internalization Signals 
In addition to well-characterized primary sequence internalization sequences such as YXXØ and 
FXNPXY, there are alternate internalization motifs. The [DE]XXXL[LI] sequence is contained 
within internalized proteins such as CD3-γ [38], and as mentioned above, phosphorylation serves 
as an internalization signal for GPCRs. 
One unusual membrane internalization motif involves the post translational addition of 
the 76 amino acid protein ubiquitin [98]. This was an unexpected role for ubiquitin, as its well-
characterized function is to promote the proteasomal degradation of proteins; in fact, in 2004, the 
Nobel Prize in Chemistry was awarded to Ciechanover, Hershko, and Rose for the discovery of 
ubiquitin-mediated protein degradation. For protein degradation, multiple ubiquitin molecules 
are sequentially attached to a targeted protein to create polyubiquitin chains that are recognized 
by the 26S proteasome for cytosolic degradation [99]. A different function for ubiquitin is now 
being described, in which ubiquitination of integral membrane proteins directs their endosomal-
based degradation in the lysosome. 
The internalization of monoubiquitin tagged proteins that lack YXXØ was first described 
using a S. cerevisiae model. The binding of α-factor and a-factor to Ste2p and Ste3p (GPCR 
pheromone receptors), respectively, induced ubiquitination on their cytoplasmic tails and 
subsequent endocytosis [100, 101]. Yeast endocytosis defective mutants allow for the 
accumulation of these ubiquitinated proteins [101]. Many other yeast plasma membrane proteins 
and receptors have since been shown to utilize ubiquitin as an internalization signal [102]. 
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As stated above, AP-2 in yeast is dispensable, and ubiquitin is the major signal for 
endocytosis, which led to my interest in whether ubiquitin is also a mammalian endocytic signal. 
Research using the growth hormone (GH) receptor in a cell background defective in the ubiquitin 
conjugation machinery showed that its endocytosis depended on this machinery [103-108]. There 
are also data indicating that ubiquitination regulates the internalization of several other proteins 
including the following receptors: EGF receptor [109], Met [110], CSF-1 [111], as well as the 
epithelial sodium channel (ENaC) [108], and Delta (a transmembrane Notch ligand in 
Drosophila) [112-115]. Because the ubiquitination of certain membrane proteins can drive their 
endocytosis, a search for the specific components that interact with the ubiquitin tag was initiated 
[116]. 
1.4.2 Epsin 1 
Using a bioinformatics approach, Hofmann and Falquet searched for proteins with amino acid 
homology to the ubiquitin recognizing subunit of the proteasome, S5a [117]. Two of the results 
were the endocytic proteins epsin 1 and eps15 as alluded to above. Epsin 1 is a CLASP and 
contains modular domains that interact with other components of the endocytic machinery and 
with membrane lipids. It has an N-terminal ENTH (epsin N-terminal homology) domain, which 
interacts with phospholipids at the plasma membrane; a central DP[FW] region (containing eight 
repeats), which interacts with the α appendage of AP-2; and a C-terminal NPF region 
(containing three motifs), which binds to EH (eps15 homology) domains of other endocytic 
proteins, including eps15 (Figure 1.4) [67]. The computer search conducted by Hofman and 
Falquet also revealed three tandemly arranged ubiquitin interacting motifs (UIMs) between the 
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 Figure  1.4: Schematic of the domain organization of epsin 1 and eps15. 
Schematic illustration of the domain organization of epsin 1 and eps15 illustrating the location of the UIM 
sequences, AP-2-binding DP[WF] sequences (blue bars), clathrin-binding sequences (green bars), and EH domain-
binding NPF triplets (pink bars). The folded ENTH (epsin N-terminal homology) domain binds physically to 
PtdIns(4,5)P2 while the remainder of the protein is largely unstructured.  
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ENTH and DPW regions in epsin 1 [117]. Eps15, an epsin 1 interacting partner, contains two 
UIM sequence motifs [67]. Epsin 1 is in an optimal position to provide a cargo binding function 
for CME. It has the ability to bind clathrin, polymerize its assembly, and is found at steady state 
in coated pits at the plasma membrane in a manner similar to previously identified CLASPs such 
as Dab2, ARH, and AP180 [118]. In addition to immunofluorescence studies, there is 
ultrastructural evidence that epsin 1 is localized to a developing clathrin lattice [119]. Data from 
yeast studies also supports a role for epsin in ubiquitin-mediated internalization. In addition to 
the lethal epsin deletion phenotype described above [92, 93], precise deletion of the UIMs in the 
yeast epsins prevents α factor receptor uptake from the cell surface [120]. The protein-protein 
interactions of epsin and its potential as a CLASP for sorting ubiquitinated cargo in mammalian 
cells are discussed in chapter 2. 
1.4.3 Role of the UIMs 
When I began my work, the role of the UIMs in the context of endocytic proteins was not clear. 
One possibility was that the UIMs found in endocytic proteins could serve as the mammalian 
ubiquitin endocytic sorting machinery, facilitating the internalization of ubiquitinated proteins. 
One potential target molecule for the UIMs at the surface is the EGF receptor, as mentioned 
above. The EGF receptor family of receptor tyrosine kinases lies at the pinnacle of a complex 
signal transduction cascade that is known to modulate cell proliferation, survival, adhesion, 
migration, and differentiation [121]. On binding of ligand to the EGF receptor, the ligand 
receptor complex undergoes dimerization, which induces autophosphorylation, recruitment of 
intracellular signaling molecules, and internalization [121]. Several recent papers revealed that 
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the ubiquitin ligase c-Cbl is recruited to activated EGF receptor and a related receptor tyrosine 
kinase, the hepatocyte growth factor receptor c-Met [114, 115].  
Like GPCRs, ligand-dependent downregulation of tyrosine kinase receptors such as EGF 
receptor and c-Met is crucial for modulating their activity. UIM-mediated sorting of 
ubiquitinated cargo into clathrin-coated vesicles would allow rapid entry of these proteins into 
the endosomal pathway for subsequent degradation in the lysosome to allow for their clearance 
from the plasma membrane and signal termination. 
One appealing model is that a mono-ubiquitin signal initiates endocytosis while a poly-
ubiquitin signal targets a protein for proteasomal degradation. Yeast apparently utilize mono-
ubiquitin for cargo internalization; adding a single ubiquitin moiety in frame to the C-terminus of 
the H+ ATPase Pma1p induced its endocytosis [122, 123]. Also, studies involving fully 
substituted arginine forms of ubiquitin (conjugation incompetent) show that, in yeast, a single 
ubiquitin residue is the minimal endocytic tag. Monoubiquitination has been described to cause 
the downregulation of receptor tyrosine kinases, immunoreceptors, and cytokine receptors in 
mammalian cells [124-126]. The covalent conjugation of a single ubiquitin moiety to several 
acceptor lysine residues in the cytoplasmic tails of these proteins (multiple monoubiquitination 
or multiubiquitination) was seen as the signal for endocytosis. The question that initiated much 
of my research is: why would the same domain in epsin and S5a recognize different substrates 
(monoubiquitin for epsin and polyubiquitin chains for S5a)? The S5a UIM domain was used to 
identify the epsin UIMs as described above, and there is a rich literature that shows that the S5a 
binds to tetraubiquitin or longer substrates. There is no structural explanation for the disparity in 
proposed ubiquitin recognition by the S5a and epsin UIMs (mono versus polyubiquitination). 
Chapter 2 addresses this question as well as many others and offers data to argue that 
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polyubiquitin chains rather than monoubiquitination serve as the signal for robust epsin 1 UIM-
mediated endocytosis. 
1.5 STONIN 2 
Endocytosis plays a critical step in the lifecycle of a synaptic vesicle during neurotransmission. 
Chemical synaptic transmission requires the release of neurotransmitter via the fusion of 
transmitter-filled synaptic vesicles with the presynaptic plasma membrane. After fusion, synaptic 
vesicle proteins deposited into the plasma membrane are promptly retrieved by endocytosis and 
recycled to new synaptic vesicles to maintain a reserve pool of synaptic vesicles and ensure 
synaptic plasticity. 
Defects in CME often cause a neurological phenotype due to the importance of CME in 
synaptic transmission. The stoned locus of Drosophila melanogaster was originally identified as 
a neurological gene in a temperature sensitive screen pioneered by David Suzuki in the 1970’s 
[127]. When shifted to a non-permissive temperature, the stoned allele caused paralysis of the 
flies within a few minutes, indicating a strong neurological defect. Further evidence that the 
stoned gene product is involved in neuronal function stemmed from the allele-specific interaction 
of stoned mutants with shibire (a dynamin homolog) mutants [128]: the double mutant resulted 
in synthetic lethality. This genetic interaction indicated that the stoned product functions in the 
same pathway as shibire, which is known to be involved in endocytosis as well as synaptic 
vesicle recycling [129, 130].  
The stoned gene gives rise to an unique bicistronic message that encodes two structurally 
unrelated proteins, stonedA and stonedB, from separate open reading frames (ORFs) [131]. 
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Mutations in both ORFs produce defects in synaptic vesicle endocytosis and exocytosis, 
depletion of synaptic vesicles, accumulation of endocytic intermediates, and mislocalization of 
synaptotagmin, a synaptic vesicle protein. Both of these proteins have structural hallmarks of 
endocytic proteins, for example stonedA has DPF motifs while stonedB has both NPF motifs and 
a μ subunit homology domain (MHD) (Figure 1.5). This domain in stonedB is located in the C-
terminal region and has a high identity to the μ2 subunit of AP-2 (42% identity with the μ 
family). Data shows that stonedB has the ability to fully restore function in mutant flies. Stoned 
mutations affect the function and morphology of synapses as well as neurotransmitter release 
[132].  
Almost all stoned mutant phenotypes are similar to those described for mutants of 
synaptotagmin, a transmembrane protein known to regulate exocytosis and the recycling of 
synaptic vesicles. Like Shibire, Stoned interacts genetically with synaptotagmin to produce a 
lethal phenotype, and biochemically the MHD of stonedB interacts with the calcium binding 
C2B domain of synaptotagmin [133]. Some of this work has been performed using the human 
homologues of stonedB, stonin 1 and 2, as the mammalian counterpart to stonedB is highly 
likely to be a functional orthologue. Stonin 2 is able to bind synaptotagmin through its MHD and 
colocalizes with synaptotagmin at axonal vesicle clusters in cells [134, 135]. Stonin 1 only binds 
weakly to synaptotagmins, while stonin 2 is able to interact robustly. There are many questions 
to be addressed in regards to stonin 2 structure and function. It is still unclear what the function 
of this protein is; it seems probable that it acts as an AP-2 dependent sorting adaptor for 
synaptotagmin and synaptic vesicle recycling, as an atypical CLASP. The mechanism for its 
interaction with the endocytic machinery is unknown and will be explored in chapter 3. 
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 Figure  1.5: Schematic illustration of the domain organization of stonin 2. 
Schematic representation of the domain organization of human (Hs) stonin 2. In this schematic are the WXXF 
motifs (seen in purple) as well as the stonin homology domain (SHD) and the μ homology domain (MHD). 
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1.6 GOALS OF THIS DISSERTATION 
Clathrin-mediated endocytosis is a rapid process, but requires the presence of at least ten soluble 
components for successful budding of a transport vesicle. Therefore, a large network of protein-
protein interactions oversees coat assembly and cargo selectivity. My dissertation research seeks 
to better understand a select set of endocytic interactions that contribute to clathrin function and 
cargo selection at the molecular level. Specifically, in chapter 2, I characterize the UIMs in epsin 
and demonstrate that polyubiquitin is an authentic internalization signal. Also, I identify a 
physiologically relevant application of the polyubiquitin modification used in the cellular 
internalization of ENaC. Most importantly, I show that epsin is acting as a CLASP sorting 
polyubiquitinated cargo proteins into a developing clathrin bud. In chapter 3, I biochemically 
characterize the WXXF endocytic interaction motifs present in stonin 2 and explore the 
biological significance of the three motif repeats. It is now clear that stonin 2 is also a CLASP, 
sorting different cargo and utilizing different interaction motifs for AP-2. This research has 
allowed the identification of a privileged binding site on AP-2 that has allowed us to better 
understand the chronology of protein recruitment during CME. It is critical to understand the 
protein-protein interactions that are important for the regulation of CME and are responsible for 
the uptake of extracellular nutrients, macromolecules, antigen presentation, synaptic 
transmission, and the downregulation or receptors. 
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2.0  EPSIN 1 IS A POLYUBIQUITIN-SELECTIVE CLATHRIN-ASSOCIATED 
SORTING PROTEIN* 
*Reprinted from Traffic, (2006, volume 7, issue 3, pp. 262-281), with permission from 
Blackwell Publishing 
2.1 ABSTRACT 
Epsin 1 engages several core components of the endocytic clathrin coat, yet the precise mode of 
operation of the protein remains controversial. The occurrence of tandem ubiquitin-interaction 
motifs (UIMs) suggests that epsin could recognize an ubiquitin internalization tag, but the 
association of epsin with clathrin-coat components or monoubiquitin is reported to be mutually 
exclusive. Here, we show that endogenous epsin 1 is clearly an integral component of clathrin 
coats forming at the cell surface and is essentially absent from caveolin-1-containing structures 
under normal conditions. The UIM region of epsin 1 associates directly with polyubiquitin 
chains but has extremely poor affinity for monoubiquitin. Polyubiquitin binding is retained when 
epsin synchronously associates with phosphoinositides, the AP-2 adaptor complex, and clathrin. 
The enrichment of epsin within clathrin-coated vesicles purified from different tissue sources 
varies and correlates with sorting of multiubiquitinated cargo and, in cultured cells, 
polyubiquitin, rather than nonconjugable monoubiquitin, promotes rapid internalization. As epsin 
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interacts with eps15, which also contains a UIM region that binds to polyubiquitin, epsin and 
eps15 do appear to be central components of the vertebrate poly/multiubiquitin-sorting endocytic 
clathrin machinery. 
2.2 INTRODUCTION 
Clathrin-mediated endocytosis governs not only the routine uptake of membrane and nutrient 
receptors, but also promotes the internalization of several ligand-stimulated receptors, ion 
channels, and transporters [1]. Selection of designated cargo depends upon appropriately 
positioned peptide internalization motifs or signals that are recognized by the protein 
components of the assembling clathrin lattice, retaining transmembrane cargo proteins at the bud 
site as invagination proceeds [38, 49]. Internalization signals were initially uncovered on analysis 
of a mutant low density lipoprotein (LDL) receptor that contains a single amino acid substitution 
within the cytosolic domain [77]. Although expressed at the cell surface, the Tyr807Cys 
substitution blocks the capacity of liganded LDL receptors to concentrate within clathrin-coated 
pits, preventing efficient LDL uptake and, ultimately, leading to pathological 
hypercholesterolemia [77]. Further analysis of LDL receptor endocytosis defined the cytosolic 
802FXNPXY internalization motif as the critical determinant recognized by the clathrin-coat 
machinery [136]. 
Several other transmembrane proteins, including the transferrin and mannose 6-phosphate 
receptors, use an alternate Tyr-based internalization motif [38]. Based on the consensus YXXØ, 
where Ø represents a residue with a bulky hydrophobic side chain, this sequence interacts 
directly with the μ2 subunit of the plasma-membrane specific heterotetrameric AP-2 adaptor 
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complex [137]. The molecular basis for this interaction has been resolved at the atomic level 
[138]. Mutations that disrupt the binding of YXXØ sequences to μ2, when inducibly expressed 
as a mutant μ2 subunit in HeLa cells, potently block transferrin internalization [139]. Indeed, the 
vital role that AP-2 plays in clathrin-mediated endocytosis is clearly demonstrated by RNA 
interference. Post-transcriptional silencing of AP-2 subunit message with siRNA 
oligonucleotides leads to a tenfold decrease in morphologically discernable clathrin coats at the 
plasma membrane [95], and severely impedes the internalization of receptors containing YXXØ-
type internalization signals [95-97]. Still, clathrin-dependent internalization of several other 
transmembrane cargo proteins, like the LDL receptor, proceeds after extinguishing AP-2, and 
current evidence suggests that a family of clathrin-associated sorting proteins (CLASPs) act in 
conjunction with AP-2 to facilitate the rapid internalization of diverse cargo types within 
clathrin-coated vesicles [27, 68, 140]. Most CLASPs share four functional attributes: physical, 
non-competitive interactions with phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), 
clathrin, AP-2, and a designated cargo class.  
Unlike nutrient cargo receptors, which internalize constitutively and repeatedly recycle 
back to the cell surface, many signal-transducing receptors avoid endocytic uptake until activated 
by ligand. For example, agonist-dependent phosphorylation of G protein-coupled receptors, like 
the β2 adrenergic receptor, recruits β-arrestin 1 or -2 to the receptor/membrane [141]. The β-
arrestin CLASPs contain discrete interaction motifs for direct binding to both clathrin trimers 
[142] and the AP-2 adaptor β subunit [91, 143]. This meshes the receptor with the clathrin-coat 
machinery for efficient downregulation from the cell surface [141].  
Another reversible signal that specifically directs transmembrane proteins at the cell 
surface for endocytic uptake, especially in the yeast Saccharomyces cerevisiae, is ubiquitin [108, 
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116]. In fact, both the β2 adrenergic receptor and β-arrestin are rapidly ubiquitinated upon ligand 
stimulation [144]. This likely increases the fidelity of receptor uptake after stimulation, but the 
identity of the components of the clathrin machinery that interface with ubiquitin in vertebrate 
cells remains controversial. We show here that epsin 1, a protein known to interact efficiently 
with the core endocytic components AP-2 and clathrin and with PtdIns(4,5)P2, binds to 
polyubiquitin via the computationally identified ubiquitin-interaction motifs (UIM) sequence 
[117]. These results extend our characterization of the emerging family of cargo-specific 
monomeric endocytic adaptors we term CLASPs [27], and argue against epsin 1 (and its binding 
partner eps15) functioning to sort monoubiquitinated cargo via caveolae [145, 146]. 
2.3 RESULTS 
The positioning of two or three tandem UIMs (Figure 2.1A and B) within alternatively-spliced 
isoforms of epsin 1 [117] has prompted the proposal that epsin (and the S. cerevisiae orthologues 
Ent1/2p), perhaps together with the binding partner eps15 (which also contains 2 UIMs [117]), 
governs the retention of monoubuiquitinated cargo molecules in assembling clathrin buds [125, 
147, 148]. Indeed, in vitro, epsin 1 binds physically to ubiquitin (Figs. 2.2-2.4). When 
immobilized upon glutathione-Sepharose, neither GST alone nor residues 1-163 of epsin 1 fused 
to GST (GST-ENTH, Figure 2.1A) associate with ubiquitin or with polymeric ubiquitin chains 
(Figure 2.2, lane b and d). By contrast, residues 1-407 fused to GST (GST-ENTH+DPW) bind 
polyubiquitin chains robustly (lane f) and deplete the higher-order ubiquitin chains from the 
supernatant fraction (lane e compared to lanes a and c). Significantly, association with di- or 
triubiquitin conjugates is minimal in this assay. That the interaction with the Lys48-linked  
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 Figure  2.1: Schematic illustration of the domain organization and sequence alignment of epsin 1 and eps15. 
A) Schematic illustration of the domain organization of epsin 1 and eps15 illustrating the location of the UIM 
sequences, AP-2-binding DP[WF] sequences (blue bars), clathrin-binding sequences (red bars), and EH domain-
binding NPF triplets (black bars). The folded ENTH (epsin N-terminal homology) domain binds physically to 
PtdIns(4,5)P2 while the remainder of the protein is largely unstructured. The location of the different constructs used 
in this study are shown in relation to the intact polypeptides. B) Sequence alignment of the epsin, eps15, S5a and 
Vps27p UIM repeats. Invariant residues are boxed in magenta while chemically conserved residues are boxed in 




Figure  2.2: Binding of Lys48-linked polyubiquitin chains to various epsin constructs. 
Binding of Lys48-linked polyubiquitin chains to 5 μg of immobilized GST or the indicated GST-fusion proteins. 
Approximately 10-fold more of each pellet (P) compared to the corresponding supernatant (S) fraction was analyzed 
on immunoblots with anti-ubiquitin antibodies. 
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polyubiquitin chains is due to the triple UIM (UIM3)-containing region of epsin 1 is confirmed 
by a GST fusion of only epsin 1 residues 168-256 (GST-UIM3) retaining full ubiquitin-binding 
capacity (lane h) [149]. Notably, the extent of UIM3 binding to polyubiquitin chains is similar to 
that of the GST-S5a control protein (lane j), an authentic polyubiquitin-recognizing subunit of 
the 19S regulatory particle of the 26S proteasome [150, 151].  
Thus, in vitro, the epsin UIM3 segment has an extremely weak apparent affinity for 
monoubiquitin. The strong preference of the epsin UIM3 for ubiquitin chains composed of four 
or more covalently-coupled monomers is apparent irrespective of whether the chains have a 
Lys48 or Lys63 linkage (Figure 2.3). Efficient binding to polyubiquitin depends upon multiple 
UIMs (Figure 2.4). Compared to the epsin GST-UIM3, which has the three tandemly-arrayed 
UIMs, GST-UIM2 and GST-UIM1 bind negligible amounts of ubiquitin. This result could 
indicate that the last of the three sequentially-arrayed UIMs in epsin 1 binds ubiquitin with high 
apparent affinity. In fact, in S5a the two UIMs do display 5-10-fold different affinities for 
ubiquitin [150], as a result of the precise positioning of the invariant UIM anchor Ala and Ser 
side chains relative to the overall UIM α-helical element, and also due to non-conserved N-
terminal residues which, in the second S5a UIM, contact ubiquitin [151]. However, when 
expressed alone, neither the first nor the third UIM of epsin 1 binds ubiquitinated proteins 
efficiently [152], supporting our conclusion that polyubiquitin binding requires multiple UIMs.  
In our pulldown assays, a hundredfold excess of monoubiquitin does not alter the binding 
of >tetraubiquitin chains to the epsin 1 UIM3 region fused to GST (Figure 2.5) and, similarly, a 
large excess of monoubiquitin does not impede the association of the immobilized epsin UIM3 
with uncharacterized polyubiquitinated proteins within a HeLa cell extract (Figure 2.6). These 
results are similar to the ~300-fold higher affinity of the UBA domain for tetraubiquitin chains 
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Figure  2.3: Comparison of Lys48- or Lys63-linked polyubiquitin chains. 
Binding of Lys48- or Lys63-linked polyubiquitin chains to 5 μg of GST, GST-epsin UIM or GST-S5a. 
Approximately 10-fold more of each pellet (P) fraction compared to the corresponding supernatant (S) fraction was 
resolved by SDS-PAGE and stained with Coomassie blue or transferred to nitrocellulose and probed with anti-
ubiquitin antibodies. Note that chain linkage affects reactivity with the anti-ubiquitin antibodies; the higher-order 
Lys63-linked chains react considerably better (right panel), despite roughly equivalent amount of protein (left 
panel). 
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 Figure  2.4: Epsin UIM truncations. 
Binding of Lys48-linked polyubiquitin chains to 5 μg of GST, GST-epsin UIM3, GST-epsin UIM2, GST-epsin 
UIM1, GST-eps15 UIM, or GST-S5a. Approximately 10-fold more of each pellet (P) fraction compared to the 
corresponding supernatant (S) fraction was resolved by SDS-PAGE and stained with Coomassie blue or transferred 
to nitrocellulose and probed with anti-ubiquitin antibodies. The selective loss of the largest ubiquitin polymers from 
the supernatant fraction after incubation with GST-epsin UIM2 (lane e compared to lanes a and g) indicates only 
weak association with two epsin UIMs, and the limited recovery of these ubiquitin chains observed in the pellet 
(lane f) suggests dissociation and loss during the washing steps. Note, however, that both the eps15 and S5a only 
have two known UIM repeats. 
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 Figure  2.5: Effect of excess monoubiquitin on the binding of polyubiquitin chains to immobilized GST-UIM. 
Effect of 10–100-fold molar excess of monoubiquitin on the binding of polyubiquitin chains to 5 μg immobilized 
GST or GST-epsin 1 UIM3. Approximately 10-fold more of each pellet (P) compared to the corresponding 
supernatant (S) fraction was resolved by SDS-PAGE and either stained with Coomassie blue or transferred to 
nitrocellulose and probed with anti-ubiquitin antibodies. Note that at high concentrations of added monoubiquitin 
(lane i) nonspecific high-molecular weight aggregates are detected (bracket). 
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 Figure  2.6: Effect of excess monoubiquitin on the association of HeLa lysate polyubiquitin proteins. 
Effect of excess monoubiquitin on the association of uncharacterized polyubiquitinated proteins present within HeLa 
cell lysate with 5 μg of immobilized GST or GST-epsin 1 UIM3. Approximately 10-fold more of each pellet (P) 
fraction compared to the corresponding supernatant (S) fraction was resolved by SDS-PAGE and stained with 
Coomassie blue or transferred to nitrocellulose and probed with anti-ubiquitin antibodies. Again note that at high 
concentrations of added monoubiquitin (lane i) nonspecific high-molecular weight aggregates are detected (bracket). 
GST-S5a affinity isolates the same set of proteins from the HeLa cell lysate and essentially identical results are 
obtained using the anti-polyubiquitin mAb FK2. 
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over monoubiquitin [153]. Importantly, the marked preference of the epsin 1 UIM3 domain for 
polyubiquitin does not change when the protein associates with a PtdIns(4,5)P2-containing 
bilayer. Bound to a liposome surface, the epsin 1 ENTH domain fails to associate with either 
mono- or polyubiquitin (Figure 2.7, lane d and f), but the epsin 1 ENTH+DPW segment 
(residues 1-407, which encompasses the UIM3 segment; Figure 2.1A) selectively binds higher-
order Lys48-linked polyubiquitin chains (lane l) over mono- or diubiquitin (lane j and l). This 
result is significant because His68, located on the periphery of the common hydrophobic 
interaction surface upon the ubiquitin molecule, is reported to interfere with UIM engagement 
[154, 155] and it is suggested that protonation, possibly promoted by a phosphoinositide-created 
low pH environment, might regulate UIM engagement [155].  
It has recently been proposed that epsin 1 binding to ubiquitin or AP-2 and clathrin are 
mutually exclusive events, and that epsin 1 promotes the internalization of ubiquitinated cargo 
molecules in a clathrin-independent manner [145, 146]. Yet, upon liposomes, epsin 1 (residues 
1-407) associated with both AP-2 and clathrin is still able to interact with polyubiquitin, while 
AP-2 and clathrin do not (Figure 2.8, lane h compared to lanes b and f). A substantial fraction of 
the bound polyubiquitin chains sediments following solubilization of the liposome membrane 
with Triton X-100 (lane j), indicative of incorporation into extensive polyhedral clathrin 
assemblies. Obviously, epsin 1 (1-407) alone is also able to bind clathrin and conjugated 
ubiquitin oligomers when associated with the liposome surface (lane d). Although we cannot be 
certain that each epsin molecule is bound simultaneously to both AP-2 and clathrin under these 
conditions, the relative stoichiometries (lanes d and j) suggest numerous contacts are possible 
and, after Triton X-100 solubilization, the epsin must be bound to either AP-2 or clathrin to 
sediment with the coat assemblage.  
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 Figure  2.7: Productive association of epsin 1 with polyubiquitin chains in the context of phosphoinositide 
containing liposomes. 
PtdIns(4,5)P2-containing liposomes were preincubated with 20 μg of either epsin 1 ENTH or ENTH+DPW domain 
and, after centrifugation and liposome resuspension, 12 μg of ubiquitin or 6 μg of Lys48-linked ubiquitin chains 
added as indicated. Following centrifugation, 8-fold more of each pellet (P) compared to each supernatant (S) 
fraction was resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose and 
probed with anti-ubiquitin antibodies. 
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 Figure  2.8: Productive association of epsin 1 with polyubiquitin chains in the presence of AP-2, clathrin, and 
phosphoinositide containing liposomes. 
PtdIns(4,5)P2-containing liposomes were incubated with 5 μg epsin 1 (1-407) and 8 μg AP-2 and then, after 
centrifugation and liposome resuspension, with 5 μg clathrin and 6 μg Lys48-linked ubiquitin chains as indicated. 
After the second-stage incubation, Triton X-100 was added to one tube to 1% and, following centrifugation, 
approximately 8-fold more of each pellet (P) compared to each supernatant (S) fraction was resolved by SDS-PAGE 
and either stained with Coomassie blue or transferred to nitrocellulose and probed with anti-ubiquitin antibodies. 
Note that in the absence of Triton, faint staining of acidic phospholipids can be seen at the bottom of the stained gel. 
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Because epsin 1 contains two clathrin-binding sites that flank the eight tandemly arrayed, AP-2-
binding DPW motifs (Figure 2.1A) the protein binds physically to clathrin [118, 156] and alone 
can assemble clathrin trimers into polyhedral cages [157]. When bound to assembled clathrin, 
epsin 1 (144-575) promotes the cosedimentation of polyubiquitin, but not monoubiquitin, with 
the cages (Figure 2.9, lane d). Similarly, epsin 1 (144-575) immobilized upon glutathione-
Sepharose containing the DPW-binding AP-2 α appendage associates with higher-order 
polyubiquitin chains (Figure 2.10, lane d) while neither the immobilized α appendage nor GST 
interacts with the added ubiquitin (lanes b and f). These experiments demonstrate that epsin 1 
physically bound either to clathrin or AP-2 can still associate productively with polyubiquitin but 
not monoubiquitin. Importantly, native epsin 1 and eps15, affinity isolated from brain cytosol 
using a GST-α appendage (R916A) mutant that selectively binds to these two endocytic proteins, 
associate with higher-order polyubiquitin chains but not with mono- or diubiquitin (Figure 2.11, 
lane f). This result is in accord with a recent study showing epsin 1 coimmunoprecipitates a 
group of uncharacterized ubiquitinated cellular proteins [152]. And lastly, when fused to GST, a 
ubiquitin-specific-protease-resistant linear tetraubiquitin efficiently affinity isolates endogenous 
epsin and eps15, as well as S5a and Hrs, from brain extracts (Figure 2.12, lane f). These proteins 
do not associate comparably with a single ubiquitin attached to GST (lane d), although the E1 
ubiquitin-activating enzyme does bind GST-ubiquitin. Overall, we conclude minimally that epsin 
1 is able to associate with polyubiquitin chains when simultaneously bound to other clathrin coat 
constituents such as AP-2 or clathrin. 
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Figure  2.9: Incubation of epsin 1 with polyubiquitin chains and preassembled clathrin cages. 
Mixtures of 25 μg preassembled clathrin cages and 0.1 mg/ml BSA with or without 15 mg His6-epsin 1 (144-575) 
were preincubated and then recovered by centrifugation before a second incubation in the presence of 6 μg Lys48-
linked polyubiquitin chains. After centrifugation, threefold more of each pellet (P) than each supernatant (S) was 
resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose and probed with 
anti-ubiquitin or anti-epsin antibodies. The recombinant epsin is prone to proteolytic degradation. 
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Figure  2.10: Binding of polyubiquitin chains to epsin 1 associated with AP-2 α appendage. 
Binding of Lys48-linked polyubiquitin chains to 15 μg epsin 1 (144-575) associated with 25 μg immobilized GST or 
GST-AP-2 αC appendage. After centrifugation, fivefold more of each pellet (P) than each supernatant (S) was 
resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose and probed with 




 Figure  2.11: Binding of polyubiquitin chains to endogenous epsin 1 and eps15. 
Binding of Lys48-linked polyubiquitin chains to endogenous epsin 1 and eps15 associated with 100 μg immobilized 
GST or GST-AP-2 αC appendage (R916A). After centrifugation, ~7-fold more of each pellet (P) than each 
supernatant (S) was resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose 
and probed with anti-ubiquitin, or anti-epsin antibodies. Open arrowheads indicate non-specific cross-reactive 
bands. 
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 Figure  2.12: Binding of endogenous endocytic and ubiquitin components to various ubiquitin GST fusion 
proteins. 
Binding of endogenous endocytic and ubiquitination components within brain cytosol to GST, GST-ubiquitin or a 
ubiquitin-protease-resistant linear GST-tetraubiquitin. After centrifugation, ~5-fold more of each pellet (P) than each 
supernatant (S) was resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose 
and probed with antibodies directed against the indicated proteins. The stained gel shows numerous proteins 
associate with the immobilized linear tetraubiquitin (lUb4). Presumptive degradation products are indicated by the 
asterisks while non-specific cross-reactive bands, which remain in the supernatant (S), are indicated by the open 
arrowhead. The weak recovery of AP-2 most probably reflects a secondary association with the immobilized epsin 1 
and eps15.  
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2.3.1 Subcellular Localization of Epsin and Eps15 
Because epsin and eps15 have been suggested to sort ubiquitinated cargo into caveolae [145, 
146], we examined the localization of these two proteins in several cell lines by both light and 
electron microscopy. The intracellular distribution of endogenous epsin 1 is highly coincident 
with AP-2 in NRK (Figure 2.13A-D), HeLa (Figure 2.14A-D), and A431 (Figure 2.15A-D) cells 
at steady state. In NRK cells, >87% of the epsin-positive structures contain AP-2, while >79% of 
AP-2 structures also stain for epsin 1. Colocalization occurs not only at the ventral plasma 
membrane, but also along the entire cell surface (Figure 2.13M). By contrast, two different 
antibodies against caveolin-1, a marker for caveolar/raft-dependent endocytic structures, fail to 
reveal substantial colocalization of caveolin-1 with either epsin 1 (<3%) or AP-2 (<8%) in NRK 
(Figure 2.13E-L) or HeLa (Figure 2.14E-H) cells. The spatial segregation of epsin from caveolae 
is confirmed by freeze-etch ultrastructural studies (Figure 2.13N). Despite high density labeling 
of polyhedral clathrin lattices on the surface with anti-epsin antibodies, caveolae, definitively 
identified by the characteristic whorl-like morphology, are essentially unlabelled. These data 
argue against epsin being a significant component of caveolae in these cells under normal 
conditions.  
After serum starvation, stimulating cultured cells with high concentrations of EGF (> 5 
ng/ml) is reported to promote epsin/eps15-dependent EGF receptor internalization within 
caveolae in addition to clathrin-coated vesicles [145]. Yet, after briefly stimulating A431 cells 
with saturating concentrations (100 ng/ml) [158] of EGF, there is little evidence of major 
redistribution of either epsin or eps15 from AP-2/clathrin-containing structures (Figure 2.15 and 
2.16). A431 cells express millions of EGF receptors [159, 160] but we do not find major 
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Figure  2.13: Epsin 1 is a component of the endocytic clathrin coat in vivo. 
A-D) A representative single optical section of methanol-fixed NRK cells stained for epsin 1 (green) and AP-2 (α 
subunit, red). Magnifications of the boxed region in A are shown in B-D with the arrowhead indicating an AP-2-
positive structure lacking epsin 1 staining. E-H) A representative single optical section of paraformaldehyde-fixed 
NRK cells stained for caveolin-1 (green) and AP-2 (α subunit, red). Magnifications of the boxed region in E are 
shown in F-H. I-L). A representative single optical section of methanol-fixed NRK cells stained for epsin 1 (green) 
and caveolin-1 (mAb, red). Magnifications of the boxed region in I are shown in J-L. M) X-Z projection of NRK 
cells stained with antibodies against epsin 1 (green) and AP-2 (α subunit, red). Scale bar is 10 μm. N) Freeze-etch 
analysis of NRK cell membranes stained with anti-epsin antibodies and 15 nm colloidal gold-conjugated secondary 
antibodies, visible as white spheres. Caveolae are indicated by the arrows on the left, and magnified views of three 
epsin/gold-containing clathrin lattices are shown in the right panels. Scale bar is 100 nm. 
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 Figure  2.14: Absence of epsin 1 in caveolae in HeLa cells. 
A representative single optical section of paraformaldehyde-fixed HeLa cells stained for AP-2 (α subunit, green) 
and epsin 1 (red). Magnifications of the boxed region in A are shown in B-D with the arrowheads indicating AP-2-
positive structures lacking epsin 1 staining. E-H) A representative single optical section of paraformaldehyde-fixed 
HeLa cells stained for AP-2 (α subunit, green) and caveolin-1 (red). Magnification of the boxed region in E are 
shown in F-H. Scale bar is 10 μm. 
 
  49
 Figure  2.15: Absence of major reorganization of epsin upon EGF internalization in A431 cells. 
Serum-starved A431 cells were incubated either without (A-D and M-P) or with 100 ng/ml Alexa488-conjugated 
EGF for 5 (E-H and Q-T) or 10 min (I-L and U-X) before fixation. A representative single optical section of the 
methanol-fixed A431 cells stained for epsin 1 (red) and either AP-2 (α subunit, blue) (A-L) or caveolin-1 (blue) (M-
X) is shown. Magnifications of the boxed regions in A, E, I, M, Q, and U are shown in B-D, F-H, J-L, N-P, R-T, and 
V-X, respectively. Scale bar is 10 μm. 
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 Figure  2.16: Co-localization of eps15 with AP-2 in EGF-stimulated HeLa and A431 cells. 
Serum-starved HeLa (A-D and I-L) or A431 (E-H and M-P) cells were stimulated with 100 ng/ml Alexa488-EGF 
for 5 min prior to fixation. A single representative optical section of methanol-fixed cells stained for eps15 (red) and 
either AP-2 (α subunit, blue) (A-H) or caveolin-1 (blue) (I-P) is shown, with the magnifications of the boxed regions 
shown in on the right of each panel. Scale bar is 10 μm. 
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reorganization of either epsin or eps15 under conditions that stimulate internalization (Figure 
2.15I and J) and extensive ubiquitination of EGF receptors. Less than 5% of either epsin 1 or 
eps15 colocalize with the caveolin-1 signal as opposed to ~80% coincidence of epsin and >90% 
of eps15 with AP-2 in A431 cells, both before and after EGF addition. Similarly, epsin (data not 
shown) and eps15 (Figure 2.16) remain extensively colocalized with clathrin-coated structures in 
HeLa cells treated with 100 ng/ml EGF. Thus, we find no evidence for bulk changes in cellular 
epsin 1 or eps15 localization or prominent redistribution during uptake of the EGF receptor; we 
favor the notion that these endocytic proteins appear to function chiefly in clathrin-mediated 
endocytosis. Our results are also concordant with recent observations showing that decorin-
driven internalization and subsequent degradation of unactivated EGF receptors is caveolin 
dependent, but that ligand-activated EGF receptors enter the cell via clathrin-mediated 
endocytosis even at relatively high EGF concentrations [161]. They are also consistent with the 
recent finding that caveolae-dependent uptake of tight junction components in MDCK cells is 
insensitive to the effects of dominant-negative eps15 [162].  
2.3.2 CLASPs and Ubiquitinated Cargo in Clathrin-Coated Vesicles 
The biochemical experiments outlined above suggest that for designated cargo to be 
efficiently sorted by tandemly-arrayed UIMs, polyubiquitination rather than monoubiquitination 
might be required. To begin to analyze this issue, we first compared clathrin-coated vesicle 
preparations purified from either brain or placental tissue. Both populations of vesicles are highly 
enriched in the core clathrin-coat components, clathrin trimers, and AP-1/AP-2 adaptor 
heterotetramers (Figure 2.17). The brain-coated vesicles also clearly demonstrate, by altered 
electrophoretic
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 Figure  2.17: Cargo and clathrin-associated sorting protein enrichment in clathrin-coated vesicles from 
different tissues. 
Samples of 25 μg of rat brain or placenta cytosol or 10 μg of purified clathrin coated vesicles were resolved by SDS-
PAGE and either stained with Coomassie blue or transferred to nitrocellulose and probed with antibodies directed 
against the indicated proteins. Presumptive degradation products are indicated by the asterisks while, a non-specific 
cross-reactive band is indicated by the arrowhead. For the anti-EGF receptor immunoblot, the top of the gel is 
indicated by the open arrowhead. pAb is polyclonal antibody. 
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mobility, the occurrence of neural-specific isoforms of the basic clathrin coat machinery. Brain 
coated vesicles contain epsin, eps15, and AP180, although none of these proteins are enriched in  
parallel with core coat constituents. Strikingly though, the placental coated vesicles are 
significantly enriched in both cargo-selective CLASPs, and contain various cargo molecules 
including the transferrin, EGF, and insulin receptors and LDL receptor-related protein 1 (LRP1). 
The different representation of signaling and cargo receptors in these clathrin-coated vesicle 
preparations undoubtedly reflects the different overall function of these transport intermediates; 
at the synapse, coated vesicles are almost completely dedicated to retrieval of synaptic vesicle 
membrane and hence the paucity of signaling receptors [163]. 
Both epsin 1 and eps15 are enriched in the placental vesicles, and this correlates with the 
marked concentration of ubiquitin-protein conjugates in this preparation, as judged by both 
polyclonal anti-ubiquitin-protein conjugate and mAb anti-ubiquitin antibodies. Thus, there 
appears to be a cargo-selective enrichment of CLASPs in placental-coated vesicles, with the 
enrichment of UIM-bearing proteins correlating with the preferential inclusion of ubiquitin 
conjugates. It is intriguing that transcripts for two transmembrane RING-type E3 ubiquitin 
ligases, termed MARCH IV and IX, which are both capable of downregulating surface 
expression of major histocompatibility complex (MHC) class I molecules via ubiquitination, are 
very highly expressed in placenta [164].  
2.3.3 Polyubiquitin Versus Monoubiquitin Triggered Endocytosis 
To better understand whether polyubiquitin represents a more efficient internalization signal than 
monoubiquitin in vivo, the uptake of several chimeras of Tac (the IL-2 receptor α subunit or 
CD25) fused to ubiquitin (Figure 2.18A) was analyzed in transiently transfected HeLa cells.  
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 Figure  2.18: Schematic depiction of Tac and Tac-ubiquitin chimeras used and lysates of HeLa cells 
transfected with the chimeras. 
A) Schematic depiction of the organization of Tac and the Tac-ubiquitin chimeras used. TM is transmembrane 
segment. B) Detergent lysates (~30 μg/lane) from HeLa cells transiently transfected with the indicated Tac 
constructs were resolved by SDS-PAGE, transferred to nitrocellulose and probed with antibodies directed against 
Tac, epsin 1 or actin. The immature glycosylated ER forms of Tac are indicated by the open arrowheads while the 
presumptive polyubiquitinated forms of TacL-UbΔGG are bracketed. 
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Lysates from the transfected cells confirm expression of the various Tac proteins, 
oligosaccharide processing, and the stability of the linearly-linked tetraubiquitin adduct, which is  
expected to be generally oriented similarly to the extended Lys63-linked ubiquitin chain [165]. 
The overall abundance of the TacL-lUb4ΔGG is much lower than either the TacL or TacL-UbΔGG 
(Figure 2.18B) and, similarly, surface expression of the TacL-lUb4ΔGG is generally substantially 
less than either the TacL or TacL-UbΔGG proteins. Crucially, using surface-bound anti-Tac 
antibodies to follow internalization, TacL-lUb4ΔGG and Alexa488-transferrin are efficiently taken 
up into common endocytic structures upon warming to 37°C (Figure 2.19I-K). This indicates that 
the two transmembrane proteins, TacL-lUb4ΔGG and the transferrin receptor, follow a common 
clathrin-dependent trajectory into the cell interior. Frequently in the transiently transfected cells 
expressing TacL-lUb4ΔGG, these two endocytic markers are located in exaggerated EEA1- and 
cation-independent mannose 6-phosphate receptor-positive endosomes, albeit within distinct 
endosome subdomains (Figure 2.19L,M). At 20 min, antibody uptake experiments show that a 
single ubiquitin-derivatized Tac (TacL-UbΔGG) is internalized poorly by comparison (Figure 
2.19F-H), while TacL only appears to enter the cell at the basal rate of bulk membrane turnover 
(Figure 2.19C-E).  
The TacL-UbΔGG protein cannot be activated by the cellular E1 activating enzyme 
(because Gly75 or G76 required for conjugation are deleted), but additional ubiquitin molecules 
could still be conjugated to acceptor lysine residues present within the fused ubiquitin; indeed, 
several higher molecular-weight forms of the TacL-UbΔGG are detected within lysates (Figure 
2.18B). To evaluate whether conversion of the single ubiquitin to a polymeric chain affects 
internalization of the TacL-UbΔGG protein, we also analyzed a Lys-for-Arg substituted TacL-
UbΔGG (TacL-Ub(K7R) ΔGG), which does not show the extra slower-migrating bands (Figure 
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 Figure  2.19: In vivo activity of polymeric ubiquitin as an endocytosis signal. 
C-K) HeLa cells transiently transfected with TacL (C-E), TacL-UbΔGG (F-H) or TacL-lUb4ΔGG (I-K) were incubated 
on ice with a mixture of 4 μg/ml anti-Tac mAb (green) and 25 μg/ml Alexa568-transferrin (red) for 60 min before 
warming to 37°C for 20 min. Representative single optical sections (panels C,D,F,G,I,J) or three-dimensional (3-D) 
reconstructions of X-Z image stacks (panels E, H, K) from fixed cells are shown. L-M) HeLa cells transiently 
expressing TacL-lUb4ΔGG as in I-J were stained for Tac (green), Alexa568-transferrin (red) or EEA1 (L, blue) or the 
cation-independent mannose 6-phosphate receptor (CI-MPR; M, blue). Color-separated magnified images of the 
mosaic Tac-positive endosomes (panel M) are shown. Scale bar is 10 μm. 
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2.18B). In short antibody uptake experiments, neither form of single ubiquitin fusion is rapidly 
internalized compared with the tetraubiquitin TacL-lUb4ΔGG (Figure 2.20A-H). We suspect that  
the quantitatively minor polyubiquitinated forms of TacL-UbΔGG seen on immunoblots (Figure 
2.18B) are responsible for low-level Tac-UbΔGG internalization observed (Figure 2.19 panel C 
and D). As numerous Tac-positive puncta accumulate in transfected cells after a 6-hour treatment 
with the lysosomal protease inhibitors leupeptin and pepstatin A (data not shown), we conclude 
that the reduced level of TacL-lUb4ΔGG at the surface and within the cell reflects, in part, the 
rapid internalization of this construct and efficient, ubiquitin-dependent trafficking toward the 
lysosomal compartment. The appearance of aberrant endosomes in these cells is presumably 
related to the inability of the linearly-linked ubiquitin to be efficiently deubiquitinated by cellular 
isopeptidases. We believe that these experiments show clearly that a linear polyubiquitin chain is 
superior to an unextendable monoubiquitin in promoting endocytosis in cultured cells. 
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 Figure  2.20: Comparison of mono- vs. polyubiquitin-conjugated Tac uptake. 
HeLa cells transiently transfected with TacL (A, B), TacL-UbΔGG (C,D), TacL-Ub(K7R)ΔGG (E,F), or TacL-lUb4ΔGG 
(G,H) were incubated with 4 μg/ml anti-Tac mAb at 37°C for either 5 (A,C,E,G) or 10 min (B,D,F,H). After rapid 
cooling on ice, the cells were fixed and extracellular anti-Tac (red) detected with Alexa568-coupled anti-mouse IgG 
while intracellular anti-Tac (green) was labeled subsequently with Alexa488-conjugated anti-mouse IgG following 
saponin permeabilization. Representative single optical sections are shown and, because of the very high level of 
expression of the TacL, TacL-UbΔGG and TacL-Ub(K7R)ΔGG proteins and poor to negligible internalization, the 




In this study, we have plainly demonstrated that the preferred binding partner for the multiply-
arrayed epsin 1 and eps15 UIMs is polyubiquitin, as is true for the UIMs of S5a [150]. In full 
accord with the grossly unstructured polypeptide main chain of the carboxy-terminal segment of 
epsin 1 [72, 157], we find that polyubiquitin engagement is still manifest when epsin is attached 
to a PtdIns(4,5)P2-containing bilayer surface, AP-2, and/or clathrin, and that, under normal 
circumstances, epsin 1 and eps15 appear to be essentially absent from caveolar structures. Taken 
altogether, these results question the recent assertion that epsin and eps15 promote the 
internalization of monoubiquitinated cargo in a clathrin-independent fashion [145, 146]. Instead, 
in conjunction with the accompanying findings of Barriere et al. [166], we believe that these 
endocytic proteins are appropriately positioned within the assembling clathrin lattice to act as 
ubiquitin-selective CLASPs.  
2.4.1 UIM Ubiquitin Selectivity 
A single UIM is an amphipathic α-helical element (Figure 2.1B) that engages a hydrophobic 
surface upon the ubiquitin molecule generated in part by residues Leu8, Leu43, Ile44, Gly47, 
His68, and Val70 [155, 167-169]. Although different individual UIMs can associate with 
ubiquitin monomers with moderate affinity (Kd ~200-1000 μM), given the purported role of 
monoubiquitin as an internalization signal [125], the affinity for the UIMs is “surprisingly weak” 
[169]. Isolated UIMs are able to associate with ubiquitin-like (UbL) domains of proteins like 
HR23A with better affinity (Kd ~3-12 μM) [154, 155], but a valine substituted for ubiquitin 
residue His68 appears to be an important determinant of the higher affinity that UbL proteins 
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display for UIMs [154, 155]; and UbL domain lysines can be modified by E3 enzymes to create 
polyubiquitin chains anchored to the UbL [170, 171]. Our analysis shows that the fundamental 
binding properties of the epsin 1 (and eps15) UIM3 segment are remarkably similar to those of a 
genuine polyubiquitin chain receptor S5a [150, 172], the protein that was used to identify the 
functional UIM domain [117]. Both bind robustly to polyubiquitin chains coupled by either 
Lys48 or Lys63 linkage. Lys63-linked chains are known to promote endocytosis in yeast [173] 
and facilitate proteasome-mediated proteolysis when appended to a model substrate [174]. 
Ubiquitin binding is cooperative [150]; tandemly arrayed epsin UIMs are required for efficient 
binding to polyubiquitin. This is consistent with endocytosis in S. cerevisiae, where Vps27p and 
Hse1p are mutually interacting, UIM-harboring sorting molecules that aid in the ubiquitin-
dependent involution of designated cargo into the lumen of multivesicular bodies [175]. Vps27p 
contains two UIMs and both are needed for ubiquitin binding, while Hse1p contains only a single 
UIM and, alone, is unable to bind ubiquitin [175]. Other multiple UIM-containing proteins are 
also judged to preferentially bind polyubiquitin chains [176, 177]. Most importantly, though, we 
find that a single unextendable ubiquitin is insufficient to promote rapid endocytosis. A linear, 
ubiquitin-protease-resistant chain is far more effective at driving uptake from the cell surface. 
Ongoing molecular dissection of the ubiquitin–proteasome system in S. cerevisiae 
indicates that there may be two (or more) parallel tracks for substrate delivery to the proteasome 
[172, 178]. The dichotomy reflects, in part, the size of the appended polymeric ubiquitin tag. 
Longer chains utilize Rpn10p (S5a) to engage the 19S complex while shorter chains appear to 
use the UbL/UBA proteins Rad23p and Dsk2p for targeting to the proteasome [178]. Yet, 
Rpn10p and Rad23p can operate redundantly in the degradation of certain model substrates 
[172]. Irrespective, the minimum chain length necessary to specify efficient proteasomal 
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degradation is four to six covalently-conjugated ubiquitins [99, 150, 178, 179]. This is in general 
accord with our observations and suggests that it seems unlikely that an as yet uncharacterized 
endocytic UbL/UBA protein, such as hPLIC/ubiquilin, governs the recognition of 
monoubiquitinated cargo at the clathrin bud site [171].  
Because available structural information shows that the UIM helix interfaces with only a 
single ubiquitin monomer [151, 155, 167-169], and as Lys48- and Lys63-linked ubiquitin 
polymers have different geometries [165, 180], we do not invoke the recognition of a unique 
structural feature of polyubiquitin chains by the UIM, as is seen with the Lys48-linked 
polyubiquitin and HR23A [180] or Mud1p [181] UBA domains. Instead, our interpretation of the 
current information is that avidity effects allow polyubiquitinated cargo molecules to engage 
UIM-containing CLASPs massed at clathrin assembly zones on the surface [151]. These 
observations also rationalize the evolutionary conservation of the polyubiquitin-binding UIM 
amongst regulatory components of the proteasome and clathrin-coat machinery [117]. On the 
basis of reactivity with mAb FK1, which apparently detects polyubiquitin chains but neither 
monoubiquitinated proteins nor free ubiquitin [182], or experiments with K7R-type ubiquitin, 
several receptors (particularly receptor tyrosine kinases) appear to be multiply 
monoubiquitinated [122, 183, 184]. Avidity-driven recognition of ubiquitin by UIMs (in cis or 
trans) positioned within the clathrin assembly zone is also compatible with selection of multiply 
monoubiquitinated receptors. While an individual monoubiquitination event or the in-frame 
fusion of a single ubiquitin may be sufficient for endocytosis of certain receptors, even in S. 
cerevisiae, where ubiquitin represents the major endocytic signal [38, 125, 147], multiubiquitin 
does seem to be appended to Ste2p under normal conditions [122] and, like other heptahelical G 
protein-coupled receptors, Ste2p might also dimerize upon ligand binding.  
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Our current work does not address monoubiquitination of epsin and eps15 and how this 
contributes to the overall operation or regulation of clathrin-mediated endocytosis, but it should 
be considered that the general failure to detect heavily polyubiquitinated cargo molecules in 
biochemical experiments could be related, in part, to the catalytic activity of abundant cellular 
deubiquitinating enzymes. In this regard, there exist modular josephin domain-containing 
deubiquitinating enzymes, such as ataxin-3, that also contain tandem UIMs to target them to 
polyubiquitin chains [176, 177]. Still other deubiquitinating isopeptidases, such as mUBPY that 
associates indirectly with the EGF receptor [185], could also modulate the ubiquitination state of 
receptors.  
2.4.2 A Poly/Multiubiquitin-Based Endocytic Sorting Signal 
In considering a role for ubiquitin chains as an endocytic signal, it is worth noting that Rsp5p, 
the S. cerevisiae HECT-type E3 ubiquitin ligase required for endocytosis [186] that is 
structurally and functionally related to vertebrate Nedd4, is clearly able to preferentially 
synthesize Lys63-linked polyubiquitin chains [187], and conjugation-competent Lys63 ubiquitin 
is required for efficient endocytosis of some transmembrane proteins in yeast [173, 188]. It has 
also just been reported that Lys63-linked polyubiquitination drives efficient internalization of the 
TrkA receptor in mammalian cells [189]. Significantly, an Rsp5p-associated deubiquitinating 
enzyme termed Ubp2p disassembles Lys63-linked polyubiquitin chains [187]. Thus, complex 
cycles of ubiquitination/deubiquitination appear to be subject to tight temporal regulation 
intracellularly. Suitably positioned deubiquitinating isopeptidases could cleave polymeric 
ubiquitin from cargo molecules promptly following cargo selection, making identification and 
isolation of extensively ubiquitinated proteins difficult. Likewise, the extensive 
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polyubiquitination that triggers endocytosis of the TrkA and TrkB receptor tyrosine kinases is 
negatively modulated by the p75 neurotrophin receptor [190].  
Strong functional evidence for polyubiquitin acting as a physiological and direct 
internalization tag comes from the action of viral-encoded, RING variant-type transmembrane 
E3 ubiquitin ligases that very efficiently downregulate surface expression of host cell 
transmembrane immunoreceptors [191-194]. These E3s robustly polyubiquitinate MHC class I, 
B7.2, ICAM-1, and CD1d to rapidly remove these transmembrane proteins from the surface of 
virus-infected cells, and a polypeptide ladder revealing the posttranslational addition of at least 
four ubiquitin monomers is clearly visible on MHC class I molecules [193]. Given the 
physiological role of these virally encoded E3 ligases, they are unlikely to have evolved binding 
sites for cognate deubiquitinating enzymes and this, along with the concentration and catalytic 
activity of the ligases, may explain why polyubiquitinated transmembrane substrates are easier to 
detect in cells expressing these E3s or infected with virus.  
Further compelling genetic and functional evidence of the importance of ubiquitination in 
promoting endocytic uptake comes from the Notch signaling pathway in Drosophila. The S3 
proteolytic cleavage event necessary for the translocation of the signaling Notch intracellular 
domain into the nucleus depends upon the co-internalization of the extracellular region of Notch, 
bound to the transmembrane ligand Delta, into the Delta-expressing signal-sending cell [195]. 
Endocytosis of Delta is both ubiquitin and epsin dependent [196-198]. Two RING-type E3 
ubiquitin ligases, Neuralized and Mind bomb, can ubiquitinate Delta as a prelude to clathrin-
mediated endocytosis governed by Liquid facets [196-198], the Drosophila epsin orthologue 
[199]. Substitution of the endogenous Delta cytosolic domain with a portion of the cytosolic 
region of the LDL receptor containing an FXNPXY internalization motif negates the requirement 
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for Liquid facets in Delta operation [200]. This attests to the active role that ubiquitination plays 
in receptor uptake and argues that regulated ubiquitination clearly represents a reversible 
internalization signal. Results from the Drosophila system are also consistent with the poor 
capability of a single ubiquitin chain to promote efficient endocytosis. Within wing imaginal 
discs, clones expressing a form of Delta with the cytosolic domain replaced with a single 
ubiquitin molecule are only able to drive the expression of the early-acting Notch target Vestigial 
boundary enhancer, and not downstream Notch-activated proteins like the homeodomain protein 
Cut, or the secreted morphogen Wingless at the developing wing margin [200]. This is in 
contrast to the Delta-LDL receptor chimera, or a Delta receptor with a random, lysine-
containing, polypeptide region substituted for the natural cytosolic domain; clones expressing 
either of these Delta constructs are able to activate Cut expression [200]. Taken together with our 
results, and those in the accompanying studies by Barriere et al. [166], we believe there is now 
strong functional evidence that epsin, together with eps15, operates as a CLASP capable of 
recognizing and packaging poly/multiubiquitin-based internalization signals into clathrin-coated 
vesicles forming at the cell surface of mammalian cells.  
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2.5 ADDITIONAL DATA 
 
Figure  2.21: ENaC interaction with epsin UIM domains is enhanced by their conjugation to ubiquitin. 
Each ENaC subunit alone, or conjugated to three tandem ubiquitins was in vitro translated in the presence of [35S] 
methionine, and equal amounts of isotope were then incubated with GST, GST-UIM, or GST-epsin constructs as 
described under “Materials and Methods.” Samples were then incubated with glutathione-Sepharose beads and the 
beads were spun down. Samples from both pellet (P) (bound to beads) and supernatant (S) were then separated by 
SDS-PAGE and analyzed on a phosphorimager. Ubiquitin conjugated β–ENaC conjugate aggregated on entry to the 
10% SDS gels and did not fully migrate, therefore, ENaC samples were separated on 8% SDS-PAGE with 8M urea. 
In vitro translated α, β, and γ ENaC were visualized at 79, 72, and 74 kDa, respectively, and were largely recovered 
in supernatant. There is a slight background interaction between unmodified ENaC and both GST and GST-UIM, 
and all three subunits have a weak interaction with GST-epsin, but the majority of the in vitro translate is in the 
supernatant. ENaC fused to ubiquitin runs typically higher in the gels as seen with α, β, and γ subunits visualized at 
107, 100, and 102 kDa respectively. All three ENaC subunits fused to 3 tandem ubiquitins show significant 
accumulation in the pellet of GST-UIM and GST-epsin, indicating an interaction (n=3). 
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3.0  DUAL-ENGAGEMENT REGULATION OF PROTEIN INTERACTIONS WITH 
THE AP-2 ADAPTOR α APPENDAGE* 
*Reprinted from Journal of Biological Chemistry, (2004, volume 279, issue 44, pp. 46191-
46203), with permission from the American Society for Biochemistry and Molecular Biology 
3.1 ABSTRACT 
Clathrin-mediated endocytosis depends upon the coordinated assembly of a large number of 
discrete clathrin-coat components in order to couple cargo selection with rapid internalization 
from the cell surface. Accordingly, the heterotetrameric AP-2 adaptor complex binds not only to 
clathrin and select cargo molecules, but also to an extensive family of endocytic accessory 
factors and alternate sorting adaptors. Physical associations between accessory proteins and AP-2 
occur primarily through DP[FW] or FXDXF motifs, which engage an interaction surface 
positioned on the carboxy-terminal platform subdomain of the independently folded α-subunit 
appendage. Here, we define structurally and functionally a second interaction site on the bilobal 
α appendage, located on the amino-terminal β-sandwich subdomain, that binds to the 
WXX[FW]X[DE] interaction motif found in several endocytic proteins, including synaptojanin 
1, stonin 2, AAK1, GAK and NECAP 1. Both α appendage binding sites can be engaged 
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synchronously, and our data reveal that varied assemblies of interaction motifs with different 
affinities for two sites upon the α appendage can provide a mechanism for temporal ordering of 
endocytic accessory proteins during clathrin-mediated endocytosis.  
3.2 INTRODUCTION 
Clathrin-coated vesicles are a major portal of entry into eukaryotic cells, carrying 
macromolecular nutrients, ligands, select transmembrane proteins, and even viruses into the cell 
interior from the plasma membrane [1, 68]. Cargo selectivity of these short-lived transport 
intermediates is often thought to be governed by a central triad of proteins, the cargo receptors, 
clathrin, and the heterotetrameric AP-2 adaptor complex. Cargo receptors contain cytosolic 
internalization sequences, such as the YXXØ motif (where X is any amino acid and Ø represents 
a residue with a bulky hydrophobic side chain) found within proteins like the receptor for the 
endocytosed iron transport protein transferrin. Several distinct internalization sequences or tags 
are known, each specifying internalization by promoting preferential incorporation into 
assembling clathrin-coated vesicles [38]. Clathrin functions as a trimer of heterodimers, 
composed of three 192-kDa heavy and three 20-25-kDa light chains, that polymerizes to form 
the characteristic polyhedral clathrin lattice [45, 201]. Assembled clathrin appears to act as a 
mechanical scaffold during the process of bud invagination. AP-2, the archetypical sorting 
adaptor, is composed of two large (~100 kDa) subunits (α and β2), a 50-kDa medium μ2 subunit 
and a 17-kDa small σ2 chain [55, 68]. AP-2 binds physically to both clathrin, through the hinge 
and appendage domains of the β2 subunit [70], and to YXXØ-type internalization sequences, via 
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the μ2 subunit, in a phosphorylation-regulated manner [54, 55, 58, 59]. AP-2 is therefore a 
multifunctional protein that couples coat assembly with cargo selection. 
Surprisingly, after siRNA silencing of either the AP-2 α or μ2 subunit mRNA in HeLa 
cells to deplete cellular AP-2 adaptor levels, certain transmembrane receptors, like the EGF and 
LDL receptors, still internalize efficiently in a clathrin-dependent manner [95]. This 
demonstrates that AP-2 is not absolutely essential for clathrin-mediated endocytosis in cultured 
mammalian cells. Yet, siRNA knockdown of AP-2 decreases the abundance of clathrin-coated 
structures at the cell surface >90% [95], and severe mutation AP-2 α subunit in Drosophila 
melanogaster [94] or targeted disruption of the μ2 subunit genes in mice (J. Bonifacino, pers. 
comm.) is lethal. Thus, the AP-2 adaptor does play a pivotal role in clathrin coat dynamics at the 
plasma membrane.  
In addition to binding YXXØ-type internalization sequences, AP-2 also binds, via the 
independently folded α and β2 subunit appendages that project off the heterotetrameric core, to 
at least twelve endocytic accessory proteins and alternate adaptors [48, 68, 201]. These 
interactions depend upon short interaction motifs or ligands often tandemly arrayed in 
structurally disordered segments of the AP-2 binding proteins. Two discrete sequences, the 
DP[FW] and FXDXF motifs, bind to a partially overlapping site on the α appendage [72]. 
Several endocytic proteins contain both of these, as well as a recently identified third α 
appendage binding sequence, the WXX[FW]X[DE] motif [82, 135, 202]. While these interaction 
motifs seem responsible, in part, for placement of endocytic accessory proteins and alternate 
adaptors at bud sites on the plasma membrane, how the complex web of protein-protein 
interactions is regulated, how temporally-ordered recruitment is achieved, and the physiological 
benefit of one type of interaction motif over another is currently unknown. In this study we show 
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that the WXX[FW]X[DE] motif engages a Trp-specific binding site on the β-sandwich 
subdomain of the appendage that is distant from the major DP[FW]/FXDXF binding site on the 
platform subdomain of the αC appendage. The sandwich site increases the number of αC 
appendage binding modes and we propose a model for hierarchical protein recruitment based on 
the representation of different interaction motifs with different affinities positioned within 
intrinsically disordered domains of endocytic αC appendage binding proteins.  
3.3 RESULTS 
3.3.1 A Second Functional αc Appendage Binding Site 
The WXX[FW]X[DE] motif occurs in several endocytic proteins, including synaptojanin 1, a 
phosphoinositide polyphosphatase, the Ser/Thr kinases AAK1 and GAK/auxilin 2, which control 
YXXØ-type internalization sequence binding through adaptor μ subunit phosphorylation, and in 
stonin 1/2 and NECAP 1/2, the precise functions of which are currently unknown [82, 135, 202]. 
Like the DP[FW] and FXDXF motifs, the WXX[FW]X[DE] motif binds physically to the AP-2 
α appendage [82, 135, 202]. Yet, in affinity interaction assays in vitro, addition of a 250-fold 
molar excess of a stonin 2-derived 90ISNWVQFEDDTP peptide, which effectively prevents 
NECAP 1 binding and significantly blunts SJ170 interactions with GST-αC appendage (Fig. 
3.1A, lane f compared to lane d), has little effect on the association epsin 1 or amphiphysin I 
with the immobilized appendage [135, 202]. This finding suggests that the WXX[FW]X[DE] 






Figure  3.1: Separable protein interactions with the AP-2 α appendage. 
(A) Approximately 50 μg of either GST (lane a and b), GST-αC appendage (lane c -f), GST-αC appendage (G725N) 
(lane g and h) or GST-αC appendage (Q782A) (lane i and j) immobilized on GSH-Sepharose was incubated with 
PC12 cell lysates in the absence or presence of 3 mM ISNWVQFEDDTP peptide. After centrifugation, aliquots 
corresponding to 1/40 of each supernatant (S) and 1/8 of each washed pellet (P) were resolved by SDS-PAGE and 
either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed with the anti-
synaptojanin 1 antibody AR/1, or anti-NECAP 1 or epsin 1 antibodies, or an anti-amphiphysin or -AP180 mAb. The 
position of the molecular mass standards (in kDa) is indicated on the left and only the relevant portion of each blot is 
shown. The different forms of AP180 in the PC12 cell lysates could be due to alternatively spliced isoforms or 
different posttranslational modifications. (B) Approximately 50 μg of either GST (lane a and b), GST-αC appendage 
(lane c -f), or GST-αC appendage (Q782A) (lane g and h) immobilized on GSH-Sepharose was incubated with rat 
brain cytosol in the absence or presence of 3 mM ISNWVQFEDDTP peptide. After centrifugation, aliquots 
corresponding to 1/60 of each supernatant (S) and 1/8 of each washed pellet (P) were resolved by SDS-PAGE and 
either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed anti-NECAP 1 
or epsin 1 antibodies, or an anti-amphiphysin or -AP180 mAb. The identity of the Coomassie-blue stained αC-
appendage binding partners is indicated and validated by the immunoblots on the right. 
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WXX[FW]X[DE] motif has an absolute requirement for Trp at the 0 position [82], we examined 
the contribution of residues located on the sandwich subdomain of the αC appendage that we 
showed previously create a Trp-specific binding site (Fig. 3.2A-C) [72]. Purified, monomeric αC  
appendage binds to a minimal SJ170-derived (1478SNPKGWVTFEEE; GST-SJ170M1) 
WXX[FW]X[DE] motif immobilized on GSH-Sepharose beads (Fig. 3.3). The majority of the 
αC appendage sediments with the GST-SJ170M1 fusion (lane d) while the appendage remains 
soluble (lane a) in the presence of GST alone (lane b). Alteration of select residues on one face 
of the amino-terminal sandwich, composed of β strands A’, A, B, and E, perturbs the association 
of the αC appendage with the immobilized WXX[FW]X[DE] motif. The effect of a Q782A 
substitution is most severe, while a G725N mutation also blunts appendage binding significantly 
(Fig. 3.4). Based on the structure of the apo-αC appendage [69, 203] (Fig. 3.2B), and an epsin 1-
derived DPW peptide co-crystallized at this site (Fig. 3.2A) [72], we suspect that Gln782 accepts 
a hydrogen bond from the indole nitrogen of the WXX[FW]X[DE] Trp 0, accounting for the 
strict Trp selectivity [82]. The G725N substitution likely fills much of the pocket required to 
accommodate the Trp residue (Fig. 3.2C). Altering several other side chains on the sandwich 
(Table 3.1) reveals that Phe740 is also required for productive interactions with the SJ170 
WXX[FW]X[DE] model protein while a K727A substitution has negligible effect (Fig. 3.3). 
Several other side chains in the vicinity of the sandwich binding pocket do not affect appendage 
binding in this assay when mutated (Table 3.1).  
The spatially distinct WXX[FW]X[DE] binding site on the sandwich subdomain is 
verified by ITC experiments. A synthetic KGWVTFEE peptide corresponding to the SJ170 
WXX[FW]X[DE] motif interacts with the wild-type αC appendage with a Kd of 10.7 ± 0.3 μM 
(Fig. 3.4 & 3.5). Mutations to the platform subdomain which have an affect on DPF (R905A, Kd  
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Figure  3.2: AP-2 schematic with a surface representation of the α appendage. 
(A) Schematic of the AP-2 adaptor based on the crystal structure of the heterotetrameric AP-2 core and showing the 
various protein- and phospholipid-interacting regions. (B) Surface representation of the AP-2 αC appendage showing 
the relative position of the platform binding site and the sandwich subdomain distal DPW surface containing a Trp-
accommodating site. The surface is colored according to sequence conservation (magenta is invariant and yellow 
exhibit a conservation index of 7 or higher as scored by ALSCRIPT). Worm representations of the FXDXF and 
DPW peptides are shown in the platform and distal DPW sites as determined in our previous structural studies. The 
dashed line represents a hypothetical polypeptide chain connecting engagement of the two sites in concert. (C) 
Close-up view of the Trp-selective pocket on the sandwich subdomain. The position of several side chains examined 
in this study is indicated with C atom conservation colored as in Figure 3.2B. The position of the DPW peptide is 




Figure  3.3: A tryptophan-specific WXXF-binding site on the α appendage. 
Approximately 400 μg of either GST (lane a, b, e, f, i, j, and m and n) or GST- SJ170M1(lane c, d, i and j) 
immobilized on GSH-Sepharose was incubated with either thrombin-cleaved, monomeric αC appendage (lane a-d), 
or αC appendage (G725N) (lane e-h), or αC appendage (K727A) (lane i-l), or αC appendage (Q782A) (lane m-p) in 
the presence of carrier BSA. After centrifugation, aliquots corresponding to 1/40 of each supernatant (S) and 1/8 of 
each washed pellet (P) were resolved by SDS-PAGE and either stained with Coomassie blue or transferred to 
nitrocellulose. The blot was probed with the anti-AP-2 α-subunit mAb 100/2. 
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Figure  3.4: ITC measurements of the SJ170 WXXF peptide to AP-2 α appendage. 
ITC measurements of the binding of SJ170 WXXF peptide to wild-type and mutant AP-2 α-appendages. Traces are 
shown after subtraction of data from injection of peptide into buffer blank. The inset shows raw data from SJ170 
WXXF peptide (1 mM) injected into wild-type α-appendage (100 μM) in 10-mL aliquots. 
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Figure  3.5: Kd values from the ITC experiments. 
Dissociation equilibrium constants (Kd’s) derived from the ITC experiments. 
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Table  3.1: Effect of sandwich domain point mutations on binding of the αc appendage to the SJ170 
WXX(FW)X(DE) motif and brain binding partners. 
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= 9 ± 1 μM) and FXDXF (R916A, Kd= 13.8 ± 0.5 μM) motif binding displayed minor 
differences in affinity for the WXX[FW]X[DE] motif peptide. However, mutations in the Trp-
preferential binding site (G725N and Q782A) completely preclude detectable binding of the  
peptide. These results also reflect the strict requirement for the first Trp in the WXX[FW]X[DE] 
motif [82] as substitution of the proximal Trp in the peptide for Ala completely abolishes 
measurable peptide binding (Fig. 3.5).  
In pull-down assays with brain cytosol, Q723A, G725N, F740D, and Q782A mutations 
each completely abolish the association of NECAP 1 (which has a single carboxy-terminal 
272WVQF sequence [202]) with the immobilized αC appendage without perturbing epsin, AP180 
or amphiphysin binding (Fig. 3.1A, 3.1B, and Table 3.1). In this assay, a K727A α appendage 
mutation perturbs soluble NECAP 1 binding less completely (Table 3.1). With PC12 cell 
extracts, the Q782A mutation also significantly blunts SJ170 binding (Fig. 3.1A); we attribute 
the remaining SJ170 binding to the intact FXDXF, DP[FW] (and WXX[FW]X[DE], see below) 
motifs binding to the unaltered platform subdomain site. The apparently normal binding of 
cytosolic SJ170 to GST-αC appendage (G725N) mutant may be related to the relatively weaker 
effect of this mutation on SJ170 binding (Fig. 3.3). Thus, five of the seven residues that generate 
the sandwich subdomain Trp-selection region are variably important for WXX[FW]X[DE] motif 
engagement.  
3.3.2 A Phylogenetically-Conserved α-Subunit Specific Binding Site 
The sandwich subdomain interaction surface appears to have been conserved on the α appendage 
through evolution. Sequence alignments reveal that of the seven key residues that generate the 
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Trp binding site (Fig. 3.2B), three (Gln723, Gly725 and Gln728) are invariant from 
Schizosaccharomyces pombe to mammals and are also conserved in Arabidopsis thaliana (Fig. 
3.6). The remaining residues (Gly714, Val715, Lys727 and Phe740) are all conservatively 
substituted (Fig. 3.6). In fact, surface exposed side chain conservation is only evident on the  
A’/A/B/E sheet of the appendage sandwich as the C/D/F/G strand-containing opposite side 
displays virtually no surface phylogenetic conservation (Fig. 3.6) [69]. The strong sequence 
preservation argues strongly that the interaction surface on the sandwich subdomain plays a 
physiologically important role in AP-2 function.  
The AP-2 β2-subunit appendage, which is structurally and functionally analogous to the 
α appendage [70], does not display a homologous interaction surface at the equivalent position 
on the sandwich subdomain. Indeed, the WXX[FW]X[DE] sequence displays a very high 
selectivity for the α appendage over the β2 (Fig. 3.7, SJ170 and NECAP 1 binding) [82, 135, 
202]. The AP-1 γ-subunit appendage and the structurally homologous GGA protein GAE domain 
[68, 204] bind to a D[FW]GXØ motif [205, 206] superficially similar to the AP-2-binding 
WXX[FW]X[DE]motif. In fact, the AP-1 γ appendage binds a 382WNSF sequence present in the 
hinge of GGA1 [207]. While the γ appendage/GAE domain is composed solely of a β-sandwich 
domain and lacks the platform subdomain characteristic of the bilobal α and β-subunit 
appendages, the binding site for the D[FW]GXØ motif is located on the opposite side of the β-
sandwich from the WXX[FW]X[DE] interaction surface and also lacks the strict specificity for 
Trp at the 0 position [208-212]. Together, these data argue that the WXX[FW]X[DE] binding 
site on the α appendage sandwich plays a unique role in AP-2 activity.  
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Figure  3.6: Evolutionary preservation of the binding site upon the α appendage sandwich. 
Primary sequence alignment of a subunits from Mus musculus (Mm; accession number P17427), Xenopus tropicalis 
(Xt; AAH67918), Homo sapiens (Hs; AAL11040), Drosophila melanogaster (Dm; NP_476819), Anopheles 
gambiae (Ag; XP_310153), Caenorhabditis elegans (Ce; NP_509572), Dictyostelium discoideum (Dd; AAO51059), 
the fungi Gibberella zeae (Gz; XP_381000), Neurospora crassa (Nc; XP_322698), Magnaporthe grisea (Mg; 
EAA53743), Ustilago maydis (Um; EAK81870), Aspergillus nidulans (An; EAA61662), Schizosaccharomyces 
pombe (Sp; NP_595595), and Arabidopsis thaliana (At; NP_197670). Residue numbering and secondary structure 
elements from the mouse αC appendage structure are indicated above while invariant side chains are highlighted in 
pink and chemically conserved substitutions in yellow. Residues that contribute to the WXX[FW]X[DE] interaction 
surface are indicated with a red asterisk. Notice little phylogenetic conservation on the strands (C and D) that form 




Figure  3.7: α appendage platform mutations affect WXXF-containing binding partners. 
Approximately 50 μg of either GST (lane a and b), GST-β2 appendage (lane c and d), GST-αC appendage (lane e 
and f) or the GST-αC appendage point mutants W840A (lane g and h), R905A (lane i and j), or R916A (lane k and l) 
immobilized on GSH-Sepharose was incubated with PC12 cell lysate. After centrifugation, aliquots corresponding 
to 1/60 of each supernatant (S) and 1/8 of each washed pellet (P) were resolved by SDS-PAGE and either stained 
with Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed with the anti-synaptojanin 1 





3.3.3 Multisite α Appendage Engagement 
Human SJ170 has an alternatively-spliced carboxy-terminal extension containing a 
WXX[FW]X[DE], a FXDXF, and two DPF motifs (see Fig. 3.16) [72, 82, 213]. In earlier work, 
we showed that the WXX[FW]X[DE] and FXDXF sequences together promote optimal αC  
appendage engagement [82]. Three lines of evidence suggest that multiple WXX[FW]X[DE] 
motifs, as found in the endocytic protein stonin 2 [134, 135, 214], might enhance α appendage 
binding similarly. First, while addition of a WXX[FW]X[DE] peptide completely abrogates 
binding of the NECAP 1 in PC12 cell extracts to immobilized GST-αC appendage, the peptide 
also weakly inhibits binding of AP180 (Fig. 3.1A, lane f), which does not contain a 
WXX[FW]X[DE] motif. By contrast, a G725N or Q782A mutation prevents NECAP binding but 
has no effect on AP180 association with the mutated αC appendage (Fig. 3.1A, lane h and j). 
Similar experiments using brain cytosol also show that the stonin 2 WXX[FW]X[DE] peptide, 
while abolishing NECAP binding, diminishes the association of AP180 and amphiphysin I and II 
with immobilized αC appendage (Fig. 3.1B lane f compared to lane d). One interpretation of 
these results is that the WXX[FW]X[DE] motif may also bind weakly to the major interaction 
surface on the platform subdomain of the αC appendage, although the ITC data with the αC 
(Q782A) mutant indicate that the affinity of this interaction is poor.  
Second, the binding of cytosolic SJ170 and NECAP 1 to the GST-αC appendage is 
perturbed not only by sandwich domain mutants (G725N, F740D, Q782A, Fig. 3.1A, 3.1B, and 
Table 3.1) but also by the platform domain mutants W840A, R916A, and somewhat less by 
R905A (Fig. 3.7). Interestingly, the reduced recovery of NECAP 1 in the supernatant fractions 
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(compare lanes g, i, and k with lane a and c) together with the trace levels of NECAP 1 in the 
GST-αC appendage pellet fractions (compare lanes h, j, and l with lane f) suggests that the 
platform mutations alter the off-rate of wild type NECAP 1, and the bound pool of protein is lost 
during the washing steps. The position of these modulatory side chains (Trp840, Arg905, 
Arg916) relative to the WXX[FW]X[DE] binding site on the sandwich subdomain (Fig. 3.2A), 
the large buried interfacial surface area between the sandwich and platform subdomains, and 
rigidity of the two subdomains relative to one another [69] makes it unlikely, in our view, that 
these platform mutations propagate a conformational effect to the sandwich subdomain.  
Third, although truncation of the amino-terminal region of stonin 2 containing three 
WXX[FW]X[DE] motifs (Fig. 3.8) to contain two motifs has little effect on AP-2 binding, a 
GST-stonin 2 fusion containing only the first WXX[FW]X[DE] sequence binds AP-2 very 
weakly (Fig. 3.9). Since the GST-stonin 2 is present in large excess in these experiments, the 
data are consistent with the idea that tandemly arrayed WXX[FW]X[DE] motifs cooperate to 
increase the apparent affinity for the AP-2 αC appendage. Similar results are obtained if 
individual WXX[FW]X[DE] motifs are inactivated singly or in combination in the context of a 
GST-stonin 2 (1-247) fusion protein (Fig. 3.10). Again, a single WXX[FW]X[DE] sequence 
shows a marked reduction in AP-2 binding that, given the selectivity of the motif for the α 
appendage, appears inconsistent with a single binding site upon the appendage. 
To extend these observations, we first established whether the amino-terminal portion of 
stonin 2, which contains only WXX[FW]X[DE] motifs, can inhibit partner protein binding to the 
αC appendage platform. Supplementing brain cytosol with 20 μM stonin 2 (1-247) largely 
prevents the association of AP180 and amphiphysin I and II with immobilized GST-αC 




Figure  3.8: Schematic representation of stonin 2 and the constructs used in this study. 
Schematic representation of the organization of human (Hs) stonin 2 and the relative location of the deletion 




Figure  3.9: Binding of the AP-2 adaptor to the stonin 2 WXXF repeats in deletion constructs. 
Approximately 100 μg of either GST (lane a and b), GST-SJ170C2 (residues 1454-1530) (lane c and d), GST-stonin 
2 (1-426) (lane e and f), (1-247) (lane g and h), (1-117) (lane i and j), or (1-30) (lane k and l) immobilized on GSH-
Sepharose was incubated with rat brain cytosol. After centrifugation, aliquots corresponding to 1/40 of each 
supernatant (S) and 1/8 of each washed pellet (P) were resolved by SDS-PAGE and either stained with Coomassie 
blue or transferred to nitrocellulose. Portions of the blots were probed with the anti-AP-2 α subunit mAb 100/2 or 
anti-μ2 subunit serum. Arrowheads indicate the position of the large α and β2 subunits of the AP-2 complex, while 
the asterisks indicate where protein transfer has be reduced by the large amount of GST-fusion protein comigrating 




Figure  3.10: Binding of the AP-2 adaptor to the stonin 2 WXXF repeats in mutant constructs. 
Approximately 100 μg of either GST (lane a and b), GST-stonin 2 (1-247) (lane c and d), (1-247) [W3→A] (lane e 
and f), (1-247) [W2→A] (lane g and h), (1-247) [W1→A] (lane i and j), (1-247) [W2,3→A] (lane k and l), or (1-247) 
[W1,2,3→A] (lane m and n) immobilized on GSH-Sepharose was incubated with rat brain cytosol. After 
centrifugation, aliquots corresponding to 1/40 of each supernatant (S) and 1/8 of each washed pellet (P) were 
resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blots 
were probed with the anti-AP-2 α subunit mAb 100/2 or anti-μ2 subunit serum. Arrowheads indicate the position of 




Figure  3.11: Residues adjacent to the WXXF motifs can contribute to platform binding once bound to the 
sandwich site. 
Approximately 50 μg of immobilized GST (lane a and b) or GST-αC appendage (lane c-k) were incubated with rat 
brain cytosol alone (lane a-d) or with cytosol supplemented with 20 μM stonin 2 (residues 1-247; lane e and f), 20 
μM stonin 2 (1-247) [W1,2,3 →A] (lane g and h), or 20 μM stonin 2 (1-117) (lane i and j). After centrifugation, 
aliquots of approximately 1/40 of each supernatant (S) and 1/6 of each washed pellet (P) were resolved by 
SDS/PAGE and either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blots were 
probed anti-NECAP 1 or epsin 1 antibodies, or an anti-amphiphysin or anti-AP180 mAb. The open arrowhead 
indicates the added wild type stonin 2 (1-247) polypeptide, the closed arrowhead the stonin 2 (1-247) [W1,2,3 →A] 
and the asterisk the stonin 2 (1-117) polypeptide. 
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difference is due to avidity/chelate effects since epsin 1 has eight tandemly arrayed DPW motifs 
while amphiphysin, for example, has only one DPF and one FXDXF motif. In these experiments, 
a portion of the added stonin 2 fragment now associates with the sedimented appendage (open 
arrowhead) and, as expected, NECAP 1 binding is completely abolished. The capability of the 
stonin 2 (1-247) fragment to inhibit when bound at only substoichiometric levels suggests that 
multiple αC appendages can be engaged by a single stonin 2 molecule. An equivalent  
concentration of a stonin 2 (1-247) [W1,2,3→A] mutant fails to bind to the GST-αC appendage 
(arrowhead), and has no effect on the association of either NECAP 1 or AP180 and amphiphysin 
with GST-αC appendage. Surprisingly, addition of a 5-fold molar excess of a smaller segment of 
stonin 2 (residues 1-117), containing only two WXX[FW]X[DE] repeats, inhibits AP180 binding 
very weakly (compare lane j to lane d) without perturbing amphiphysin binding. Nevertheless, 
the stonin 2 (1-117) binds to the immobilized appendage (asterisk) abolishing the NECAP 1 
interaction. These results suggest that other residues adjacent to the WXX[FW]X[DE] motifs can 
also contribute to binding to the platform once the polypeptide is bound to the sandwich.  
To dissect the mode of inhibition further, we analyzed the effect of inactivating the 
sandwich site on the inhibitory action of the stonin 2 (1-247) and SJ170C2 (residues 1454-1530) 
protein segments. When added to cytosol, each segment binds to the GST-αC appendage 
preventing binding of AP180 and amphiphysin as well as NECAP 1 (Fig. 3.12, lanes f and h 
compared to lane d). Similar experiments with immobilized GST-αC appendage (Q782A) reveal 
that an intact sandwich site is necessary for optimal inhibition by both the stonin 2 (1-247) and 
SJ170C2 proteins (lanes l and n compared to lanes d and j). Our interpretation of these results is 
that the WXX[FW]X[DE] motif, by binding to the sandwich site, enhances the affinity of other 
interaction sequences located within these essentially unstructured protein regions for the  
  88
  
Figure  3.12: The WXXF motif enhances the affinity of other sequences for the platform site. 
Approximately 50 μg of immobilized GST (lane a and b), GST-αC appendage (lane c-h), GST-αC appendage 
(Q782A) (lane i-n) were incubated with rat brain cytosol alone (lane a-d) or with cytosol supplemented with 20 μM 
SJ170C2 (residues 1-247) (lane e, f and k, l), or 20 μM stonin 2 (1-247) (lane g, h and m, n). After centrifugation, 
aliquots of approximately 1/40 of each supernatant (S) and 1/6 of each washed pellet (P) were resolved by 
SDS/PAGE and either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blots were 
probed anti-NECAP 1 or epsin 1 antibodies, or an anti-amphiphysin or anti-AP180 mAb. The open arrowheads 
indicate the position of the added wild type stonin 2 (1-247) polypeptide. 
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platform site. AP180 binding to GST-αC appendage (Q782A) is inhibited by these protein 
fragments but we believe this is because AP180 has the lowest apparent affinity for the αC 
appendage [69] and freely soluble WXX[FW]X[DE] motifs can perturb this interaction (Fig. 
3.1).  
For the SJ170C2 protein segment, which contains one FXDXF and one 
WXX[FW]X[DE] motif, the concerted action of both motifs in αC appendage binding is clearly  
seen upon mutagenic inactivation of either motif separately (Fig. 3.13). Importantly, in this case, 
altering the FXDXF motif to AXAXF (SJ170C2 [FD→A]) reverses the competitive effect of the 
inhibitor on AP180 and amphiphysin binding but has no effect on NECAP 1 inhibition (lane j 
compared to lane h). By contrast, substituting the WXX[FW]X[DE] motif with AXX[FW]X[DE] 
(SJ170C2 [W→A]) still reverses the inhibitory effect of the fragment on AP180 and 
amphiphysin binding but relieves the inhibition of NECAP 1 binding (lane l compared to lanes h 
and j). Together, these data show that the capability of the SJ170C2 portion to inhibit αC 
appendage interactions requires both interaction motifs and both αC appendage-binding sites.   
Combinations of WXX[FW]X[DE] and DP[FW] motifs are also found tandemly arrayed 
in invertebrate endocytic components. In D. melanogaster Numb-associated kinase (NAK; 
NP_477165), an Ark1/Prk1 family Ser/Thr protein kinase related to mammalian AAK1 and 
GAK/auxilin 2 [215], a 586WNPFEEE sequence is positioned between two DPF triplets in a 
central segment predicted to be unstructured. Related sequences are present in presumptive 
Anopheles gambiae (WNPFGDP; XP_321932) and Apis mellifera (WNPFEDV; BI515476) 
orthologues with adjacent DPF triplets. The WNPFX[DE] sequence is homologous to a major 
695WNPFDD AP-2 interaction motif in human AAK1 [82] and conforms to the general 
consensus WXX[FW]X[DE] [82]. In a C. elegans protein that is a possible stonin 2 orthologue  
  90
  
Figure  3.13: The inhibitory ability of SJ170C2 requires both the FXDXF and WXXF motifs. 
Approximately 50 μg of immobilized GST (lane a and b) or GST-αC appendage (lane c-l) were incubated with rat 
brain cytosol alone (lane a-d) or with cytosol supplemented with 20 μM epsin 1 DPW domain (residues 229-407; 
lane e and f), 20 μM SJ170C2 fragment (lane g and h), 20 μM SJ170C2 (FD→A) (lane i and j), or 20 μM SJ170C2 
(W→A) (lane k and l). After centrifugation, aliquots of approximately 1/40 of each supernatant (S) and 1/6 of each 
washed pellet (P) were resolved by SDS/PAGE and either stained with Coomassie blue or transferred to 
nitrocellulose. Portions of the blots were probed anti-NECAP 1 or epsin 1 antibodies, or an anti-amphiphysin or 
anti-AP180 mAb. The open arrowheads indicate the position of the added epsin DPW (229-407) polypeptide, while 
the closed arrowheads indicate immunological detection of the added epsin DPW competitor polypeptide. 
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(APT-10; NP_505566), a potential sandwich binding sequence WADFETS lies between one 
proximal and two distal DPF repeats. In all these proteins, the individual motifs are separated by 
al least 15 amino acids, providing ~50 Å of flexible linker polypeptide. Although the activity of 
these sequences must be confirmed experimentally, the data are consistent with the phylogenetic 
conservation of the WXX[FW]X[DE] binding surface on the α appendage sandwich subdomain 
(Figure 3.2A, 3.2B, and 3.6). 
Next, we analyzed the functional effect of reducing the number of WXX[FW]X[DE] 
repeats within the full-length stonin 2 protein on AP-2 localization and transferrin uptake in 
transiently transfected cells. Others have shown that overexpression of stonin 2 in either HeLa or 
COS7 cells disrupts the intracellular distribution of the AP-2 adaptor and inhibits transferrin, 
LDL and EGF internalization [135, 214]. We also find that overexpression of GFP-tagged stonin 
2 (1-905) in HeLa cells perturbs AP-2 (Fig. 3.14A). In GFP-stonin 2-expressing cells, there is 
clearly a more prominent pool of cytosolic AP-2, seen as a diffuse haze compared to the non-
transfected cells. The GFP-stonin 2 transfected cells also have fewer punctate AP-2 structures 
compared to adjacent untransfected cells and, generally, the fluorescence intensity of the 
remaining AP-2 puncta is reduced in the overexpressing cells. Similar results are obtained upon 
overexpression of AAK1 in HeLa cells [216]. Overexpression of GFP-stonin 2 (1-905) 
[W2,3→A], with only one functional WXX[FW]X[DE] motif, almost completely reverses the 
effect on AP-2 however (Fig. 3.14B). Likewise, overexpression of wild-type GFP-stonin 2 
inhibits the uptake of biotin-transferrin and accumulation in juxtanuclear endosomes (Fig. 3.14C) 
but the GFP-stonin 2 (1-905) [W2,3→A] protein does not (Fig. 3.14D). Taken altogether, our data 
show that the sandwich site is a functional interaction surface upon the αC appendage that  
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 Figure  3.14: Inactivation of two of the three WXXF motifs in stonin 2 prevents overexpression-induced AP-2 
reorganization and endocytosis defects. 
HeLa cells transiently transfected with either GFP-stonin 2 (1-905) (A and C; green) or GFP-stonin 2 (1-905) 
[W2,3→A] (B and D; green) were fixed and stained with the anti-AP-2 α subunit mAb AP.6 (A and B; red) or pulsed 
with 25 μg/ml transferrin for 15 min at 37°C before fixation (C and D; red). Transfected cells expressing roughly 
comparable levels of GFP-stonin are indicated by the arrows. 
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expands the number of engagement modes to permit proteins with tandemly arrayed interaction 
motifs to regulate the occupancy of the platform.  
3.3.4 Motif Arrays Govern Hierarchical Recruitment 
Different apparent affinities of soluble αC appendage binding partners in brain or PC12 cell 
extracts can be seen in titration experiments (Figure 3.15). In agreement with our competition 
studies, intact epsin 1 displays the highest affinity for the α appendage while AP180 and NECAP  
1 have relatively low apparent affinities (Figure 3.15). In general, there is a good correlation 
between the presence of multiple interaction motifs and/or the extent of motif repetition (Fig. 
3.16) and the observed apparent affinity for immobilized αC appendage. Importantly, SJ170 has 
a high affinity for the appendage, and the difference in binding between SJ170 and the short, 
neuronal-specific isoform of synaptojanin 1, SJ145, is clear. SJ145, which contains only a single 
WXX[FW]X[DE] motif, binds GST-αC appendage with an affinity roughly comparable to 
NECAP 1. A striking finding is that several of the alternate adaptors, including epsin 1, Dab2 
and HIP1, that expand the sorting repertoire of clathrin-coated vesicles that form at the plasma 
membrane have high apparent affinities for the GST-αC appendage.  
In no instance do we observe effective displacement of epsin 1 from immobilized αC 
appendage, irrespective of the interaction motifs present in the competitor protein (Fig. 3.1 and 
3.7). This indicates that, unlike dynamin and actin [217], epsin might not display dramatic 
temporal fluctuations during clathrin coat assembly. At steady state, there is a high degree of 
colocalization of endogenous epsin 1 with clathrin or AP-2 [118] demonstrating that epsin 1 




Figure  3.15: A hierarchical set of α appendage binding-partners. 
Immobilized GST or GST-αC appendage (0-100 μg) was incubated with either rat brain or PC12 cell extracts. 
Aliquots of approximately 1/40 of each supernatant (S) and 1/6 of each washed pellet (P) were resolved by 
SDS/PAGE and either stained or transferred to nitrocellulose. Portions of the blots were probed anti-epsin 1, -
synaptojanin 1, -Dab2, -HIP1, -SNX9, -amphiphysin, -AP180, CALM, NECAP 1 or -numb antibodies. 
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analysis of the distribution of endogenous epsin 1 at the ventral surface of disrupted NRK or 
PC12 cells using freeze-etch EM shows that the protein is almost exclusively present within 
regions of assembled polygonal clathrin lattice (Fig. 3.17B and C). Antibodies against the AP-2 
α subunit and epsin 1 reveal extensive presence of these endocytic proteins within regions of flat 
clathrin lattice. Significantly, epsin 1 labeling is not only restricted to flat lattices but is also 
found in rounded structures and deeply invaginated profiles reflecting all stages of clathrin-
coated vesicle assembly (Fig. 3.17C, arrows). A very recent report, using our anti-epsin 
antibodies, also shows that epsin 1 is found in flat clathrin lattices at the cell surface as well as in  
deeply invaginated clathrin-coated buds in HeLa cells [218]. Together, these results suggest that 
epsin does not obligatorily exit the assembling clathrin bud prior to the fission event. Indeed, the 
only accessory factor identified in a recent proteomic analysis of purified brain clathrin-coated 
vesicles was epsin 1 and epsin is enriched in purified clathrin-coated vesicle preparations [163]. 
These observations support the proposed action of epsin as an alternate adaptor [48, 147] and 
again underscore the differential residencies conferred upon endocytic proteins by assemblies of 




Figure  3.16: Schematic representation of α-appendage binding domains in endocytic accessory proteins. 
Regions not corresponding to known domains are symbolized by straight lines (—) while similar regions for which 
secondary structure cannot be predicted (Jpred2) are indicated by a zig-zag line ( ). Note that α-appendage and 
clathrin binding motifs occur in regions for which secondary structure cannot be predicted. Domain labels are: 
ANTH, AP180 N-terminal-homology; BAR, BIN-amphiphysin-RVS; CC, coiled coil; EH, eps15 homology; ENTH, 
epsin N-terminal-homology; IPP5c, inositol 5-phosphatase catalytic domain; J, DNAJ domain; PTB, 
phosphotyrosine binding domain; PX, phox domain; Sac1, suppressor of actin 1; SH3, Src homology 3; TEN, tensin 
homology; THATCH, talin-HIP1/1R actin-tethering C-terminal homology. 
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 Figure  3.17: Ultrastructural localization of epsin 1 in clathrin-coated structures at the cell surface. 
(A-C) Fixed plasma membranes sheets prepared from either NRK (A and B) or PC12 (C) cells labeled with either 
anti-AP-2 a subunit (A) or anti-epsin 1 antibodies (B and C) and secondary antibodies conjugated to 15 nm colloidal 
gold particles. Individual gold particles appear as white spheres and representative freeze-etch images show the 
distribution of endogenous AP-2 and epsin 1. Note extensive labeling for epsin in flat clathrin lattices as well as 





Although the assembly of clathrin-coated vesicles at the plasma membrane requires only a 
minute or two, the process is characterized by an intricate and complex series of protein-protein 
interactions. These interactions govern the assembly of polyhedral clathrin lattice, the 
preferential retention of select cargo molecules, the invagination of the nascent transport 
intermediate and, finally, scission from the cell surface and uncoating. At least 20 accessory 
factors, in addition to the clathrin–AP-2–cargo triad, participate in these events [67]. Several of 
these so-called accessory proteins (AP180, HIP1, epsin 1, Dab2) appear to be bona fide alternate 
adaptors that cooperate with AP-2 during lattice assembly while simultaneously expanding the 
sorting repertoire of the bud [48]. Others, like amphiphysin, play a more structural role while 
enzymatic proteins like AAK1, GAK and synaptojanin 1 regulate cargo selection and clathrin 
coat disassembly [67, 68, 215]. Despite these distinct functions, many of the accessory proteins 
contact the assembling coat in a similar fashion, by binding to the AP-2 α appendage. A critical 
deficiency in our understanding of the molecular basis of clathrin-coated vesicle assembly is a 
lack of a detailed knowledge of the precise chronology and location of the myriad of protein-
protein contacts necessary for the successful fabrication and release of a vesicle. We show here 
that associations with the α appendage utilize two spatially distinct binding surfaces and at least 
three discrete interaction sequence types. Furthermore, different assemblies of distinct interaction 
sequences produce proteins with different apparent affinities for AP-2 and generate a hierarchical 
set of interaction partners. 
The measured affinities of the different α appendage binding motifs are in accord with a 
hierarchical model for binding, a Kd of ~10 μM for the WXX[FW]X[DE] sequence in SJ170 
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making the sandwich site the highest affinity single interaction. In the alternatively-spliced 
SJ170 carboxyl terminus, the WXX[FW]X[DE] sequence is the dominant interaction motif, as 
are the WNPF and WAAW sequences in AAK1 and GAK/auxilin 2, respectively [82]. A single 
DPF motif has a Kd of ~120 μM [203], and model proteins with one to three DPF triplets bind 
AP-2 extremely poorly [82, 118]. The FXDXF motif likely has an intermediate affinity as the 
stonin 2 (1-247) protein, with 3 WXX[FW]X[DE] motifs, effectively competes off amphiphysin 
and AP180, both with FXDXF sequences. The WNPF and WAAW sequences in AAK1 and 
GAK/auxilin 2 are atypical WXX[FW]X[DE] motifs that might enable these proteins to bind to 
both AP-2 and AP-1, through the sandwich domain of the γ subunit appendage, albeit via 
different interaction surfaces. The γ appendage binds a related WNSF sequence in GGA1 [207] 
and a bifunctional interaction motif could allow AAK1 to regulate cargo capture by 
phosphorylation of adaptor μ subunits [57] at different intracellular sites. Similarly, GAK is 
found in clathrin-coated vesicle preparations [56, 163, 219], binds both the AP-1 γ subunit and 
the AP-2 α subunit appendages and phosphorylates the μ subunits of these adaptors [219, 220]. 
The lack of a discernable phenotype after AAK1 silencing by RNAi in HeLa cells [216] also 
suggests functional redundancy between these Ark1/Prk1 family kinases. However, it is 
important to note that there is currently no direct evidence for a binary AAK1•γ appendage 
interaction, and the presence of an acidic residues following the distal Phe (WNPFDD) could 
interfere with or prevent binding to the γ appendage sandwich site.  
Our studies have uncovered two general modes of αC appendage engagement both 
characterized by multisite binding. Two fixed binding sites on the appendage and arrays of 
varied interaction motifs within the binding partners dictate different thresholds for binding to 
and residency on the αC appendage. For endocytic proteins like epsin 1 and eps15, tandemly 
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repeated DP[FW] sequences can promote simultaneous binding to multiple AP-2 molecules by 
both the αC and β2 appendages. However, the Kd for these interactions are weak (>100 μM) 
[203] and, consequently, display interaction half times of only a few seconds which will allow 
other proteins access to the platform. Yet, the multiplicity of binding motifs counteracts diffusion 
limited exit by statistically favoring rapid rebinding. This accounts for the high apparent affinity 
of epsin 1 for the αC appendage [69]. These motifs, together with embedded clathrin binding 
sequences, ensure placement of epsin within the lattice throughout the assembly process. A 
second strategy, typified by SJ170, stonin 2, and possibly AAK1 and GAK [82], is engagement 
of a spatially distinct binding site on the appendage that, through avidity effects, can promote 
engagement of other motifs in the platform site. One utility of the spatially distinct 
WXX[FW]X[DE] binding site on the sandwich subdomain could be that it prevents mutually 
exclusive interactions by providing a relatively privileged surface for the recruitment of 
important regulatory components. For AAK1 and GAK, this would ensure that cargo capture by 
membrane associated AP-2 is not impeded by other interactions occurring at the platform, where 
a battery of at least ten other endocytic proteins are known to bind.   
The majority of AP-2 binding partners have additional docking determinants (like 
modular phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2)-binding domains) or interaction 
sequences that can engage other clathrin coat components. The growing consensus is that it is the 
combinatorial effect of these associations that governs precise compartmental recruitment of 
structurally related adaptors like AP-1, AP-2 and AP-3, and epsin 1 and epsinR [68, 221, 222]. 
For example, epsin 1 has a PtdIns(4,5)P2-binding amino-terminal ENTH domain, eight DPW 
repeats, two clathrin-binding sequences as well as NPF triplets that can bind to EH domain 
proteins like eps15 and intersectin [68, 147]. These additional contacts with the assembling coat 
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could also contribute to the steady presence of epsin 1 in clathrin-coated regions throughout the 
assembly and fission process. PtdIns(4,5)P2 engagement by the epsin ENTH domain involves the 
ordering of a new α-helix that, once formed, inserts several aliphatic side chains into the bilayer 
[223]. The penetration of these residues is thought to induce membrane curvature as clathrin 
lattice assembly progresses [223]. We find extensive epsin 1 labeling of flat hexagonal clathrin 
arrays. These results indicate that the presence of epsin 1 does not obligatorily dictate membrane 
curvature.  
A significant issue is whether, in individual cells, the entire cohort of binding partners is 
available to associate with the appendage or whether tissue-specific expression patterns limit the 
complexity of α appendage interactions. In brain, all but two of the 15 proteins shown 
schematically in Fig. 3.16 are expressed, and many have been directly localized to the 
presynaptic region, a site of intensive endocytic activity because regulated exocytosis of 
neurotransmitter is tightly coupled to compensatory clathrin-mediated endocytosis. Therefore, 
the hierarchical pattern of recruitment we see in our biochemical affinity-association assays have 
direct physiological relevance. A important component that is not present in brain is SJ170, the 
long splice-isoform of synaptojanin 1. In neurons, the critical phosphoinositide polyphosphatase 
function is preformed by SJ145, an alternate splice isoform that lacks the carboxy-terminal 
extension which contains the DPF, FXDXF and WXX[FW]X[DE] motifs [224]. A single 
WXX[FW]X[DE] motif is present within SJ145 but the phosphatase is expressed at considerably 
higher concentrations in brain than in other tissues and is predominantly recruited to the bud site 
by endophilin or amphiphysin, through proline-rich region–SH3 domain interactions [67]. The 
abundance of SJ145 in nerve terminals may therefore facilitate function without a requirement 
for more complex adaptor interaction information. In fact, the interaction of SJ145 with 
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endophilin and amphiphysin is regulated by phosphorylation [225, 226] and, because of the 
higher concentration of synaptojanin 1 at the synapse, the long splice isoform could conceivably 
be recruited prematurely to the developing bud and impede the rapid completion of the vesicle, 
which is dependent on PtdIns(4,5)P2.  
Many of the AP-2 binding endocytic accessory proteins are reversibly phosphorylated 
and regulation of the physical interaction between the α appendage and binding partners by 
cycles of phosphorylation/dephosphorylation could add an additional layer of control by 
modulating the accessibility and/or affinity of α appendage interaction motifs [227]. However, at 
the synapse, many of these proteins, collectively termed dephosphins [228] are coordinately 
dephosphorylated by calcineurin upon depolarization and Ca2+ influx.  
 In conclusion, our results identify a clear function for the α appendage sandwich 
subdomain in AP-2 interactions through its ability to bind the WXX[FW]X[DE] sequence. The 
finding that WXX[FW]X[DE] motif engagement allows other binding motifs to engage the 
adjacent major platform binding site suggests a potential manner to regulate α appendage 
occupancy. Finally, our data lead us to predict that temporal ordering of alternate adaptors and 
accessory proteins necessary for proper clathrin-coated vesicle assembly is governed, in part, by 
particular sets of α appendage interaction motifs. 
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3.5 ADDITIONAL DATA 
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 Figure  3.18: Stonin 2 interacts with AP-2. 
Approximately 100 μg of either GST-stonin 2 (1-426) (lanes c and d), GST-Dab2 (1-368) (lanes e and f), or GST 
(lanes a and b) immobilized on GSH-Sepharose was incubated with rat brain cytosol. After centrifugation, aliquots 
corresponding to one-fortieth of each supernatant (S) and one-eighth of each washed pellet (P) were resolved by 
SDS-PAGE and either stained with Coomassie Blue or transferred to nitrocellulose. Portions of the blots were 
probed with anti-AP2 α subunit mAb 100/2 or anti-μ2 subunit serum. This data does not conclude if the interaction 
between stonin 2 and AP-2 is direct or indirect. 
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 Figure  3.19: The WXXF domain of stonin 2 binds AP-2 independently of eps15. 
Approximately 100 μg of either GST-SJ170C2 (lanes a and b) or GST-stonin 2 (residues 1-426) (lanes c-f) 
immobilized on GSH-Sepharose was incubated with either mock (GST)-depleted (lanes a-d) or GST-αc appendage-
depleted (lanes e and f) rat brain cytosol (which was prepared by preincubation with either 150 μg of immobilized 
GST or GST-αc appendage; the resulting pellets (lanes g and h) demonstrate capture of AP-2 binding partners, 
including eps15). After centrifugation, aliquots corresponding to 1/60 of each supernatant (S) and 1/8 (lanes b, d, 
and f) or 1/12 (lanes g and h) of each washed pellet (P) were resolved by SDS-PAGE and either stained with 
Coomassie Blue or transferred to nitrocellulose. The position of the bound AP-2 α- and β2-subunits are indicated 
with open arrowheads, whereas the intact GST-stonin 2 fusion protein is indicated with filled arrowheads. Portions 
of the blots were probed with the anti-AP-2 α-subunit mAb 100/2, anti-AP-2 μ2 subunit, or anti-eps15 antiserum. *, 
cross-reactivity of the anti-eps15 antiserum with the intact GST-stonin 2 fusion protein. This data indicates that 
stonin 2 interacts with AP-2 directly. 
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 Figure  3.20: Two WXXF motifs bind AP-2 α appendage well, while one WXXF motif binds weakly. 
Approximately 100 μg of either GST (lane a and b), GST-stonin 2 (residues 91-247) (lane c and d), GST-stonin 2 
(91-247) [W2->A] (lane e and f), (91-247) [W2W3->A] (lane g and h), (91-111) (lane i and j), or (91-111) [W2->A] 
(lane k and l) immobilized on GSH-Sepharose was incubated with rat brain cytosol. After centrifugation, aliquots 
corresponding to 1/40 of each supernatant (S) and 1/8 of each washed pellet (P) were resolved by SDS-PAGE and 
either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed with the anti-
AP-2 α subunit mAb 100/2 or anti-μ2 subunit serum. The asterisks indicate where protein transfer has be reduced by 
the large amount of GST-fusion protein comigrating at that position. This data indicates that two WXXF motifs are 
able to engage AP-2 well while one WXXF motif engages AP-2 weakly. 
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 Figure  3.21: Additional binding information is contained within stonin 2 between residues 111-145. 
Approximately 100 μg of either GST (lane a and b), GST-stonin 2 (residues 91-247) (lane c and d), GST-stonin 2 
(91-179) (lane e and f), (91-145) (lane g and h), (91-111) (lane i and j) immobilized on GSH-Sepharose was 
incubated with rat brain cytosol. After centrifugation, aliquots corresponding to 1/40 of each supernatant (S) and 1/8 
of each washed pellet (P) were resolved by SDS-PAGE and either stained with Coomassie blue or transferred to 
nitrocellulose. Portions of the blots were probed with the anti-AP-2 α subunit mAb 100/2 or anti-μ2 subunit serum. 
This data indicates that additional binding information is contained within the stonin 2 region 111-145. Additional 






4.0  CONCLUSIONS 
4.1 INTRODUCTION 
While CME is the best-studied form of endocytosis in mammalian cells, the advancements of 
recent years have brought our understanding well beyond the traditionally accepted model of 
CME. This simplified “textbook” model posits that clathrin-coated pits are assembled with the 
help of AP-2 at the plasma membrane surface, and cargo molecules are selected for 
internalization at these sites, which ultimately form vesicles that are released with the help of 
dynamin. Yet, over twenty accessory proteins have now been identified that bind to core CME 
components and participate in endocytic events, and novel sorting signals and interactions have 
been recognized [48, 67, 68]. Phosphorylation of AP-2 is required to enable its interaction with 
cargo, and the role of plasma membrane lipids in CME has also become appreciated [54, 56, 57]. 
These numerous advances have important implications, as understanding the molecular 
interactions and chronology of CME allows insights into how nutrients, extracellular 
macromolecules, and receptors are internalized, and how these processes are altered in 
pathological states. 
In this dissertation, I examined several aspects of the CME process. The major theme of 
my work has been describing the protein-protein interactions involved in CME; specifically, the 
interactions of epsin 1 UIMs and stonin 2 WXXF motifs. Within these two different projects are 
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some unifying themes. Both epsin and stonin 2 are able to interact with the AP-2 α appendage. 
Epsin engages the platform site utilizing the DP[FW] repeats while stonin 2 uses its WXXF 
motifs at the sandwich site. Another similar theme is the endocytic motif repeats in these two 
proteins: three UIM repeats in epsin and three WXXF repeats in stonin 2. Functionally, these 
tandem repeats may enable an increased effective affinity for their binding sites, as discussed 
below. More globally, these protein interactions are important in the chronology of AP-2 
interactions during CME. Another major theme is that both epsin 1 and stonin 2 act as CLASPs, 
epsin 1 for polyubiquitin cargo proteins and stonin 2 for synaptotagmin, as recently shown by the 
Haucke group [229]. 
4.2 POLYUBIQUITIN IS A BONA FIDE ENDOCYTIC SIGNAL RECOGNIZE BY 
THE CLASP EPSIN 1 
A large portion of my research has focused on the endocytic tag ubiquitin. One question that 
arises is why do cells utilize multiple endocytic tags, for example YXXØ, FXNPXY, di-leucine, 
and ubiquitin (Figure 4.1). Possibly by embedding primary sequence motifs such as YXXØ, 
FXNPXY or dileucine motifs in the cytoplasmic tail of a trafficking protein, these “different 
endocytic classes” can be differentiated by the appropriate endocytic sorting machinery and thus 
allow for differential endocytosis of the cargo. Distinct endocytic pathways can be sorted from 
each other via their unique motifs that require various CLASPs. In addition to this explanation, 
having multiple signals embedded in the tail may create redundant endocytic tags and may result 
in an increased fidelity of endocytic uptake. Finally, ubiquitin as an internalization signal is 
distinct from the embedded signals in that it can be reversibly added to a target protein, in a  
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 Figure  4.1: CLASP family of proteins. 
Interactions between AP-2, clathrin (modeled after known structures) and other CLASPs is denoted by the lines. A 
PtdIns(4,5)P2 interaction is indicated by the shaded oval. Known or probable cargo sorted by the different CLASPs 
is indicated in the black boxes. 
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similar manner as phosphorylation of GPCRs, thus imparting an endocytic signal where one may 
not have already existed or adding an additional signal to increase the fidelity or rate of 
internalization. The advantages of this type of sorting signal are discussed below. 
My dissertation research has investigated and biochemically characterized the various 
domains in epsin 1, specifically focusing on the UIMs. I showed that these UIMs have a marked 
preference for polyubiquitin chains (tetraubiquitin or longer) and there is virtually no stable 
association with monoubiquitin. This is a particularly interesting finding because other 
prominent researchers in the field maintain that the ubiquitin endocytic signal in mammalian 
cells is a single ubiquitin, similar to yeast [145, 146]. 
To fortify my data in support of polyubiquitin endocytic signals, competition studies 
utilizing excess monoubiquitin in the presence of polyubiquitin chains were performed. These 
results showed that monoubiquitin is unable to compete (even at high excess) the polyubiquitin 
binding capacity of the UIMs. The relative affinity for polyubiquitin chains was comparable for 
both Lys48- and Lys63-linked polyubiquitin chains, and was qualitatively far greater than that 
for monoubiquitinated cargo. My results are in contradiction with data that suggests that 
monoubiquitination may be sufficient for internalization of receptor tyrosine kinases such as 
EGF receptor [125]. The Luckacs group used the monomeric type 1 membrane protein CD4 to 
show that only multiple ubiquitin moieties can be recognized by the clathrin endocytic 
machinery [166]. One possible explanation is that these receptors dimerize upon activation, and 
single ubiquitin moieties are attached at multiple sites on their cytoplasmic tails; perhaps this 
“effective multiubiquitination,” though distinct from polyubiquitin chains, is enough to engage 
the UIMs and drive their endocytosis. In contrast, a recent publication has shown that within 2 
minutes of stimulation by EGF, at least 50% of ubiquitin added to the EGF receptor is in fact 
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polyubiquitin, and the vast majority is the Lys63-linked form [230]. My data revealed that UIMs 
are able to engage both Lys48- and Lys63- linked ubiquitin chains (the lUb4 constuct used 
mimics Lys63-linked chains in structure).  The majority of EGF receptor has Lys63 linkages, 
which suggests a possible mechanism for segregating the endosomal and proteasomal pathways.  
Traditionally, Lys48-linked ubiquitinated proteins are destined for degradation.  The linkage 
pattern may allow for specific ubiquitin-modifying enzymes (such as ligases and 
deubiquitinating enzymes) to act at the surface and preferentially modulate endocytic uptake. 
My contention that polyubiquitin is vital as an internalization signal for epsin-dependent 
CME is supported by other research groups [166, 231, 232]. In a collaborative study with the 
Johnson laboratory this model was tested with respect to ENaC, whose surface expression is 
known to be regulated by ubiquitination [231]. Using a pull-down approach, I showed that an 
ENaC-polyubiquitin fusion protein interacts with the epsin 1 UIM more robustly than ENaC-
monoubiquitin. This finding was supported by data from the Xenopus oocyte model, in which 
epsin expression down-regulated ENaC surface activity [231].  
These findings support a role for the epsin 1 and polyubiquitin-mediated CME model in 
physiology, which may have implications for disease. Liddle’s syndrome, an inherited form of 
hypertension, is caused by mutations that delete a C-terminal motif in ENaC [233]. This motif is 
responsible for binding Nedd4-2, an E3 ubiquitin ligase that acts upon the ENaC cytoplasmic tail 
[233]. The resulting decrease in ENaC ubiquitination causes a reduction in ENaC CME via UIM- 
containing CLASPs. The functional consequence is increased ENaC at the surface of cells, 
which allows increased membrane sodium conductance, and ultimately the hypertension 
phenotype. The understanding of the ubiquitination of ENaC and its subsequent CME via UIM-
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containing CLASPs could help in our understanding of disease phenotypes with similar 
pathophysiology. 
In addition to regulation of membrane constituents such as ENaC for physiological 
purposes, the epsin 1 polyubiquitin internalization machinery may also be exploited by viruses in 
disease states. Kaposi’s sarcoma, caused by the Kaposi’s sarcoma herpesvirus (KSHV), is the 
most common cancer in AIDS patients [234, 235]. Intracellular KSHV evades recognition by the 
immune system by promoting the internalization of surface immunoreceptors, such as major 
histocompatibility class-I (MHC-I) [194, 236]. The KSHV proteins, modulator of immune 
recognition 1 and 2 (MIR 1/2), act as a viral E3 ligase and polyubiquitinate MHC-I to drive its 
endocytosis [194, 236]. It has now been shown by the Lehner group that monoubiquitinated 
MHC-I acts as a poor endocytic signal, while polyubiquitination acts efficiently and utilizes 
epsin as its adaptor protein [232]. One could extend some of the Lehner studies by researching 
the significance of UIM-containing proteins during the course of a KSHV infection. It will be 
important to show that the UIM in epsin is necessary and sufficient for MHC-I internalization in 
KSHV-infected cells by utilizing siRNA mediated silencing and rescue with a mutant construct. 
Also, other endocytic proteins may be important as evidenced by the weak effect of epsin RNAi. 
A better understanding of the mechanism of MIR proteins in the pathophysiology of 
Kaposi’s sarcoma could conceivably be used diagnostically or therapeutically. Diagnostically, 
assays could be performed to detect the presence and levels of the MIR proteins (or ubiquitin E3 
ligase activity), which could allow for more tailored treatment regimens for Kaposi’s sarcoma 
patients. Therapeutically, targeting of either the polyubiquitin signal or the ubiquitin sorting 
CLASPs such as epsin could be utilized to slow the progression of disease (e.g. by saturating 
endocytic machinery). There may be problems with therapeutically targeting epsin in humans, 
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though. Data from the De Camilli lab has shown that mice deficient in either epsin 1 or epsin 2 
(both expressed in brain) do not have a gross phenotype. However, when both of these genes are 
disrupted simultaneously, the effect is early embryonic lethality, most likely due to defects in 
endocytosis during development. Similarly, other important endocytic protein deletions result in 
the same phenotype. Although targeting epsin for a therapeutic approach may be difficult, 
understanding the molecular mechanism of the ubiquitin endocytic tag and the machinery that 
recognizes this tag may offer insights into possible downstream targets.  
Interestingly, the viral MIR proteins have homology to several endogenous mammalian 
proteins. Membrane-associated RING-CH (MARCH) gene products are human proteins related 
to MIRs and are also known to downregulate MHC-I in cells, potentially by utilizing the epsin or 
UIM-containing CLASP endocytic machinery [164, 237]. These proteins are very highly 
expressed in placental tissue, which I showed to be a site of enriched polyubituitinated cargo and 
epsin 1. The functions of MARCH gene products within the cell remain to be explored. 
Ubiquitin as a signal has a major advantage over other endocytic motifs in that it can be 
easily regulated in a spatial and temporal manner. This signal can be added or removed quickly 
from a target protein and thus enable a signaling receptor to be rapidly cleared from the surface 
or remain at the surface until activated. A surface protein can exist at the plasma membrane and 
ligand binding or other triggers can cause its ubiquitination and subsequent internalization. For 
other sorting signals in which peptide motifs are embedded in the proteins, the internalization is 
constitutive and only controlled by steric availability or exposure of the motif.  
An important system that exploits the dynamic regulation of ubiquitin-mediated CME is 
the Notch signaling pathway, which is highly conserved from Drosophila to humans and is 
involved in cell fate choice and pattern formation during development. Data from the Drosophila 
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model system implicates Neuralized (an E3 ligase) and Lqf (a homolog of epsin containing 
UIMs) in the modulation of Notch signaling through Delta (the transmembrane ligand of Notch) 
endocytosis [238]. Endocytosis was first recognized as a regulatory mechanism when the 
dynamin mutant shits was shown to be necessary in both the signal generating cell (Delta 
expressing cell) and the signal receiving cell (Notch receptor expressing cell) for normal Notch 
mediated signaling [239]. The dynamic nature of ubiquitin addition and removal makes it an 
ideal internalization signal during development. If Delta had a primary amino acid sequence 
endocytic signal, this would cause its constitutive endocytosis. Conversely, the ability of the 
ubiquitin signal to be dynamically added to Delta enables its internalization at specific stages by 
CME. Another key aspect of the Drosophila model is that in sensory organ precursor (SOP) 
cells, numb, an endocytic CLASP that is thought to engage a binding partner of Notch known as 
Sanpodo (Spdo), is able to sort one type of cargo while Lqf is able to sort another (ubiquitinated 
cargo). This is an important example because in the same cell, different CLASPs are able to sort 
different cargo molecules simultaneously. 
Another intriguing ubiquitinated protein system involves colony stimulating factor 1 
(CSF-1), the primary regulator of macrophage and osteoclast development which is mediated 
through the CSF-1 receptor [153, 240]. CSF-1 receptor is a receptor tyrosine kinase and when 
activated recruits Cbl, which then ubiquitinates CSF-1 receptor to induce the receptor’s 
internalization [153, 240]. This activity can attenuate macrophage proliferation and is vital for 
proper immune system function, which also requires dynamic modulation in a manner that only 
ubiquitin as a sorting signal provides. 
In addition to studying the role of UIM-containing CLASPs in the regulation of 
physiologic protein internalization, much work remains in the study of the CLASPs themselves. 
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It is intriguing that while able to bind ubiquitin, epsin is also a substrate for covalent 
monoubiquitination itself [241, 242]. I think it would be interesting to explore the effects of the 
state of ubiquitination of epsin on its interactions with ubiquitinated cargo or with coat 
components. One possibility is that the ubiquitination state may influence its ability to bind to 
polyubiquitinated cargo [120].   
To study the role of the ubiquitination of epsin, one could first map and then mutate its 
ubiquitination sites, express the constructs in cells with silenced endogenous epsin, and look for 
changes in internalization of various substrates. However, these experiments may become quite 
complicated because there are multiple UIM-containing CLASPs that may have redundant 
effects, such as epsin 2, eps15, and eps15R (which are also known to be ubiquitinated 
themselves). Among the challenges to appropriately explore this question are that it may require 
silencing of many endogenous endocytic CLASPs as well as other accessory proteins to 
determine the true implications of a mutation in one of these proteins. This is a likely necessity, 
as the epsin 1 silencing experiment performed by Lehner’s group revealed only a mild phenotype 
[232].   
An important regulator of ubiquitinated processes is deubiquitination, and it might be 
expected that deubiquitinating enzymes are present and active at the clathrin-coated pit to 
regulate ubiquitin-mediated CME. Upon the deletion of the main deubiquitinating enzyme in S. 
cerevisiae (Doa4), many plasma membrane proteins are stabilized [243]. It is thought that this 
phenotype is a result of depletion of cellular free ubiquitin, causing impaired ubiquitination 
[243]. The importance of ubiquitination as a signal for CME begs the question whether there is a 
deubiquitinating enzyme that is active at clathrin coated pits. Such an enzyme might modulate 
internalization of ubiquitinated cargo and provide an additional layer of regulation for CME of 
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important surface cargo. One recently identified candidate is associated molecule with the SH3 
domain of STAM (AMSH) protein. AMSH has been shown to have a role in the deubiquitination 
of endosomal cargo preceding lysosomal degradation [244]. Another possible candidate protein 
that has deubiquitination activity is ataxin-3. In addition to this activity, ataxin-3 has two UIMs, 
which are known to bind to polyubiquitin and not mono- or diubiquitin moieties [177, 245]. 
Another approach is to perform an extensive database search in a manner similar to that which 
identified epsin as a UIM-containing protein. Using a computer algorithm that I developed, I 
have performed a preliminary database search of proteins that contain DP[FW], WXXF, 
FXDXF, NPF, clathrin binding, and β appendage binding motifs, which are known endocytic 
interaction motifs, to broadly search for other proteins that are localized to clathrin-coated pits. 
Interestingly, I noticed that among known binding proteins, this search returned candidates that 
included several proposed ubiquitin proteases (See Appendix A). In order to confirm that these 
are functioning at clathrin coated pits, it would be important to perform biochemical experiments 
to verify interactions with clathrin, AP-2, and lipids. Other important studies are to assay their 
catalytic activity and localize the putative deubiquitinating enzymes to clathrin-coated pits.  
The study of deubiquitinating enzymes may help us understand how the same signal 
(tetraubiquitin or longer chains) allows for endocytosis at the surface and degradation in the 
cytosol. Deubiquitinating enzymes are potentially able to act rapidly at the surface once the 
ubiquitinated cargo protein is sorted into a clathrin-coated pit. The computer search results 
(shown in Appendix A) identify many possible deubiquitinating enzymes containing multiple 
endocytic motifs allowing for these enzymes to localize preferentially to the surface and act 
rapidly to deubiquitinate the cargo once sorted into a pit.  In this manner, polyubiquitinated 
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endocytosed cargo may be deubiquitinated upon internalization prior to its recognition by the 
degradation machinery. 
4.3 PROTEIN-PROTEIN INTERACTIONS DICTATE THE CHRONOLOGY OF AP-
2’S INVOLVEMENT DURING CME 
Recent progress has clearly improved our understanding of the precise molecular 
chronology that occurs during the creation, progression, scission, release, and uncoating of a 
clathrin-coated vesicle. This rapid assembly and disassembly is governed by protein-protein 
interactions that are carried out in a strict spatial and temporal sequence to ensure vectoral 
progress. My work has detailed the role of epsin as a CLASP and has enhanced our 
understanding of the biochemical interactions between ubiquitinated cargo and the endocytic 
machinery. Another of my research endeavors focused on AP-2 and its interaction with stonin 2, 
a protein that had been examined in the Drosophila melanogaster model system but was 
relatively unstudied in mammalian cells. 
My work has described a novel α appendage binding sequence and cognate contact 
surface, known as the β-sandwich site. A common question throughout this work is why do 
proteins have several sequences and multiple sites for α appendage engagement? Having distinct 
sites with different affinities can account for the fidelity of incorporating endocytic components 
at the bud site. In addition to increasing fidelity, these sites can enable a chronology of events, 
with early-acting proteins being displaced by later-acting proteins that possess multiple higher-
affinity engagements for the appendage binding sites. Another advantage to having multiple sites 
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is that this can create a web of interactions at the bud site and enable an increased local 
concentration of endocytic components based on these interactions. 
The AP-2 α appendage WXXF binding sequence occurs in three tandem repeats in stonin 
2. I became interested in this protein due to its arrangement of arrayed endocytic motifs (similar 
to my other project involving epsin 1, which has tandem UIMs, along with tandem AP-2 
interacting DP[FW] motifs), and the potential of stonin 2 as a sorting adaptor. Through studies 
described in chapter 3, it was shown that there are two surfaces on the AP-2 α appendage and at 
least three distinct binding sequences that allow for interactions with proteins that provide 
diverse functions including sorting, lattice assembly, structural, and enzymatic functions.  
Proteins with multiple, tandemly arrayed AP-2 interaction motifs (such as epsin 1, which 
has eight DPW sequences) can engage several AP-2 α and β2 appendage subunits 
simultaneously. This strategy, of utilizing weak binding of tandemly arrayed motifs, ensures that 
the protein has a high apparent affinity: when the protein diffuses, the multiple motifs enable an 
increased probability of rebinding the same site. The affinity of the WXXF motif for the β 
sandwich-binding site (~10 μM) is an order of magnitude greater than the affinity of the platform 
binding sequences (~120 μM) for their respective binding sites. In this manner, tandemly arrayed 
low-affinity interaction sequences allow for a “kinetic trap:” once a protein binds to its substrate, 
multiple interactions retain the interaction of the two proteins despite cycles of binding and 
release. Also, the low affinity reactions allow for easy displacement by a higher affinity 
interaction and thus a coordination of events. If the proteins had one motif with a much higher 
affinity it would be difficult to disassemble many of these interaction webs that the endocytic 
process is known to create.   
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This difference in “platform” site binding affinity, as well as the competition of many 
proteins with “platform” binding sequences versus few proteins possessing β-sandwich-binding 
sequences, allows for the β-sandwich site to behave as a “privileged” surface on the AP-2 α 
appendage. Proteins possessing these privileged sequences can be incorporated into developing 
buds with a higher fidelity compared to proteins competing for one of the “platform” sites.  
A physiologically relevant example of this “privileged” site system occurs at the synapse. 
Stonin 2 is a brain-enriched endocytic protein that in D. melanogaster (stonedB) has been linked 
to the function of synaptotagmin 1, an important mediator of calcium dependent neurosecretion 
at the synaptic plasma membrane [246]. My studies biochemically characterized the endocytic 
motifs embedded within stonin 2 and demonstrated its capacity to function as a potential sorting 
adaptor. Stonin 2 is an atypical member of the CLASP family though, as it does not possess a 
clathrin binding or membrane engagement domain. It instead has the tandemly arrayed WXXF 
motifs that enable its interaction with AP-2, and a μ homology domain (MHD), which enables its 
interaction with its putative cargo, the synaptic vesicle protein synaptotagmin 1. Recently, the 
Haucke group extended my findings on stonin 2, demonstrating that this protein is indeed able to 
specifically sort synaptotagmin 1 into clathrin-coated pits [229].  
Another putative class of cargo proteins that may be sorted by stonin 2 are the cysteine 
string proteins (CSPs). CSPs contain a ”J” domain and an unusual cysteine rich region. In 
Drosophila, CSPs were shown to associate with synaptic vesicles and were mislocalized, along 
with synaptotagmin, in stonedB mutant flies [247]. It would be interesting to study the potential 
of stonin 2 to act as a dedicated sorting adaptor for CSP in addition to synaptotagmin. To further 
confirm stonin 2’s role as a sorting adaptor for synaptotagmin 1 and CSP, one could utilize 
siRNA to silence stonin 2 in a relevant cell type (such as a neurons) and observe the cargo 
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proteins. Synaptotagmin is an important protein to retrieve from the surface because it is a 
synaptic vesicle (SV) protein involved in SV fusion with the plasma membrane and is critical in 
exocytosis and neurotransmitter release. 
While many proteins are known to engage AP-2, it is possible that additional AP-2 
interacting proteins with interesting functions in CME have yet to be described. To identify these 
proteins, one could utilize the technique of phage display, in which peptides are fused to capsid 
proteins on the phage surface. Libraries of these phage-displayed peptides can then be screened 
for binding and the exact peptide sequence can be determined. This approach would further 
characterize interactions of the WXXF motif within AP-2 to recognize peptides with affinities 
that may be relevant for CME. Additionally it could be used to identify anchor residues, or 
possibly even novel sequences that do not occur in the proteome for use to modify CME. 
Alternatively, phage or peptide display could be used to identify novel binding sites and 
substrates for both the AP-2 α and β2 appendages, which are where most endocytic protein-
protein interactions occur. 
The dual site on AP-2 is based on affinity, in which a higher-affinity binding partner 
displaces a lower-affinity interaction. There may be additional mechanisms that regulate the 
hierarchy of binding to AP-2 which act on top of the dual site system. One mechanism for 
regulation of binding that is utilized by endocytic proteins is post-translational modification, 
such as phosphorylation. In fact, it is known that several endocytic proteins are phospho-
proteins, and their phosphorylation may regulate their ability to interact with AP-2. These 
phosphorylation reactions, among other post-translational modifications, may add another level 
of complexity and regulation to the system. 
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4.4 CLOSING COMMENTS 
In this dissertation, I presented data that has furthered our understanding of the biochemical 
nature and chronology of the protein-protein interactions that are important during CME. The 
recognition of epsin as a bona fide CLASP and subsequent identification of poly-ubiquitination 
as an endocytic signal have important implications for pathological states that involve this 
machinery to impact the cell. The identification of AP-2 interaction sites has allowed a greater 
understanding of the sequence and mechanism of cargo engagement during CME. My research 
has raised questions regarding the importance of multiple sorting signals, multiple protein 
interaction motifs within endocytic proteins, and regulation of these interactions. CME is critical 
in many physiological processes, and future studies may help us better understand its function in 




5.0  MATERIALS AND METHODS 
5.1 CHAPTER 2 MATERIALS AND METHODS 
5.1.1 Recombinant DNA Manipulations 
All epsin constructs were prepared from a rat epsin 1 cDNA kindly provided by Pietro de Camilli 
(Yale University School of Medicine, New Haven, CT, USA). Generation of GST-epsin 1 (1-
407) has been described [248] while the plasmid encoding His6-epsin 1 (144-575) was kindly 
provided by Ernst Ungewickell (Hannover Medical School, Hannover, Germany). GST-eps15 
UIM (residues 828-896) was prepared by PCR using a human eps15 cDNA kindly provided by 
Alexander Sorkin (University of Colorado Health Science Center, Denver, CO, USA) as the 
template, and ligated into pGEX-4T-1. GST-ubiquitin was prepared similarly by PCR using a 
monoubiquitin cDNA as a template, while GST-linear tetraubiquitin was generated by inserting a 
single in-frame ubiquitin between the BamHI and NotI sites at the end of a GST-triubiquitin 
plasmid kindly provided by Gergely Lukacs (Hospital for Sick Children, Toronto, Canada). The 
first three of these tandemly-arrayed ubiquitins have Gly76 substituted for Val to prevent 
cotranslational cleavage by ubiquitin-specific processing proteases. The GST-S5a plasmid was a 
gift from Martin Rechsteiner (University of Utah, Salt Lake City, UT, USA). Tac (CD25; the IL-
2 receptor a subunit) in pcDNA3 was a gift from Rebecca Hughey (University of Pittsburgh, 
Pittsburgh, PA, USA). The TacL-Ub in pcDNA3 was constructed by first extending the 11-amino 
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acid cytosolic domain of Tac to the linker sequence (TacL) 
RRQRKGGGSGGGTGGGSGKSRRTLEAAAAAI incorporating terminal, adjacent XhoI and 
NotI restriction sites. A single ubiquitin, an all-arginine-substituted (K7R) ubiquitin kindly 
provided by Cecile Pickart (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 
USA), or the linear, ubiquitin protease-resistant tetraubiquitin was then inserted into the modified 
TacL plasmid using the XhoI and NotI sites. To prevent activation by the E1 ubiquitin-activating 
enzyme, the terminal Gly pair of the final ubiquitin in these vectors were removed using site-
directed mutagenesis to convert Gly75 to a stop codon. All constructs were verified by 
automated dideoxynucleotide sequencing and full oligonucleotide and sequence details are 
available upon request. 
5.1.2 Protein Preparations and Purification 
Lys48- or Lys63-linked polyubiquitin chains were purchased from Biomol (Plymouth Meeting, 
PA, USA) or Boston Biochem (Boston, MA, USA). The preparation of clathrin-coated vesicles, 
clathrin, AP-2, and GST-fusion proteins has been described [248]. Briefly, coated vesicles were 
purified in buffer A (100 mM MES-OH, pH 6.5, 1 mM EGTA, 0.5 mM magnesium chloride, and 
0.02% sodium azide) from homogenized tissue using sequential differential centrifugation 
followed by a 12.5 % Ficoll 400/12.5% sucrose isopycnic step. The placental preparation was 
further purified by chromatography over a Sephacryl S-1000 column equilibrated in buffer A to 
remove smooth membrane contaminants. Coat proteins were extracted from coated vesicles with 
~1 M Tris-HCl, pH 7.0 and fractionated on a Superose 6 column equilibrated in 0.5 M Tris-HCl, 
pH 7.2, 0.1% β-mercaptoethanol, and 0.02% sodium azide. The clathrin peak was pooled while 
the adaptor peak was further fractionated on a hydroxylapatite column using a linear gradient of 
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2-500 mM potassium phosphate, pH 8.0 in 20 mM Tris-HCl, 10% glycerol to prepare purified 
AP-2. Prior to use, clathrin and AP-2 were gel-filtered into assay buffer (25 mM HEPES, pH 7.2, 
125 mM potassium acetate, 5 mM magnesium acetate, 2 mM EDTA, 2 mM EGTA, 1 mM DTT). 
GST and the various GST fusion proteins were all expressed in E. coli strain BL21, while the 
His6-epsin 1 (144-575) was produced in the Rosetta strain (Novagen, San Diego, CA, USA). 
After lysis, GST fusions were purified using glutathione-Sepharose by standard procedures and 
dialyzed into PBS. The preparation of HeLa cell lysates and rat brain Tris-Triton lysates has been 
described elsewhere [248]. To examine the expression of the Tac chimeras in transiently 
transfected HeLa cells, PBS-washed cells were lysed in 25 mM HEPES-OH, pH 7.2, 250 mM 
sucrose, 2 mM EDTA, 2 mM EGTA, 0.5% Triton X-100, 10 mM N-ethylmaleimide, 20 mM 
MG132, 1 mM PMSF, and Complete protease inhibitor cocktail on ice for 30 min. Lysates was 
scraped off the culture dishes and then centrifuged at 10,000 × gmax for 10 min at 4°C. 
Supernatants were collected and used for immunoblotting.   
5.1.3 Protein Binding Studies 
Pull down-type assays, typically in 300 ml total volume, contained 5-100 μg of GST or the 
appropriate GST-fusion protein first immobilized upon ~25 ml packed GSH-Sepharose by 
incubation at 4°C. The Sepharose beads containing the required immobilized proteins were 
washed and resuspended to 50 ml in assay buffer. Clarified rat brain cytosol or Tris-Triton 
extract, HeLa cell lysate, or ubiquitin chains (in the presence of 0.1 mg/ml carrier BSA) were 
added and the tubes incubated at 4°C for 60 min with continuous gentle mixing. The GSH-
Sepharose beads were then recovered by centrifugation at 10,000 × gmax at 4°C for 1 min and an 
aliquot of each supernatant removed and adjusted to 100 ml with SDS-sample buffer. After 
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washing the GSH-Sepharose pellets 4 times each with ~1.5 ml ice-cold PBS by centrifugation, 
the supernatants were aspirated and each pellet resuspended in SDS-sample buffer. Liposome 
binding assays used 0.4 mg/ml synthetic multilamellar liposomes composed of 35% 
phosphatidylcholine, 35% phosphatidylethanolamine, 10% phosphatidylserine, 10% cholesterol 
and 10% PtdIns(4,5)P2, which were recovered by centrifugation at 20,000 × gmax for 20 min at 
4°C. For cage binding experiments, preassembled clathrin cages, prepared by dialysis of 
Superose 6-column purified clathrin into buffer A supplemented with 3 mM calcium chloride, 
were used.  
5.1.4 Antibodies and Immunoblotting 
Affinity-purified polyclonal antibodies directed against epsin 1, Dab2, the cation-independent 
mannose 6-phosphate receptor (CI-MPR), and the anti-AP-1/2 β1/β2 subunit and anti-AP-1 μ1 
subunit antibodies designated GD/2 and RY/1, respectively, were produced in our laboratory by 
standard procedures. Affinity-purified anti-eps15 antibodies and serum were generously 
provided by Ernst Ungewickell, polyclonal anti-AP-2 m2 subunit and anti-Tac antisera were 
generously provided by Juan Bonifacino (NIH, Bethesda, MD, USA), the anti-Hrs serum was a 
kind gift from Harald Stenmark (Norwegian Radium Hospital, Oslo, Norway), the anti-EEA1 
antibodies were kindly provided by Silvia Corvera (University of Massachusetts Medical School, 
Worchester, MA, USA), and anti-LRP1 antibodies were a gift from Guojun Bu (Washington 
University School of Medicine, St. Louis, MO, USA). Polyclonal anti-ubiquitin-protein 
conjugate antibodies were purchased from Biomol, affinity-purified polyclonal anti-caveolin-1 
(N-20) from Santa Cruz Laboratories (Santa Cruz, CA, USA), anti-S5a antiserum from Boston 
Biochem, and polyclonal anti-EGF receptor antibody from Cellular Signaling Technology 
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(Beverly, MA, USA). The anti-AP-2 α subunit mAb AP.6 hybridoma was kindly provided by 
Frances Brodsky (UCSF, San Francisco, CA, USA), the neuronal-specific anti-clathrin light 
chain mAb Cl57.3 was provided by Reinhard Jahn (Max-Planck-Institute for Biophysical 
Chemistry, Göttingen, Germany), anti-actin mAb C4 by Dorothy Schafer (University of 
Virginia, Charlottesville VA, USA), and the anti-insulin receptor b subunit mAb CT-1 by 
Guillermo Romero (University of Pittsburgh, PA, USA). Anti-ubiquitin mAb Ubi-1 was 
purchased from Novus Biologicals (Littleton, CO, USA), the anti-ubiquitin mAb FK2 from 
Biomol, anti-caveolin-1 mAb 2297 and anti-AP180 mAb 34 from BD Transduction Laboratories 
(Lexington, KY, USA), the anti-E1 mAb from Covance (Berkeley, CA, USA), and the anti-Tac 
mAb 7G7B6 from Ancell Immunology Research Products (Bayport, MN). Alexa dye-conjugated 
secondary antibodies were from Molecular Probes (Carlsbad, CA, USA) and Cy5-coupled 
antibodies from Jackson ImmunoResearch (West Grove, PA, USA). 
Samples were resolved on polyacrylamide gels prepared with an altered acrylamide:bis-
acrylamide (30:0.4) ratio stock solution. After SDS-PAGE, proteins were either stained with 
Coomassie blue or transferred to nitrocellulose in ice-cold 15.6 mM Tris, 120 mM glycine. Blots 
were usually blocked overnight in 5% skim milk in 10 mM Tris-HCl, pH 7.8, 150 mM NaCl, 
0.1% Tween 20 and then portions incubated with primary antibodies as indicated in the 
individual figure legends. After incubation with HRP-conjugated anti-mouse or anti-rabbit IgG, 
immunoreactive bands were visualized with enhanced chemiluminescence. 
5.1.5 Cell Culture, Transfection, Immunofluorescence, and Electron Microscopy 
HeLa SS6 cells (kindly provided by Ernst Ungewickell), A431 cells (ATCC CRL-1555) and 
NRK cells (ATCC CRL-1570) were grown in DMEM supplemented with 10% fetal calf serum 
  128
and 4 mM L-glutamine in a humidified atmosphere containing 5% CO2. Typically, cells were 
plated onto 12-mm round glass cover slips prior to stimulation with EGF or transfection. 
Alexa488-conjugated EGF and Alexa568-conjugated transferrin were from Molecular Probes. 
Transfections with Lipofectamine 2000, using 500 ng plasmid DNA/35-mm dish, was as 
recommended by the manufacturer. Approximately 14-20 hours post-transfection, cells were 
fixed either with 2-4% paraformaldehyde in PBS for 10-20 min at room temperature or with 
methanol at -20°C for 5 min. Alternatively, prior to fixation, the cells were incubated in DMEM, 
0.5% BSA, 25 mM HEPES, pH 7.2 at 37°C for 60 min for transferrin uptake, or overnight for 
EGF uptake experiments. EGF (100 ng/ml), transferrin (25 μg/ml) and/or anti-Tac mAb (4 
μg/ml) were then incubated with the cells on ice for 60 min before warming to 37°C for the 
indicated period prior to fixation. In some experiments, antibodies were added directly to the cell 
culture medium at 37°C and, after 5 or 10 min, the cells cooled rapidly on ice-water and washed 
in ice-cold PBS. The cells were then fixed in 2% paraformaldehyde in PBS, blocked with 10% 
normal goat serum in PBS, and then incubated with Alexa568-conjugated anti-mouse IgG. After 
washing, the cells were refixed and permeabilized with 0.2% saponin and then incubated with 
Alexa488-conjugated anti-mouse IgG.  
All confocal images were acquired using an Olympus Fluoview 500 microscope 
equipped with a 60X 1.40 NA objective and a 560 nm short pass filter with a 505 nm barrier 
filter for the 488-nm argon laser line, a 630 short pass filter and 560-600 nm barrier filter, and a 
660-nm long pass filter for the 543- and 633-nm helium-neon laser lines, respectively. Signals in 
the different emission channels were collected sequentially and processed either with Photoshop 
(Adobe Systems Incorporated, San Jose, CA, USA) or Imaris (Bitplane AG, Saint Paul, MN, 
USA) for 3-dimensional reconstructions from acquired X-Z image stacks.  
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For freeze-etch immunogold analysis, cells were cultured on small oriented pieces of 
carbon-coated glass cover slip and ruptured by brief sonication to generate ‘unroofed’ cell 
cortices. After washing in 30 mM HEPES-OH, pH 7.3, 70 mM potassium chloride, 5 mM 
magnesium chloride and 3 mM EGTA (KHMgE buffer), the cells were fixed in 2% 
paraformaldehyde, 0.025% glutaraldehyde in KHMgE, quenched with 50 mM ammonium 
chloride, 50 mM L-lysine in KHMgE, and blocked with 1% BSA in KHMgE. Coverslips were 
then incubated with affinity-purified anti-epsin antibodies followed by anti-rabbit antibodies 
conjugated to 15 nm colloidal gold. After washing in KHMgE, the membranes were refixed in 
2% glutaraldehyde in KHMgE and prepared for freeze-etch analysis [119, 249]. 
5.2 CHAPTER 3 MATERIALS AND METHODS 
5.2.1 DNA and Plasmids 
The GST-αC appendage and GST-αC appendage mutants W840A, R905A, R916A, GST-
SJ170M1, GST-SJ170C2, GST-SJ170C2 mutants (FD→A) and (W→A), and GST-stonin 2 (1-
426) have been described previously [69, 72, 82]. The GST-αC appendage mutants R707S, 
N712Y, G725N, K727A, R731A, F740D, and Q782A, and the GST-stonin 2 (1-247), -(1-117), -
(1-30), -(1-247) [W3→A], -[W2→A], -[W1→A], -[W2,3→A], and -[W1,2,3→A] constructs were 
generated by site-directed mutagenesis using the QuikChange system (Stratagene) and the 
appropriate mutagenic primers (the sequences of which are available upon request). The full-
length GFP-stonin 2 construct was generated by inserting the missing amino terminal residues 
into a GFP-stonin 2 vector [214] kindly provided by Juan Bonifacino. First, the internal BclI site 
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in the GFP-stonin 2 (204-905) plasmid was inactivated by QuikChange mutagenesis. Then, 
residues 1-426 of stonin 2 were amplified by PCR from human clone C14981 (Stratagene) with 
primers 5’-TTAAGCTTATATGACTTTGGACCATGTG-3’ and 5’-
AAGCGGCCGCCTAGTCACGAGGCTGGGACCG-3’, digested with HindIII and BclI, 
purified, and ligated into the HindIII and BclI digested GFP-stonin 2 plasmid. This procedure 
inserts residues 1-393, generating full-length stonin 2 (1-905) fused in frame to the carboxyl 
terminus of GFP in pEGFP-C1. The GFP-stonin 2 [W2,3→A] was generated as outlined above. 
All the clones and mutations were verified by automated dideoxynucleotide sequencing. 
5.2.2 Recombinant Proteins, Cell Extracts and Antibodies 
GST and the various GST-fusion proteins were produced in E. coli BL21. The standard induction 
protocol entails shifting log-phase cultures (A600 ~0.6) from 37°C to room temperature and then 
adding isopropyl-1-thio-b-D-galactopyranoside to a final concentration of 100 mM. After 3-5 
hours at room temperature with constant shaking, the bacteria were recovered by centrifugation 
at 15,000 × gmax at 4°C for 15 min and stored at -80°C until used. Bacteria were lysed on ice in 
50 mM Tris-HCl, pH 7.5, 300 mM sodium chloride, 0.2% (w/v) Triton X-100, 10 mM b-
mercaptoethanol with sonication or in B-PER reagent (Pierce). Insoluble material was removed 
by centrifugation at 23,700 × gmax at 4°C for 15 min and then the GST fusions collected on 
glutathione (GSH)-Sepharose. After extensive washing in PBS, GST fusions were eluted with 10 
mM Tris-HCl, pH 8.0, 10 mM GSH, 5 mM DTT on ice and dialyzed into PBS, 1 mM DTT 
before use in binding assays. For some experiments, proteins were cleaved off the GST with 
thrombin and then PPACK (D-Phe-Pro-Arg chloromethyl ketone, Calbiochem), an irreversible 
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thrombin inhibitor, added to 25 mM. For quantitative affinity measurements, thrombin-cleaved 
αC appendage was further purified by gel filtration over a Superdex S200 column.  
Cytosol was prepared from frozen rat brain (PelFreez) by sequential differential 
centrifugation after homogenization in 25 mM Hepes-KOH, pH 7.2, 250 mM sucrose, 2 mM 
EDTA and 2 mM EGTA supplemented with 1 mM PMSF and Complete (Roche) protease 
inhibitor cocktail. The 105,000 × gmax supernatant is defined as cytosol and was stored in small 
aliquots at –80°C. PC12 cell lysates were prepared after collecting the cells by trypsinization and 
washing with PBS. Pelleted PC12 cells were solubilized in 25 mM Hepes-KOH, pH 7.2, 250 
mM sucrose, 2 mM EDTA and 2 mM EGTA supplemented with 1% Triton X-100 on ice for 30 
min in the presence of Complete (Roche) protease inhibitor cocktail and 1 mM PMSF. Following 
centrifugation at 20,000 × gmax at 4°C for 15 min, aliquots of the lysate were stored frozen at –
80°C. Before use, thawed samples of either rat brain cytosol or PC12 cell lysates were adjusted 
to 25 mM Hepes-KOH, pH 7.2, 125 mM potassium acetate, 5 mM magnesium acetate, 2 mM 
EDTA, 2 mM EGTA and 1 mM DTT (assay buffer) by addition of a 10X stock and then 
centrifuged at 245,000 × gmax (TLA-100.4 rotor) at 4°C for 20 min to remove insoluble 
particulate material.  
Polyclonal serum against NECAP 1 was generously provided by Peter McPherson, while 
the anti-m2 subunit serum was a generous gift from Juan Bonifacino. Polyclonal antibodies 
against sorting nexin 9 (SNX9) were generated in rabbits using residues 1-240 of SNX9 as the 
antigen. Affinity purified anti-numb antibodies were generously provided by Kozo Kaibuchi. 
Affinity purified rabbit antibodies to epsin 1, Disabled-2 (Dab2), and synaptojanin 1 
(recognizing both SJ145 and SJ170) have been described [72, 75, 82]. The anti-AP-2 a subunit 
monoclonal 100/2 was a generous gift of Ernst Ungewickell and the anti-CALM mAb a generous 
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gift from Jeong-Ah Kim, while monoclonal antibodies directed against AP180 and amphiphysin 
were from BD-Transduction Laboratories. The anti-HIP1 mAb 1C5 was from Novus 
Biologicals. 
5.2.3 Protein Binding Studies 
Pull-down-type assays, in 300 ml total volume, were performed as described [72, 82]. Typically, 
50-400 μg of GST and the GST-fusion proteins were first each immobilized upon ~25 ml packed 
GSH-Sepharose by incubation at 4°C for 2 hours with continuous mixing. The Sepharose beads 
containing the required immobilized proteins were then washed and resuspended to 50 ml in 
assay buffer. Clarified rat brain cytosol, PC12 cell lysates, or purified, thrombin-cleaved αC 
appendage (in the presence of 0.1 mg/ml carrier BSA) were added and the tubes incubated at 4°C 
for 60 min with continuous gentle mixing. For the competition assays, a WXX[FW]X[DE] 
peptide (ISNWVQFEDDTP) or thrombin-cleaved proteins (in the presence of 25 mM PPACK) 
were added directly into the assay mixture. The GSH-Sepharose beads were then recovered by 
centrifugation at 10,000 × gmax at 4°C for 1 min and an aliquot of each supernatant removed and 
adjusted to 100 ml with SDS-sample buffer. After washing the GSH-Sepharose pellets 4 times 
each with ~1.5 ml ice-cold PBS by centrifugation, the supernatants were aspirated and each 
pellet resuspended in SDS-sample buffer. 
5.2.4 Isothermal Titration Calorimetry (ITC) Experiments 
The SJ170 KGWVTFEE peptide was synthesized in the laboratory of Paul M. Allen 
(Washington University). Superdex S200-purified αC appendages were concentrated and then 
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proteins and peptides prepared for ITC by overnight dialysis against a buffer of 50 mM 
phosphate, pH 7.5, 100 mM sodium chloride, and 1 mM TCEP. All ITC experiments were 
carried out at 30º C using a VP-ITC instrument (MicroCal) at Washington University. Typically 
the cell contained 1.4 ml of 100 mM a appendage while SJ170 WXXF peptide, at a concentration 
of 1 mM, was titrated in 30 injections of 10 ml each. The exception was the a-appendage R905A 
mutant, which, due to low expression and solubility, was run with a protein concentration of 30 
mM and peptide concentration of 0.90 mM. Traces were corrected by subtracting blank 
measurements of SJ170 WXXF peptide injected into the ITC buffer and analyzed using Origin 
5.0 (MicroCal). Binding constants were calculated by fitting the integrated data to a one-site 
binding model. 
5.2.5 Cells, Transfection, Immunofluorescence and Freeze-Etch EM 
NRK cells were cultured at 37°C in DMEM, 10% FCS and 2 mM L-glutamine while 
undifferentiated PC12 cells were grown at 37°C in DMEM supplemented with 10% horse serum, 
5% FCS and 2 mM L-glutamine. HeLa SS6 cells were grown in DME supplemented with 10% 
fetal calf serum and 2 mM L-glutamine at 37°C in a humidified 10 % CO2 atmosphere. Cells 
were passaged onto 12 mm glass cover slips one day prior to transfection with Lipofectamine 
2000. One day after transfection, cells were fixed in 2% paraformaldehyde and prepared for 
immunofluorescence as previously described [75]. For transferrin internalization, cells were 
serum starved for 1 hour, pulsed with 25 μg/ml biotin transferrin for 15 min at 37°C, washed and 
fixed.   
For freeze-etch immunogold analysis, cells were cultured on small oriented pieces of 
carbon-coated glass coverslip and ruptured by sonication to generate ‘unroofed’ cell cortices 
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precisely as described [249]. After washing in 30 mM Hepes-KOH, pH 7.3, 70 mM potassium 
chloride, 5 mM magnesium chloride and 3 mM EGTA (KHMgE buffer), the cells were fixed in 
2% paraformaldehyde, 0.025% glutaraldehyde in KHMgE, quenched with 50 mM ammonium 
chloride, 50 mM L-lysine in KHMgE, and blocked with 1% BSA in KHMgE. Coverslips were 
then incubated with anti-AP-2 a subunit mAb AP.6 [250] or affinity purified anti-epsin 
antibodies followed by anti-mouse or -rabbit antibodies conjugated to 15 nm colloidal gold. 
After washing in KHMgE, the membranes were fixed in 2% glutaraldehyde in KHMgE and then 
prepared for freeze-etch analysis [249]. 
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APPENDIX A 
DATABASE SEARCH FOR PROTEINS WITH REPEATED ENDOCYTIC MOTIFS 
A.1 INTRODUCTION 
A database search was conducted utilizing a PERL computer program that I wrote during my 
dissertation research. The search was performed using regular expression nomenclature to 
identify proteins containing pairs of known endocytic motifs. The database that was searched 
was the Homo sapiens proteome Release 17 from May 1, 2006 that contains 40,880 protein 
entries, and is freely available at the NCBI RefSeq website. Table A.1 presents the motifs used in 
the search. The search was conducted with pairs of protein motifs as follows: 1,1; 1,2; 1,3; 1,4; 
1,5; 1,6; 2,1; etc. 
Table A.1: Motifs used in computer protein database search 
Number Motif Recognition Domain or Protein Example Proteins
1 DP[FW] α/β2 appendage platform subdomain of AP-2 Epsin 1, Eps15, Dab2 
2 F.D.F α appendage platform subdomain of AP-2 AP180, amphiphysin, synaptojanin 1 
3 W..[FW].[DE] α appendage sandwich subdomain of AP-2 Synaptojanin 1, Stonin 2, AAK1 
4 DDGLDEAFSRLAQSRT β2 appendage platform subdomain of AP-2 ARH, β-arrestin 1/2 
5 L[LMIF][DEN][LMIF][DEN] Clathrin HC terminal domain AP-2, Epsin 1, Dab2, ARH, β-arrestin 1/2 
6 NPF EH domain Epsin 1, Dab2 
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A.2 DATABASE SEARCH RESULTS 
************************************************************ 
************************************************************ 




146 matches found in protein 
############################## 
ACCESSION  = NP_055963 
DEFINITION = PAS domain containing serine/threonine kinase   
 
ACCESSION  = XP_055481 
DEFINITION = PREDICTED: myb-like, SWIRM and MPN domains 1   
 
ACCESSION  = NP_067051 
DEFINITION = serine arginine-rich pre-mRNA splicing factor SR-A1   
 
ACCESSION  = NP_005179 
DEFINITION = Cas-Br-M (murine) ecotropic retroviral transforming sequence   
 
ACCESSION  = NP_004289 
DEFINITION = nucleoporin 155kDa isoform 2   
 
ACCESSION  = XP_942672 
DEFINITION = PREDICTED: similar to epiplakin 1   
 
ACCESSION  = XP_496799 
DEFINITION = PREDICTED: similar to Nuclear envelope pore membrane protein 
POM 121 (Pore membrane protein of 121 kDa) (P145)   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_006304 
DEFINITION = ubiquitin specific protease 15   
 
ACCESSION  = XP_933019 
DEFINITION = PREDICTED: hypothetical protein XP_933019   
 
ACCESSION  = NP_001005743 
DEFINITION = numb homolog isoform 1   
 
ACCESSION  = NP_620151 
DEFINITION = hypothetical protein BC014608   
 
ACCESSION  = NP_057368 
DEFINITION = CCR4-NOT transcription complex, subunit 1 isoform a   
 
ACCESSION  = NP_037465 
DEFINITION = epsin 1   
 
ACCESSION  = XP_946889 
DEFINITION = PREDICTED: similar to myb-like, SWIRM and MPN domains 1   
 
ACCESSION  = NP_683723 
DEFINITION = epsin 2 isoform a   
 
ACCESSION  = XP_379933 
DEFINITION = PREDICTED: similar to Ubinuclein (Ubiquitously expressed nuclear 
protein) (VT4)   
 
ACCESSION  = XP_946663 
DEFINITION = PREDICTED: similar to Goliath homolog precursor (RING finger 
protein 130) (R-goliath) isoform 4   
 
ACCESSION  = XP_062871 
DEFINITION = PREDICTED: similar to Temporarily Assigned Gene name family 
member (tag-58)   
 
ACCESSION  = NP_490647 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 6 isoform a   
 
ACCESSION  = NP_705618 
DEFINITION = nucleoporin 155kDa isoform 1   
 
ACCESSION  = NP_009099 
DEFINITION = ATP-binding cassette, sub-family A member 8   
 
ACCESSION  = NP_001005744 
DEFINITION = numb homolog isoform 2   
 
ACCESSION  = NP_000325 
DEFINITION = sodium channel, voltage-gated, type IV, alpha   
 
ACCESSION  = NP_757366 
DEFINITION = interleukin 16 isoform 2   
 
ACCESSION  = NP_476436 
DEFINITION = cytochrome P450, family 3, subfamily A, polypeptide 43 isoform 2   
 
ACCESSION  = NP_054858 
DEFINITION = sodium channel, voltage-gated, type XI, alpha   
 
ACCESSION  = XP_944191 
DEFINITION = PREDICTED: similar to Ubinuclein (Ubiquitously expressed nuclear 
protein) (VT4)   
 
ACCESSION  = NP_059989 
DEFINITION = AT rich interactive domain 1B (SWI1-like) isoform 1   
 
ACCESSION  = NP_055889 
DEFINITION = kinesin family member 1B isoform b   
 
ACCESSION  = NP_001005158 
DEFINITION = Scm-like with four mbt domains 1   
 
ACCESSION  = XP_942211 
DEFINITION = PREDICTED: similar to double homeobox 4c   
 
ACCESSION  = NP_055602 XP_375737 
DEFINITION = DnaJ (Hsp40) homolog, subfamily C, member 6   
 
ACCESSION  = NP_733762 
DEFINITION = Cas-Br-M (murine) ecotropic retroviral transforming sequence b   
 
ACCESSION  = NP_647478 
DEFINITION = livin inhibitor of apoptosis isoform alpha   
 
ACCESSION  = NP_775183 
DEFINITION = FXYD domain containing ion transport regulator 4   
 
ACCESSION  = NP_001005745 
DEFINITION = numb homolog isoform 4   
 
ACCESSION  = NP_002968 
DEFINITION = sodium channel, voltage-gated, type IX, alpha   
 
ACCESSION  = NP_877417 
DEFINITION = polycystin 1-like 2 isoform b   
 
ACCESSION  = NP_055726 
DEFINITION = AP2 associated kinase 1   
 
ACCESSION  = NP_056084 XP_038288 
DEFINITION = zinc finger, CCHC domain containing 11 isoform b   
 
ACCESSION  = NP_001009881 XP_038288 
DEFINITION = zinc finger, CCHC domain containing 11 isoform a   
 
ACCESSION  = NP_443715 
DEFINITION = WD repeat domain 10 isoform 2   
 
ACCESSION  = NP_003354 
DEFINITION = ubiquitin specific protease, proto-oncogene isoform a   
 
ACCESSION  = NP_006505 
DEFINITION = sodium channel, voltage-gated, type X, alpha   
 
ACCESSION  = XP_944352 
DEFINITION = PREDICTED: similar to Zinc finger protein 469   
 
ACCESSION  = NP_001005159 
DEFINITION = Scm-like with four mbt domains 1   
 
ACCESSION  = NP_942595 
DEFINITION = BMP-2 inducible kinase isoform a   
 
ACCESSION  = NP_689512 
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DEFINITION = kleisin beta isoform 2   
 
ACCESSION  = NP_001008566 
DEFINITION = tyrosylprotein sulfotransferase 2   
 
ACCESSION  = XP_950366 
DEFINITION = PREDICTED: similar to Goliath homolog precursor (RING finger 
protein 130) (R-goliath) isoform 6   
 
ACCESSION  = XP_933562 
DEFINITION = PREDICTED: hypothetical protein XP_933562   
 
ACCESSION  = NP_115801 
DEFINITION = KIAA1822 protein   
 
ACCESSION  = NP_443124 
DEFINITION = polycystin 1-like 2 isoform a   
 
ACCESSION  = NP_001005526 
DEFINITION = splicing factor 3b, subunit 1 isoform 2   
 
ACCESSION  = XP_938981 
DEFINITION = PREDICTED: zinc and ring finger 3 isoform 3   
 
ACCESSION  = XP_377445 
DEFINITION = PREDICTED: similar to double homeobox 4c   
 
ACCESSION  = XP_376679 
DEFINITION = PREDICTED: hypothetical protein LOC254048   
 
ACCESSION  = NP_060570 
DEFINITION = EF-hand domain (C-terminal) containing 1   
 
ACCESSION  = NP_003586 
DEFINITION = tyrosylprotein sulfotransferase 2   
 
ACCESSION  = NP_877439 XP_294213 XP_353565 
DEFINITION = putative binding protein 7a5   
 
ACCESSION  = NP_000756 
DEFINITION = cytochrome P450, family 3, subfamily A, polypeptide 7   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = NP_005485 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 6 isoform b   
 
ACCESSION  = NP_002410 
DEFINITION = mitogen-activated protein kinase kinase kinase 11   
 
ACCESSION  = NP_955475 
DEFINITION = ubiquitin specific protease, proto-oncogene isoform b   
 
ACCESSION  = NP_689940 
DEFINITION = copine II   
 
ACCESSION  = NP_003777 
DEFINITION = ATP-binding cassette, sub-family C, member 3 isoform MRP3   
 
ACCESSION  = NP_006635 
DEFINITION = heat shock 105kD   
 
ACCESSION  = NP_055006 
DEFINITION = sodium channel, voltage gated, type VIII, alpha   
 
ACCESSION  = NP_001972 
DEFINITION = epidermal growth factor receptor pathway substrate 15   
 
ACCESSION  = XP_945788 
DEFINITION = PREDICTED: similar to voltage-gated sodium channel type V alpha 
isoform b   
 
ACCESSION  = NP_056385 
DEFINITION = autism susceptibility candidate 2   
 
ACCESSION  = NP_001028228 
DEFINITION = glutamine synthetase   
 
ACCESSION  = XP_290972 
DEFINITION = PREDICTED: zinc and ring finger 3 isoform 1   
 
ACCESSION  = NP_061130 NP_060076 
DEFINITION = zinc finger protein 395   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = NP_055779 
DEFINITION = epsin 2 isoform b   
 
ACCESSION  = XP_935565 
DEFINITION = PREDICTED: similar to AT rich interactive domain 1B (SWI1-like) 
isoform 1 isoform 1   
 
ACCESSION  = NP_624361 
DEFINITION = AT rich interactive domain 1A (SWI- like) isoform b   
 
ACCESSION  = NP_005856 
DEFINITION = protease, serine, 16   
 
ACCESSION  = NP_071444 
DEFINITION = livin inhibitor of apoptosis isoform beta   
 
ACCESSION  = NP_060427 
DEFINITION = epsin 3   
 
ACCESSION  = XP_040592 
DEFINITION = PREDICTED: zinc finger protein 469   
 
ACCESSION  = NP_006805 
DEFINITION = proteasome inhibitor subunit 1 isoform 1   
 
ACCESSION  = NP_057608 
DEFINITION = B/K protein   
 
ACCESSION  = NP_932173 
DEFINITION = voltage-gated sodium channel type V alpha isoform a   
 
ACCESSION  = NP_004066 
DEFINITION = cryptochrome 1 (photolyase-like)   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_848693 
DEFINITION = proteasome inhibitor subunit 1 isoform 1   
 
ACCESSION  = NP_065870 XP_371832 
DEFINITION = hypothetical protein LOC57579   
 
ACCESSION  = XP_945310 
DEFINITION = PREDICTED: similar to Nuclear envelope pore membrane protein 
POM 121 (Pore membrane protein of 121 kDa) (P145)   
 
ACCESSION  = NP_001010855 XP_375404 
DEFINITION = hypothetical protein LOC146850   
 
ACCESSION  = NP_006006 
DEFINITION = AT rich interactive domain 1A (SWI- like) isoform a   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_059488 NP_000767 
DEFINITION = cytochrome P450, subfamily IIIA, polypeptide 4   
 
ACCESSION  = NP_003735 
DEFINITION = numb homolog isoform 3   
 
ACCESSION  = NP_055656 XP_498116 
DEFINITION = synaptosomal-associated protein, 91kDa homolog   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = NP_057413 NP_056294 
DEFINITION = Scm-like with four mbt domains 1   
 
ACCESSION  = NP_079303 
DEFINITION = zinc finger protein 606   
 
ACCESSION  = NP_653205 
DEFINITION = conserved nuclear protein NHN1   
 
ACCESSION  = NP_065731 
DEFINITION = SCY1-like 1   
 
ACCESSION  = NP_036565 
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DEFINITION = splicing factor 3b, subunit 1 isoform 1   
 
ACCESSION  = NP_443716 
DEFINITION = WD repeat domain 10 isoform 4   
 
ACCESSION  = NP_008851 
DEFINITION = sodium channel, voltage-gated, type I, alpha   
 
ACCESSION  = NP_005236 
DEFINITION = FAT tumor suppressor 1 precursor   
 
ACCESSION  = XP_933588 
DEFINITION = PREDICTED: similar to vasoactive intestinal peptide receptor 2   
 
ACCESSION  = NP_005551 
DEFINITION = laminin alpha 5   
 
ACCESSION  = NP_003894 
DEFINITION = CDC16 homolog   
 
ACCESSION  = NP_067058 
DEFINITION = epidermal growth factor receptor pathway substrate 15-like 1   
 
ACCESSION  = NP_060722 
DEFINITION = hypothetical protein LOC55248   
 
ACCESSION  = NP_002056 
DEFINITION = glutamine synthetase   
 
ACCESSION  = NP_054788 
DEFINITION = SPR1 protein   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_003473 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 2   
 
ACCESSION  = XP_293293 
DEFINITION = PREDICTED: similar to BMP-2 inducible protein kinase (BIKe)   
 
ACCESSION  = NP_001028216 
DEFINITION = glutamine synthetase   
 
ACCESSION  = XP_942348 
DEFINITION = PREDICTED: hypothetical protein XP_942348   
 
ACCESSION  = NP_065783 
DEFINITION = AT rich interactive domain 1B (SWI1-like) isoform 2   
 
ACCESSION  = XP_938832 
DEFINITION = PREDICTED: RW1 protein isoform 3   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
 
ACCESSION  = NP_000326 
DEFINITION = voltage-gated sodium channel type V alpha isoform b   
 
ACCESSION  = NP_060732 
DEFINITION = WD repeat domain 10 isoform 3   
 
ACCESSION  = XP_931161 
DEFINITION = PREDICTED: similar to epiplakin 1   
 
ACCESSION  = NP_001009882 XP_038288 
DEFINITION = zinc finger, CCHC domain containing 11 isoform c   
 
ACCESSION  = NP_066287 
DEFINITION = sodium channel, voltage-gated, type II, alpha 2   
 
ACCESSION  = XP_941787 
DEFINITION = PREDICTED: similar to BMP-2 inducible protein kinase (BIKe)   
 
ACCESSION  = XP_949481 
DEFINITION = PREDICTED: similar to RW1 protein isoform 8   
 
ACCESSION  = NP_005246 
DEFINITION = cyclin G associated kinase   
 
ACCESSION  = NP_569713 
DEFINITION = kelch-like 6   
 
ACCESSION  = NP_055180 
DEFINITION = heat shock 27kDa protein 8   
 
ACCESSION  = NP_055462 
DEFINITION = limkain b1   
 
ACCESSION  = NP_001026859 
DEFINITION = phospholipase A2-activating protein isoform 1   
 
ACCESSION  = NP_787059 
DEFINITION = AT rich interactive domain 1B (SWI1-like) isoform 3   
 
ACCESSION  = NP_443711 
DEFINITION = WD repeat domain 10 isoform 1   
 
ACCESSION  = NP_005112 
DEFINITION = thyroid hormone receptor associated protein 1   
 
ACCESSION  = NP_004244 
DEFINITION = phospholipase A2-activating protein isoform 2   
 
ACCESSION  = NP_073731 
DEFINITION = cytochrome P450, family 3, subfamily A, polypeptide 43 isoform 1   
 
ACCESSION  = NP_996816 XP_117190 XP_371342 XP_372814 
DEFINITION = usherin isoform B   
 
ACCESSION  = NP_476437 
DEFINITION = cytochrome P450, family 3, subfamily A, polypeptide 43 isoform 3   
 
ACCESSION  = NP_005849 
DEFINITION = A-kinase anchor protein 8   
 
ACCESSION  = NP_071897 
DEFINITION = fibrosin 1   
 
ACCESSION  = XP_942645 
DEFINITION = PREDICTED: similar to Temporarily Assigned Gene name family 
member 
(tag-58)   
 
ACCESSION  = NP_008853 









66 matches found in protein 
############################## 
ACCESSION  = XP_932418 
DEFINITION = PREDICTED: similar to ovo-like 2 isoform A   
 
ACCESSION  = NP_579899 
DEFINITION = myoferlin isoform b   
 
ACCESSION  = NP_612149 
DEFINITION = ataxia telangiectasia mutated protein isoform 2   
 
ACCESSION  = XP_942672 
DEFINITION = PREDICTED: similar to epiplakin 1   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_000229 
DEFINITION = voltage-gated potassium channel, subfamily H, member 2 isoform a   
 
 
ACCESSION  = NP_003465 
DEFINITION = ADAM metallopeptidase domain 12 isoform 1 preproprotein   
 
ACCESSION  = NP_065816 
DEFINITION = retinoblastoma-associated factor 600   
 
ACCESSION  = NP_071343 
DEFINITION = abhydrolase domain containing 4   
 
ACCESSION  = NP_006109 
DEFINITION = HCLS1 associated protein X-1 isoform a   
 
ACCESSION  = NP_490647 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 6 isoform a   
 
ACCESSION  = NP_476436 
DEFINITION = cytochrome P450, family 3, subfamily A, polypeptide 43 isoform 2   
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ACCESSION  = NP_171608 
DEFINITION = hypothetical protein LOC84752   
 
ACCESSION  = NP_000042 
DEFINITION = ataxia telangiectasia mutated protein isoform 1   
 
ACCESSION  = NP_015628 
DEFINITION = ankyrin-like protein 1   
 
ACCESSION  = NP_067673 
DEFINITION = ADAM metallopeptidase domain 12 isoform 2 preproprotein   
 
ACCESSION  = NP_000519 
DEFINITION = mannosidase, alpha, class 2B, member 1 precursor   
 
ACCESSION  = XP_941968 
DEFINITION = PREDICTED: similar to jumonji domain containing 2D   
 
ACCESSION  = XP_943991 
DEFINITION = PREDICTED: similar to syntaxin binding protein 5-like   
 
ACCESSION  = NP_776152 
DEFINITION = PDZ domain containing 8   
 
ACCESSION  = NP_057692 
DEFINITION = armadillo repeat containing, X-linked 1   
 
ACCESSION  = NP_001005526 
DEFINITION = splicing factor 3b, subunit 1 isoform 2   
 
ACCESSION  = NP_055660 
DEFINITION = Sac domain-containing inositol phosphatase 3   
 
ACCESSION  = NP_037534 
DEFINITION = fatty acid desaturase 1   
 
ACCESSION  = NP_002482 
DEFINITION = NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa   
 
ACCESSION  = NP_653283 
DEFINITION = likley ortholog of mouse schlafen 10   
 
ACCESSION  = NP_005485 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 6 isoform b   
 
ACCESSION  = NP_065843 
DEFINITION = arylacetamide deacetylase-like 1   
 
ACCESSION  = NP_078898 
DEFINITION = hypothetical protein LOC79675   
 
ACCESSION  = NP_001972 
DEFINITION = epidermal growth factor receptor pathway substrate 15   
 
ACCESSION  = NP_060466 
DEFINITION = de-etiolated 1   
 
ACCESSION  = NP_525023 
DEFINITION = ATP-binding cassette, sub-family A, member 6   
 
ACCESSION  = NP_000760 
DEFINITION = cytochrome P450, family 2, subfamily C, polypeptide 19   
 
ACCESSION  = NP_005382 
DEFINITION = pyruvate dehydrogenase kinase, isoenzyme 3   
 
ACCESSION  = NP_004845 
DEFINITION = HNK-1 sulfotransferase   
 
ACCESSION  = NP_055434 
DEFINITION = glutamate receptor KA1 precursor   
 
ACCESSION  = NP_002967 
DEFINITION = sodium channel, voltage-gated, type VII, alpha   
 
ACCESSION  = XP_372429 
DEFINITION = PREDICTED: similar to jumonji domain containing 2D   
 
ACCESSION  = NP_005430 
DEFINITION = myeloid leukemia factor 2   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_056271 
DEFINITION = cofactor of BRCA1   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_059488 NP_000767 
DEFINITION = cytochrome P450, subfamily IIIA, polypeptide 4   
 
ACCESSION  = XP_945298 
DEFINITION = PREDICTED: similar to ovo-like 2 isoform A   
 
ACCESSION  = NP_055656 XP_498116 
DEFINITION = synaptosomal-associated protein, 91kDa homolog   
 
ACCESSION  = NP_005751 
DEFINITION = CCAAT/enhancer binding protein zeta   
 
ACCESSION  = NP_004527 
DEFINITION = baculoviral IAP repeat-containing 1   
 
ACCESSION  = NP_001027 
DEFINITION = ryanodine receptor 3   
 
ACCESSION  = NP_067058 
DEFINITION = epidermal growth factor receptor pathway substrate 15-like 1   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_038479 
DEFINITION = myoferlin isoform a   
 
ACCESSION  = XP_944474 
DEFINITION = PREDICTED: similar to cofactor of BRCA1   
 
ACCESSION  = NP_065201 
DEFINITION = sorting nexin 14 isoform b   
 
ACCESSION  = XP_931161 
DEFINITION = PREDICTED: similar to epiplakin 1   
 
ACCESSION  = NP_722523 
DEFINITION = sorting nexin 14 isoform a   
 
ACCESSION  = NP_955452 NP_054844 
DEFINITION = DNA polymerase theta   
 
ACCESSION  = XP_045911 
DEFINITION = PREDICTED: syntaxin binding protein 5-like   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = NP_064450 XP_371352 
DEFINITION = formin 2   
 
ACCESSION  = NP_001026859 
DEFINITION = phospholipase A2-activating protein isoform 1   
 
ACCESSION  = XP_945884 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATM (Ataxia 
telangiectasia mutated) (A-T, mutated)   
 
ACCESSION  = NP_004244 
DEFINITION = phospholipase A2-activating protein isoform 2   
 
ACCESSION  = NP_073731 
DEFINITION = cytochrome P450, family 3, subfamily A, polypeptide 43 isoform 1   
 
ACCESSION  = NP_996816 XP_117190 XP_371342 XP_372814 
DEFINITION = usherin isoform B   
 
ACCESSION  = NP_476437 
DEFINITION = cytochrome P450, family 3, subfamily A, polypeptide 43 isoform 3   
 
ACCESSION  = NP_004811 
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ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = XP_093087 
DEFINITION = PREDICTED: similar to family with sequence similarity 48, member 
A isoform b   
 
ACCESSION  = NP_006304 
DEFINITION = ubiquitin specific protease 15   
 
ACCESSION  = NP_002582 
DEFINITION = cytosolic phosphoenolpyruvate carboxykinase 1   
 
ACCESSION  = NP_079284 
DEFINITION = thrombospondin repeat containing 1 isoform 2   
 
ACCESSION  = NP_060087 
DEFINITION = notch1 preproprotein   
 
ACCESSION  = NP_037513 
DEFINITION = thyrotropin-releasing hormone degrading enzyme   
 
ACCESSION  = NP_004196 
DEFINITION = ubiquitin specific protease 2 isoform a   
 
ACCESSION  = NP_115946 
DEFINITION = ubiquitin specific protease 38   
 
ACCESSION  = XP_056455 
DEFINITION = PREDICTED: Melanoma associated gene isoform 1   
 
ACCESSION  = NP_647478 
DEFINITION = livin inhibitor of apoptosis isoform alpha   
 
ACCESSION  = NP_851607 
DEFINITION = SCY1-like 3 isoform 2   
 
ACCESSION  = NP_003354 
DEFINITION = ubiquitin specific protease, proto-oncogene isoform a   
 
ACCESSION  = XP_293352 
DEFINITION = PREDICTED: similar to family with sequence similarity 48, member 
A isoform a   
 
ACCESSION  = NP_689512 
DEFINITION = kleisin beta isoform 2   
 
ACCESSION  = NP_004642 
DEFINITION = ubiquitin specific protease 11   
 
ACCESSION  = XP_947700 
DEFINITION = PREDICTED: similar to family with sequence similarity 48, member 
A isoform b   
 
ACCESSION  = XP_933562 
DEFINITION = PREDICTED: hypothetical protein XP_933562   
 
ACCESSION  = NP_004548 
DEFINITION = notch4 preproprotein   
 
ACCESSION  = NP_006668 XP_496642 
DEFINITION = ubiquitin specific protease 19   
 
ACCESSION  = NP_061905 
DEFINITION = thrombospondin repeat containing 1 isoform 1   
 
ACCESSION  = NP_002410 
DEFINITION = mitogen-activated protein kinase kinase kinase 11   
 
ACCESSION  = NP_955475 
DEFINITION = ubiquitin specific protease, proto-oncogene isoform b   
 
ACCESSION  = NP_064581 
DEFINITION = XPA binding protein 2   
 
ACCESSION  = NP_065769 XP_049683 
DEFINITION = ubiquitin specific protease 31   
 
ACCESSION  = XP_933202 
DEFINITION = PREDICTED: hypothetical protein XP_933202   
 
ACCESSION  = NP_068570 
DEFINITION = interleukin 21 receptor precursor   
 
ACCESSION  = NP_036397 
DEFINITION = chromosome 22 open reading frame 3   
 
ACCESSION  = NP_006528 
DEFINITION = ubiquitin specific protease 3   
 
ACCESSION  = NP_071444 
DEFINITION = livin inhibitor of apoptosis isoform beta   
 
ACCESSION  = NP_001010870 XP_166443 
DEFINITION = tudor domain containing 6   
 
ACCESSION  = NP_851564 
DEFINITION = interleukin 21 receptor precursor   
 
ACCESSION  = NP_002842 
DEFINITION = protein tyrosine phosphatase, receptor-type, Z polypeptide 1   
 
ACCESSION  = NP_851565 
DEFINITION = interleukin 21 receptor precursor   
 
ACCESSION  = NP_004066 
DEFINITION = cryptochrome 1 (photolyase-like)   
 
ACCESSION  = NP_689947 
DEFINITION = hypothetical protein LOC221477   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_114128 
DEFINITION = RALBP1 associated Eps domain containing 1   
 
ACCESSION  = NP_891550 
DEFINITION = ADAM metallopeptidase with thrombospondin type 1 motif, 9 
preproprotein   
 
ACCESSION  = NP_004554 
DEFINITION = mitochondrial phosphoenolpyruvate carboxykinase 2 isoform 1 
precursor   
 
ACCESSION  = NP_008860 
DEFINITION = superkiller viralicidic activity 2-like homolog   
 
ACCESSION  = NP_001027 
DEFINITION = ryanodine receptor 3   
 
ACCESSION  = NP_005693 
DEFINITION = Era G-protein-like 1   
 
ACCESSION  = NP_065156 
DEFINITION = SCY1-like 3 isoform 1   
 
ACCESSION  = XP_933588 
DEFINITION = PREDICTED: similar to vasoactive intestinal peptide receptor 2   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_000123 
DEFINITION = coagulation factor VIII isoform a precursor   
 
ACCESSION  = NP_037434 
DEFINITION = elongation factor-2 kinase   
 
ACCESSION  = NP_002323 
DEFINITION = low density lipoprotein-related protein 1   
 
ACCESSION  = XP_944058 
DEFINITION = PREDICTED: hypothetical protein XP_944058   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = NP_005246 
DEFINITION = cyclin G associated kinase   
 
ACCESSION  = XP_941879 
DEFINITION = PREDICTED: similar to peroxidasin isoform 7   
 
ACCESSION  = NP_061027 
DEFINITION = low density lipoprotein-related protein 1B   
 
ACCESSION  = NP_741994 
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ACCESSION  = NP_079146 
DEFINITION = DEP domain containing 2 isoform a   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_775080 
DEFINITION = zonadhesin isoform 4   
 
ACCESSION  = NP_057368 
DEFINITION = CCR4-NOT transcription complex, subunit 1 isoform a   
 
ACCESSION  = NP_003377 
DEFINITION = zonadhesin isoform 3   
 
ACCESSION  = NP_055860 XP_290471 
DEFINITION = KIAA0261   
 
ACCESSION  = NP_003697 
DEFINITION = phospholipase A2, group IVC   
 
ACCESSION  = XP_379933 
DEFINITION = PREDICTED: similar to Ubinuclein (Ubiquitously expressed nuclear 
protein) (VT4)   
 
ACCESSION  = NP_001026971 
DEFINITION = LIM domain kinase 2 isoform 1   
 
ACCESSION  = NP_055751 XP_376503 
DEFINITION = ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative 
function)   
 
ACCESSION  = XP_944191 
DEFINITION = PREDICTED: similar to Ubinuclein (Ubiquitously expressed nuclear 
protein) (VT4)   
 
ACCESSION  = NP_059447 
DEFINITION = major vault protein   
 
ACCESSION  = NP_009094 
DEFINITION = solute carrier family 14 (urea transporter), member 2   
 
ACCESSION  = NP_085124 
DEFINITION = dicer1   
 
ACCESSION  = NP_001003935 
DEFINITION = poly (ADP-ribose) polymerase family, member 3 isoform b   
 
ACCESSION  = XP_946300 
DEFINITION = PREDICTED: similar to FRAS1-related extracellular matrix protein 
2 precursor (ECM3 homolog)   
 
ACCESSION  = XP_934977 
DEFINITION = PREDICTED: FRAS1 related extracellular matrix protein 2   
 
ACCESSION  = XP_931292 
DEFINITION = PREDICTED: FAT tumor suppressor homolog 3   
 
ACCESSION  = NP_877417 
DEFINITION = polycystin 1-like 2 isoform b   
 
ACCESSION  = NP_443715 
DEFINITION = WD repeat domain 10 isoform 2   
 
ACCESSION  = NP_775082 
DEFINITION = zonadhesin isoform 6   
 
ACCESSION  = NP_055935 
DEFINITION = ALMS1   
 
ACCESSION  = NP_004227 
DEFINITION = COP9 constitutive photomorphogenic homolog subunit 2   
 
ACCESSION  = NP_005106 
DEFINITION = major vault protein   
 
ACCESSION  = NP_071373 XP_371779 
DEFINITION = transposon-derived Buster3 transposase-like   
 
ACCESSION  = NP_443124 
DEFINITION = polycystin 1-like 2 isoform a   
 
ACCESSION  = NP_003485 
DEFINITION = dysferlin   
 
ACCESSION  = NP_005436 
DEFINITION = chondroitin sulfate proteoglycan 6 (bamacan)   
 
ACCESSION  = XP_376679 
DEFINITION = PREDICTED: hypothetical protein LOC254048   
 
ACCESSION  = NP_149132 XP_027237 
DEFINITION = mitogen-activated protein kinase kinase kinase 9   
 
ACCESSION  = NP_065928 XP_209041 
DEFINITION = protein similar to dynein   
 
ACCESSION  = NP_060241 
DEFINITION = PX domain containing serine/threonine kinase   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = NP_001004051 
DEFINITION = G protein-coupled receptor associated sorting protein 2   
 
ACCESSION  = NP_078898 
DEFINITION = hypothetical protein LOC79675   
 
ACCESSION  = NP_071762 
DEFINITION = semaphorin B   
 
ACCESSION  = NP_003728 
DEFINITION = dachsous 1 precursor   
 
ACCESSION  = NP_058632 
DEFINITION = ubinuclein 1   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = NP_114068 
DEFINITION = neighbor of BRCA1 gene 1   
 
ACCESSION  = NP_037373 
DEFINITION = formin homology 2 domain containing 1   
 
ACCESSION  = NP_005137 
DEFINITION = squamous cell carcinoma antigen recognized by T cells 1   
 
ACCESSION  = NP_055249 
DEFINITION = NADPH dependent diflavin oxidoreductase 1   
 
ACCESSION  = NP_803187 
DEFINITION = dicer1   
 
ACCESSION  = NP_775079 
DEFINITION = zonadhesin isoform 2   
 
ACCESSION  = NP_932173 
DEFINITION = voltage-gated sodium channel type V alpha isoform a   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_733751 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 3 isoform 2   
 
ACCESSION  = NP_114128 
DEFINITION = RALBP1 associated Eps domain containing 1   
 
ACCESSION  = NP_775081 
DEFINITION = zonadhesin isoform 5   
 
ACCESSION  = NP_075463 
DEFINITION = hypothetical protein CG003   
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ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = NP_443716 
DEFINITION = WD repeat domain 10 isoform 4   
 
ACCESSION  = XP_945361 
DEFINITION = PREDICTED: similar to NADPH dependent diflavin oxidoreductase 
1   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_003473 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 2   
 
ACCESSION  = NP_005890 
DEFINITION = neighbor of BRCA1 gene 1   
 
ACCESSION  = NP_115495 
DEFINITION = very large G-protein coupled receptor 1   
 
ACCESSION  = NP_002437 
DEFINITION = mitogen-activated protein kinase kinase kinase 10   
 
ACCESSION  = NP_000326 
DEFINITION = voltage-gated sodium channel type V alpha isoform b   
 
ACCESSION  = NP_060732 
DEFINITION = WD repeat domain 10 isoform 3   
 
ACCESSION  = NP_067053 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 3 isoform 1   
 
ACCESSION  = NP_955452 NP_054844 
DEFINITION = DNA polymerase theta   
 
ACCESSION  = XP_093839 
DEFINITION = PREDICTED: hypothetical protein LOC23045 isoform 1   
 
ACCESSION  = NP_005476 
DEFINITION = poly (ADP-ribose) polymerase family, member 3 isoform b   
 
ACCESSION  = NP_001003931 
DEFINITION = poly (ADP-ribose) polymerase family, member 3 isoform a   
 
ACCESSION  = NP_612446 
DEFINITION = G protein-coupled receptor associated sorting protein 2   
 
ACCESSION  = NP_937762 
DEFINITION = laminin alpha 3 subunit isoform 1   
 
ACCESSION  = XP_946679 
DEFINITION = PREDICTED: similar to CG32045-PB, isoform B isoform 5   
 
ACCESSION  = NP_443711 
DEFINITION = WD repeat domain 10 isoform 1   
 
ACCESSION  = XP_941631 
DEFINITION = PREDICTED: similar to fat3   
 
ACCESSION  = NP_001026877 
DEFINITION = hypothetical protein LOC55239 isoform 1   
 
ACCESSION  = NP_114064 
DEFINITION = neighbor of BRCA1 gene 1   
 
ACCESSION  = NP_775078 
DEFINITION = zonadhesin isoform 1   
 
ACCESSION  = NP_008965 
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ACCESSION  = NP_003613 
DEFINITION = PTPRF interacting protein binding protein 1 isoform 1   
 
ACCESSION  = NP_055963 
DEFINITION = PAS domain containing serine/threonine kinase   
 
ACCESSION  = NP_612149 
DEFINITION = ataxia telangiectasia mutated protein isoform 2   
 
ACCESSION  = XP_945150 
DEFINITION = PREDICTED: similar to human immunodeficiency virus type I 
enhancer binding protein 3   
 
ACCESSION  = NP_001005743 
DEFINITION = numb homolog isoform 1   
 
ACCESSION  = NP_037465 
DEFINITION = epsin 1   
 
ACCESSION  = NP_683723 
DEFINITION = epsin 2 isoform a   
 
ACCESSION  = NP_940961 XP_351515 
DEFINITION = hypothetical protein LOC375307   
 
ACCESSION  = NP_001004454 XP_071150 
DEFINITION = olfactory receptor, family 1, subfamily L, member 8   
 
ACCESSION  = NP_001002847 
DEFINITION = decreased expression in renal and prostate   
 
ACCESSION  = NP_996535 
DEFINITION = myelin oligodendrocyte glycoprotein isoform alpha2 precursor   
 
ACCESSION  = NP_060043 
DEFINITION = proprotein convertase subtilisin/kexin type 4   
 
ACCESSION  = XP_372255 
DEFINITION = PREDICTED: similar to CG4768-PA   
 
ACCESSION  = NP_001208 
DEFINITION = carbonic anhydrase XI precursor   
 
ACCESSION  = XP_942656 
DEFINITION = PREDICTED: hypothetical protein XP_942656   
 
ACCESSION  = NP_001005744 
DEFINITION = numb homolog isoform 2   
 
ACCESSION  = NP_000454 
DEFINITION = UDP glycosyltransferase 1 family, polypeptide A1 precursor   
 
ACCESSION  = NP_000042 
DEFINITION = ataxia telangiectasia mutated protein isoform 1   
 
ACCESSION  = NP_054789 
DEFINITION = STG protein   
 
ACCESSION  = XP_931423 
DEFINITION = PREDICTED: hypothetical protein XP_931423   
 
ACCESSION  = XP_942211 
DEFINITION = PREDICTED: similar to double homeobox 4c   
 
ACCESSION  = NP_001005745 
DEFINITION = numb homolog isoform 4   
 
ACCESSION  = XP_086287 
DEFINITION = PREDICTED: similar to protein tyrosine phosphatase, receptor type, 
V   
 
ACCESSION  = NP_113686 
DEFINITION = guanine nucleotide binding protein-gamma transducing activity 
polypeptide 2   
 
ACCESSION  = NP_006067 
DEFINITION = HIV-1 Rev-binding protein-like protein   
 
ACCESSION  = NP_001005736 
DEFINITION = lysosomal trafficking regulator isoform 2   
 
ACCESSION  = NP_955525 
DEFINITION = 5-hydroxytryptamine (serotonin) receptor 4 isoform g   
 
ACCESSION  = NP_001501 
DEFINITION = glutamate receptor, ionotropic, delta 2   
 
ACCESSION  = NP_620278 
DEFINITION = TBP-associated factor 1 isoform 2   
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ACCESSION  = NP_000861 
DEFINITION = 5-hydroxytryptamine (serotonin) receptor 4 isoform b   
 
ACCESSION  = NP_115801 
DEFINITION = KIAA1822 protein   
 
ACCESSION  = XP_946113 
DEFINITION = PREDICTED: similar to protein tyrosine phosphatase, receptor type, 
V   
 
ACCESSION  = NP_001004737 
DEFINITION = olfactory receptor, family 5, subfamily K, member 2   
 
ACCESSION  = XP_377445 
DEFINITION = PREDICTED: similar to double homeobox 4c   
 
ACCESSION  = NP_003546 
DEFINITION = olfactory receptor, family 1, subfamily G, member 1   
 
ACCESSION  = NP_000027 
DEFINITION = adenosine monophosphate deaminase 1 (isoform M)   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = NP_002410 
DEFINITION = mitogen-activated protein kinase kinase kinase 11   
 
ACCESSION  = NP_689940 
DEFINITION = copine II   
 
ACCESSION  = NP_001805 
DEFINITION = cathepsin C isoform a preproprotein   
 
ACCESSION  = NP_009097 
DEFINITION = phosphatidylinositol-binding clathrin assembly protein isoform 1   
 
ACCESSION  = NP_058632 
DEFINITION = ubinuclein 1   
 
ACCESSION  = NP_060115 
DEFINITION = hypothetical protein LOC54801   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = NP_055779 
DEFINITION = epsin 2 isoform b   
 
ACCESSION  = NP_060274 
DEFINITION = decreased expression in renal and prostate   
 
ACCESSION  = NP_060427 
DEFINITION = epsin 3   
 
ACCESSION  = NP_061753 
DEFINITION = protocadherin beta 10 precursor   
 
ACCESSION  = NP_002967 
DEFINITION = sodium channel, voltage-gated, type VII, alpha   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_733751 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 3 isoform 2   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_079022 
DEFINITION = hypothetical protein LOC79802   
 
ACCESSION  = NP_000183 
DEFINITION = T-box 5 isoform 1   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_003735 
DEFINITION = numb homolog isoform 3   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = NP_055719 
DEFINITION = RAB11 family interacting protein 2 (class I)   
 
ACCESSION  = NP_955372 XP_351142 
DEFINITION = hypothetical protein LOC374819   
 
ACCESSION  = NP_003390 
DEFINITION = X-prolyl aminopeptidase 2, membrane-bound   
 
ACCESSION  = NP_000072 
DEFINITION = lysosomal trafficking regulator isoform 1   
 
ACCESSION  = XP_066058 
DEFINITION = PREDICTED: hypothetical protein LOC128611   
 
ACCESSION  = NP_996532 
DEFINITION = myelin oligodendrocyte glycoprotein isoform alpha1 precursor   
 
ACCESSION  = NP_064563 
DEFINITION = carbonic anhydrase X   
 
ACCESSION  = NP_061992 
DEFINITION = protocadherin beta 9 precursor   
 
ACCESSION  = NP_055790 
DEFINITION = microtubule associated serine/threonine kinase 1   
 
ACCESSION  = NP_004248 
DEFINITION = TGF beta receptor associated protein -1   
 
ACCESSION  = NP_542448 
DEFINITION = T-box 5 isoform 3   
 
ACCESSION  = NP_004747 
DEFINITION = numb homolog (Drosophila)-like   
 
ACCESSION  = XP_950074 
DEFINITION = PREDICTED: hypothetical protein XP_950074   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
 
ACCESSION  = NP_067053 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 3 isoform 1   
 
ACCESSION  = NP_542449 
DEFINITION = T-box 5 isoform 2   
 
ACCESSION  = NP_955452 NP_054844 
DEFINITION = DNA polymerase theta   
 
ACCESSION  = NP_060958 
DEFINITION = T-box 4   
 
ACCESSION  = NP_000341 
DEFINITION = ATP-binding cassette, sub-family A member 4   
 
ACCESSION  = XP_940860 
DEFINITION = PREDICTED: hypothetical protein LOC54801   
 
ACCESSION  = XP_941802 
DEFINITION = PREDICTED: similar to CG4768-PA   
 
ACCESSION  = NP_060225 
DEFINITION = NOL1/NOP2/Sun domain family 2 protein   
 
ACCESSION  = NP_066267 
DEFINITION = ankyrin 3 isoform 1   
 
ACCESSION  = NP_722516 
DEFINITION = TBP-associated factor RNA polymerase 1-like   
 
ACCESSION  = XP_945884 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATM (Ataxia 
telangiectasia mutated) (A-T, mutated)   
 
ACCESSION  = NP_659490 
DEFINITION = hypothetical protein LOC143630   
 
ACCESSION  = NP_059509 
DEFINITION = ubiquilin 3   
 
ACCESSION  = NP_919268 XP_089143 
DEFINITION = spindle assembly abnormal protein 6   
 
ACCESSION  = XP_946024 
DEFINITION = PREDICTED: similar to fibrillarin   
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ACCESSION  = NP_852259 
DEFINITION = T-box 5 isoform 1   
 
ACCESSION  = NP_001008229 
DEFINITION = myelin oligodendrocyte glycoprotein isoform alpha3 precursor   
 
ACCESSION  = NP_004597 
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ACCESSION  = NP_543009 
DEFINITION = G protein-coupled receptor 78   
 
ACCESSION  = NP_005582 
DEFINITION = meiotic recombination 11 homolog A isoform 1   
 
ACCESSION  = NP_079146 
DEFINITION = DEP domain containing 2 isoform a   
 
ACCESSION  = NP_004289 
DEFINITION = nucleoporin 155kDa isoform 2   
 
ACCESSION  = NP_877963 
DEFINITION = phospholipase C gamma 1 isoform b   
 
ACCESSION  = NP_005622 
DEFINITION = smoothened   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_001626 
DEFINITION = amphiphysin isoform 1   
 
ACCESSION  = NP_000435 
DEFINITION = X-linked phosphate regulating endopeptidase homolog   
 
ACCESSION  = NP_075561 
DEFINITION = hypothetical protein LOC65250   
 
ACCESSION  = NP_065997 XP_497076 
DEFINITION = hypothetical protein LOC57706 isoform 1   
 
ACCESSION  = NP_001082 
DEFINITION = amiloride binding protein 1 precursor   
 
ACCESSION  = NP_705618 
DEFINITION = nucleoporin 155kDa isoform 1   
 
ACCESSION  = NP_009099 
DEFINITION = ATP-binding cassette, sub-family A member 8   
 
ACCESSION  = XP_943763 
DEFINITION = PREDICTED: hypothetical protein LOC348487   
 
ACCESSION  = NP_005329 
DEFINITION = huntingtin interacting protein 1   
 
ACCESSION  = NP_001008536 XP_060104 
DEFINITION = trichohyalin-like 1   
 
ACCESSION  = NP_055889 
DEFINITION = kinesin family member 1B isoform b   
 
ACCESSION  = NP_000042 
DEFINITION = ataxia telangiectasia mutated protein isoform 1   
 
ACCESSION  = NP_005581 
DEFINITION = meiotic recombination 11 homolog A isoform 2   
 
ACCESSION  = NP_085124 
DEFINITION = dicer1   
 
ACCESSION  = NP_652761 
DEFINITION = A-kinase anchor protein 11 isoform 2   
 
ACCESSION  = XP_371501 
DEFINITION = PREDICTED: hypothetical protein LOC200424   
 
ACCESSION  = XP_944352 
DEFINITION = PREDICTED: similar to Zinc finger protein 469   
 
ACCESSION  = NP_703143 
DEFINITION = G protein-coupled receptor 26   
 
ACCESSION  = XP_943674 
DEFINITION = PREDICTED: similar to pleckstrin homology domain containing, 
family M (with RUN domain) member 1   
 
ACCESSION  = NP_036586 
DEFINITION = T-cell lymphoma invasion and metastasis 2 isoform a   
 
ACCESSION  = NP_005207 
DEFINITION = dolichyl-diphosphooligosaccharide-protein glycosyltransferase   
 
ACCESSION  = NP_071373 XP_371779 
DEFINITION = transposon-derived Buster3 transposase-like   
 
ACCESSION  = NP_061111 
DEFINITION = carbohydrate (chondroitin 4) sulfotransferase 12   
 
ACCESSION  = NP_690867 
DEFINITION = kelch repeat and BTB (POZ) domain-containing 6   
 
ACCESSION  = NP_871626 
DEFINITION = protein phosphatase 2, regulatory subunit B'', alpha isoform 2   
 
ACCESSION  = NP_919224 
DEFINITION = otoferlin isoform a   
 
ACCESSION  = NP_004377 
DEFINITION = chondroitin sulfate proteoglycan 3 (neurocan)   
 
ACCESSION  = NP_055146 
DEFINITION = solute carrier family 7, (cationic amino acid transporter, y+ system) 
member 11   
 
ACCESSION  = NP_689522 
DEFINITION = phosphoinositide-3-kinase adaptor protein 1   
 
ACCESSION  = NP_006039 
DEFINITION = ubiquitination factor E4B   
 
ACCESSION  = NP_001008226 
DEFINITION = CCR4-NOT transcription complex, subunit 4 isoform b   
 
ACCESSION  = NP_957720 
DEFINITION = membrane-bound transcription factor site-1 protease isoform 2 
preproprotein   
 
ACCESSION  = NP_006635 
DEFINITION = heat shock 105kD   
 
ACCESSION  = NP_647477 
DEFINITION = amphiphysin isoform 2   
 
ACCESSION  = NP_061859 
DEFINITION = SH3 domain and tetratricopeptide repeats 1   
 
ACCESSION  = NP_001028228 
DEFINITION = glutamine synthetase   
 
ACCESSION  = XP_941991 
DEFINITION = PREDICTED: similar to jumonji domain containing 2D   
 
ACCESSION  = NP_055139 
DEFINITION = alpha-methylacyl-CoA racemase isoform 1   
 
ACCESSION  = XP_947119 
DEFINITION = PREDICTED: similar to CXXC finger 6   
 
ACCESSION  = NP_002709 
DEFINITION = protein phosphatase 2, regulatory subunit B'', alpha isoform 1   
 
ACCESSION  = NP_005586 
DEFINITION = nuclear factor I/A   
 
ACCESSION  = XP_040592 
DEFINITION = PREDICTED: zinc finger protein 469   
 
ACCESSION  = NP_065871 
DEFINITION = PREX1 protein   
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ACCESSION  = NP_803187 
DEFINITION = dicer1   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = XP_371542 
DEFINITION = PREDICTED: RW1 protein isoform 1   
 
ACCESSION  = NP_002651 
DEFINITION = phospholipase C gamma 1 isoform a   
 
ACCESSION  = NP_037448 
DEFINITION = CCR4-NOT transcription complex, subunit 4 isoform a   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_055656 XP_498116 
DEFINITION = synaptosomal-associated protein, 91kDa homolog   
 
ACCESSION  = NP_057114 
DEFINITION = tetratricopeptide repeat domain 15   
 
ACCESSION  = XP_945025 
DEFINITION = PREDICTED: similar to RW1 protein isoform 6   
 
ACCESSION  = NP_525021 
DEFINITION = ATP-binding cassette, sub-family A, member 10   
 
ACCESSION  = NP_055731 
DEFINITION = lemur tyrosine kinase 2   
 
ACCESSION  = NP_067058 
DEFINITION = epidermal growth factor receptor pathway substrate 15-like 1   
 
ACCESSION  = NP_002056 
DEFINITION = glutamine synthetase   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_001028216 
DEFINITION = glutamine synthetase   
 
ACCESSION  = XP_931595 
DEFINITION = PREDICTED: similar to jumonji domain containing 2D   
 
ACCESSION  = NP_056234 
DEFINITION = adlican   
 
ACCESSION  = NP_000341 
DEFINITION = ATP-binding cassette, sub-family A member 4   
 
ACCESSION  = NP_002652 
DEFINITION = phospholipase C, gamma 2 (phosphatidylinositol-specific)   
 
ACCESSION  = NP_057332 
DEFINITION = A-kinase anchor protein 11 isoform 1   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = NP_002363 
DEFINITION = mannosidase, alpha, class 2A, member 1   
 
ACCESSION  = NP_001026859 
DEFINITION = phospholipase A2-activating protein isoform 1   
 
ACCESSION  = XP_290944 
DEFINITION = PREDICTED: pleckstrin homology domain containing, family M 
(with RUN domain) member 2   
 
ACCESSION  = NP_055753 
DEFINITION = mondoA   
 
ACCESSION  = NP_065121 
DEFINITION = dystonin isoform 1eB precursor   
 
ACCESSION  = NP_061948 
DEFINITION = UDP glycosyltransferase 1 family, polypeptide A10 precursor   
 
ACCESSION  = XP_945884 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATM (Ataxia 
telangiectasia mutated) (A-T, mutated)   
 
ACCESSION  = NP_003905 
DEFINITION = cyclin A1   
 
ACCESSION  = NP_004244 
DEFINITION = phospholipase A2-activating protein isoform 2   
 
ACCESSION  = NP_996816 XP_117190 XP_371342 XP_372814 
DEFINITION = usherin isoform B   
 
ACCESSION  = NP_115514 
DEFINITION = kelch repeat and BTB (POZ) domain containing 7   
 
ACCESSION  = XP_113971 
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ACCESSION  = NP_065965 XP_290768 
DEFINITION = chromosome 17 open reading frame 27   
 
ACCESSION  = NP_001017372 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = XP_947086 
DEFINITION = PREDICTED: similar to stereocilin   
 
ACCESSION  = NP_000755 
DEFINITION = cytochrome P450, family 2, subfamily A, polypeptide 7 isoform 1   
 
ACCESSION  = NP_055595 
DEFINITION = cullin 7   
 
ACCESSION  = NP_001295 
DEFINITION = carboxypeptidase D precursor   
 
ACCESSION  = NP_937756 
DEFINITION = CUB and Sushi multiple domains 3 isoform 1   
 
ACCESSION  = XP_943763 
DEFINITION = PREDICTED: hypothetical protein LOC348487   
 
ACCESSION  = NP_000042 
DEFINITION = ataxia telangiectasia mutated protein isoform 1   
 
ACCESSION  = NP_694857 
DEFINITION = solute carrier family 22 member 1 isoform b   
 
ACCESSION  = NP_612144 
DEFINITION = deltex 3-like   
 
ACCESSION  = NP_003048 
DEFINITION = solute carrier family 22 member 1 isoform a   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_036252 
DEFINITION = CD2-associated protein   
 
ACCESSION  = NP_085079 
DEFINITION = cytochrome P450, family 2, subfamily A, polypeptide 7 isoform 2   
 
ACCESSION  = NP_000753 
DEFINITION = cytochrome P450, family 2, subfamily A, polypeptide 6   
 
ACCESSION  = NP_150094 
DEFINITION = CUB and Sushi multiple domains 1   
 
ACCESSION  = NP_000757 
DEFINITION = cytochrome P450, family 2, subfamily A, polypeptide 13   
 
ACCESSION  = NP_477513 
DEFINITION = monoacylglycerol O-acyltransferase 1   
 
ACCESSION  = NP_055995 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform a   
 
ACCESSION  = NP_775774 
DEFINITION = hypothetical protein LOC146779   
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ACCESSION  = NP_955456 
DEFINITION = WW domain containing E3 ubiquitin protein ligase 2 isoform 2   
 
ACCESSION  = NP_054750 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = NP_008944 
DEFINITION = WW domain containing E3 ubiquitin protein ligase 1   
 
ACCESSION  = NP_001026 
DEFINITION = ryanodine receptor 2   
 
ACCESSION  = NP_005752 
DEFINITION = plexin C1   
 
ACCESSION  = NP_001015045 XP_371697 XP_376328 
DEFINITION = family with sequence similarity 13, member A1 isoform b   
 
ACCESSION  = NP_060466 
DEFINITION = de-etiolated 1   
 
ACCESSION  = XP_943543 
DEFINITION = PREDICTED: similar to zinc finger and BTB domain containing 36   
 
ACCESSION  = XP_941345 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_060828 
DEFINITION = ATP-binding cassette, sub-family F (GCN20), member 3   
 
ACCESSION  = XP_940697 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_037506 
DEFINITION = programmed cell death 6 interacting protein   
 
ACCESSION  = NP_005303 
DEFINITION = guanine nucleotide-releasing factor 2 isoform a   
 
ACCESSION  = NP_001019837 
DEFINITION = SH3-domain kinase binding protein 1 isoform b   
 
ACCESSION  = NP_937757 
DEFINITION = CUB and Sushi multiple domains 3 isoform 2   
 
ACCESSION  = NP_008945 
DEFINITION = WW domain containing E3 ubiquitin protein ligase 2 isoform 1   
 
ACCESSION  = NP_065708 
DEFINITION = zinc finger protein 304   
 
ACCESSION  = NP_004659 
DEFINITION = maltase-glucoamylase   
 
ACCESSION  = NP_001032 
DEFINITION = sucrase-isomaltase (alpha-glucosidase)   
 
ACCESSION  = XP_944522 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_055434 
DEFINITION = glutamate receptor KA1 precursor   
 
ACCESSION  = NP_444267 
DEFINITION = UDP glycosyltransferase 2 family, polypeptide B28   
 
ACCESSION  = NP_061720 
DEFINITION = axonemal dynein heavy chain 7   
 
ACCESSION  = NP_001019820 
DEFINITION = calnexin precursor   
 
ACCESSION  = NP_055656 XP_498116 
DEFINITION = synaptosomal-associated protein, 91kDa homolog   
 
ACCESSION  = NP_001027 
DEFINITION = ryanodine receptor 3   
 
ACCESSION  = NP_001596 
DEFINITION = alanyl-tRNA synthetase   
 
ACCESSION  = NP_001737 
DEFINITION = calnexin precursor   
 
ACCESSION  = NP_036460 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 9   
 
ACCESSION  = NP_005115 
DEFINITION = nucleoporin 153kDa   
 
ACCESSION  = NP_055698 XP_376328 
DEFINITION = family with sequence similarity 13, member A1 isoform a   
 
ACCESSION  = NP_612152 
DEFINITION = polycystin-1L1   
 
ACCESSION  = XP_931230 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_006155 
DEFINITION = nuclear factor (erythroid-derived 2)-like 2   
 
ACCESSION  = NP_001037 
DEFINITION = solute carrier family 12 (sodium/potassium/chloride transporters), 
member 2   
 
ACCESSION  = NP_002290 
DEFINITION = lactase-phlorizin hydrolase preproprotein   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = NP_055904 
DEFINITION = p53-associated parkin-like cytoplasmic protein   
 
ACCESSION  = NP_714544 
DEFINITION = stereocilin   
 
ACCESSION  = NP_055753 
DEFINITION = mondoA   
 
ACCESSION  = NP_061948 
DEFINITION = UDP glycosyltransferase 1 family, polypeptide A10 precursor   
 
ACCESSION  = NP_000763 
DEFINITION = cytochrome P450, family 2, subfamily C, polypeptide 18   
 
ACCESSION  = XP_945884 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATM (Ataxia 
telangiectasia mutated) (A-T, mutated)   
 
ACCESSION  = NP_114098 
DEFINITION = SH3-domain kinase binding protein 1 isoform a   
 
ACCESSION  = NP_941372 
DEFINITION = guanine nucleotide-releasing factor 2 isoform b   
 
ACCESSION  = XP_113971 
DEFINITION = PREDICTED: similar to zinc finger and BTB domain containing 36   
 
ACCESSION  = NP_443132 
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ACCESSION  = XP_946284 
DEFINITION = PREDICTED: similar to ataxia telangiectasia and Rad3 related 
protein   
 
ACCESSION  = NP_001017372 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = XP_947086 
DEFINITION = PREDICTED: similar to stereocilin   
 
ACCESSION  = XP_951183 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 5   
 
ACCESSION  = XP_497655 
DEFINITION = PREDICTED: similar to PRAME family member 8   
 
ACCESSION  = NP_055595 
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DEFINITION = cullin 7   
 
ACCESSION  = NP_758872 
DEFINITION = potassium voltage-gated channel, subfamily H, member 1 isoform 1   
 
ACCESSION  = NP_004891 
DEFINITION = apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 
3B   
 
ACCESSION  = NP_115643 
DEFINITION = regulator of G-protein signalling like 2   
 
ACCESSION  = NP_004643 
DEFINITION = ubiquitin specific protease 9, X-linked isoform 1   
 
ACCESSION  = XP_951187 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 8   
 
ACCESSION  = NP_775659 
DEFINITION = phosphodiesterase 8A isoform 4   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_001012276 XP_372762 
DEFINITION = PRAME family member 8   
 
ACCESSION  = NP_002596 
DEFINITION = phosphodiesterase 8A isoform 1   
 
ACCESSION  = XP_945571 
DEFINITION = PREDICTED: NYD-SP11 protein   
 
ACCESSION  = XP_943984 
DEFINITION = PREDICTED: similar to SMC hinge domain containing 1   
 
ACCESSION  = NP_004516 
DEFINITION = low density lipoprotein-related protein 2   
 
ACCESSION  = NP_055995 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform a   
 
ACCESSION  = NP_689639 
DEFINITION = apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 
3D   
 
ACCESSION  = NP_003487 
DEFINITION = transformation/transcription domain-associated protein   
 
ACCESSION  = NP_054750 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = NP_690867 
DEFINITION = kelch repeat and BTB (POZ) domain-containing 6   
 
ACCESSION  = NP_002702 
DEFINITION = protein phosphatase 1 glycogen-binding regulatory subunit 3   
 
ACCESSION  = NP_689522 
DEFINITION = phosphoinositide-3-kinase adaptor protein 1   
 
ACCESSION  = XP_942822 
DEFINITION = PREDICTED: similar to TBC1 domain family member 12   
 
ACCESSION  = NP_005699 
DEFINITION = glypican 6 precursor   
 
ACCESSION  = XP_947633 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 2   
 
ACCESSION  = NP_001175 
DEFINITION = ataxia telangiectasia and Rad3 related protein   
 
ACCESSION  = NP_149351 
DEFINITION = surfeit 4   
 
ACCESSION  = NP_000313 
DEFINITION = retinal degeneration slow protein   
 
ACCESSION  = XP_371164 
DEFINITION = PREDICTED: NYD-SP11 protein   
 
ACCESSION  = NP_001439 
DEFINITION = glypican 4   
 
ACCESSION  = XP_933775 
DEFINITION = PREDICTED: similar to CG15133-PA   
 
ACCESSION  = NP_004659 
DEFINITION = maltase-glucoamylase   
 
ACCESSION  = NP_775658 
DEFINITION = phosphodiesterase 8A isoform 4   
 
ACCESSION  = XP_951179 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 3   
 
ACCESSION  = NP_060142 
DEFINITION = transient receptor potential cation channel, subfamily M, member 7   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_775656 
DEFINITION = phosphodiesterase 8A isoform 2   
 
ACCESSION  = NP_004645 
DEFINITION = ubiquitin specific protease 9, Y-linked   
 
ACCESSION  = NP_001027 
DEFINITION = ryanodine receptor 3   
 
ACCESSION  = NP_036348 
DEFINITION = midline 2 isoform 1   
 
ACCESSION  = XP_951188 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 9   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_006819 
DEFINITION = activating signal cointegrator 1 complex subunit 3 isoform a   
 
ACCESSION  = NP_612409 XP_049384 XP_374590 
DEFINITION = nucleolar protein with MIF4G domain 1   
 
ACCESSION  = NP_056969 
DEFINITION = pre-mRNA cleavage complex II protein Pcf11   
 
ACCESSION  = NP_000457 
DEFINITION = peroxisome biogenesis factor 1   
 
ACCESSION  = NP_001037 
DEFINITION = solute carrier family 12 (sodium/potassium/chloride transporters), 
member 2   
 
ACCESSION  = NP_002290 
DEFINITION = lactase-phlorizin hydrolase preproprotein   
 
ACCESSION  = NP_068706 
DEFINITION = ubiquitin specific protease 9, X-linked isoform 2   
 
ACCESSION  = NP_055493 
DEFINITION = hypothetical protein LOC9701   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = XP_113962 
DEFINITION = PREDICTED: structural maintenance of chromosomes flexible hinge 
domain containing 1   
 
ACCESSION  = NP_775657 
DEFINITION = phosphodiesterase 8A isoform 3   
 
ACCESSION  = NP_055904 
DEFINITION = p53-associated parkin-like cytoplasmic protein   
 
ACCESSION  = XP_051081 
DEFINITION = PREDICTED: TBC1 domain family, member 12   
 
ACCESSION  = NP_714544 
DEFINITION = stereocilin   
 
ACCESSION  = NP_001012277 XP_497651 
DEFINITION = PRAME family member 7   
 
ACCESSION  = NP_002229 
DEFINITION = potassium voltage-gated channel, subfamily H, member 1 isoform 2   
 
ACCESSION  = XP_945854 
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DEFINITION = PREDICTED: similar to Serine-protein kinase ATR (Ataxia 
telangiectasia and Rad3-related protein) (FRAP-related protein 1)   
 
ACCESSION  = NP_065712 
DEFINITION = activation-induced cytidine deaminase   
 
ACCESSION  = NP_115514 
DEFINITION = kelch repeat and BTB (POZ) domain containing 7   
 
ACCESSION  = NP_060782 
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ACCESSION  = NP_060808 
DEFINITION = WD repeat domain 52   
 
ACCESSION  = NP_079146 
DEFINITION = DEP domain containing 2 isoform a   
 
ACCESSION  = NP_065965 XP_290768 
DEFINITION = chromosome 17 open reading frame 27   
 
ACCESSION  = NP_647593 
DEFINITION = bridging integrator 1 isoform 1   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_001626 
DEFINITION = amphiphysin isoform 1   
 
ACCESSION  = NP_058633 
DEFINITION = polymerase (DNA-directed), alpha   
 
ACCESSION  = XP_947055 
DEFINITION = PREDICTED: hypothetical protein LOC57571 isoform 3   
 
ACCESSION  = NP_001008536 XP_060104 
DEFINITION = trichohyalin-like 1   
 
ACCESSION  = NP_055950 XP_371954 XP_374530 
DEFINITION = nucleoporin 205kDa   
 
ACCESSION  = XP_208522 
DEFINITION = PREDICTED: hypothetical protein LOC57571 isoform 1   
 
ACCESSION  = NP_085124 
DEFINITION = dicer1   
 
ACCESSION  = NP_659462 
DEFINITION = hypothetical protein LOC221264   
 
ACCESSION  = NP_055928 
DEFINITION = zinc finger, ZZ type with EF hand domain 1   
 
ACCESSION  = NP_060552 
DEFINITION = polymerase (RNA) III (DNA directed) polypeptide B   
 
ACCESSION  = NP_001617 
DEFINITION = v-akt murine thymoma viral oncogene homolog 2   
 
ACCESSION  = NP_005839 XP_050909 
DEFINITION = c-myc promoter binding protein   
 
ACCESSION  = NP_055995 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform a   
 
ACCESSION  = NP_071373 XP_371779 
DEFINITION = transposon-derived Buster3 transposase-like   
 
ACCESSION  = NP_003162 
DEFINITION = suppressor of var1, 3-like 1   
 
ACCESSION  = NP_001355 
DEFINITION = chapsyn-110   
 
ACCESSION  = NP_937883 
DEFINITION = restin isoform b   
 
ACCESSION  = NP_005752 
DEFINITION = plexin C1   
 
ACCESSION  = NP_647477 
DEFINITION = amphiphysin isoform 2   
 
ACCESSION  = NP_055426 
DEFINITION = MDN1, midasin homolog   
 
ACCESSION  = NP_001578 
DEFINITION = phosphatidylinositol polyphosphate 5-phosphatase isoform b   
 
ACCESSION  = NP_002947 
DEFINITION = restin isoform a   
 
ACCESSION  = NP_055778 XP_375553 
DEFINITION = KIAA0963   
 
ACCESSION  = NP_001175 
DEFINITION = ataxia telangiectasia and Rad3 related protein   
 
ACCESSION  = NP_001870 
DEFINITION = mannan-binding lectin serine protease 1 isoform 1 precursor   
 
ACCESSION  = NP_008983 
DEFINITION = NADPH oxidase 1 isoform long   
 
ACCESSION  = NP_039249 
DEFINITION = NADPH oxidase 1 isoform long variant   
 
ACCESSION  = NP_803187 
DEFINITION = dicer1   
 
ACCESSION  = NP_006486 
DEFINITION = ecotropic viral integration site 2B   
 
ACCESSION  = NP_000267 
DEFINITION = phosphatidylinositol polyphosphate 5-phosphatase isoform a   
 
ACCESSION  = NP_039248 
DEFINITION = NADPH oxidase 1 isoform short   
 
ACCESSION  = XP_942685 
DEFINITION = PREDICTED: similar to RIKEN cDNA 4832428D23   
 
ACCESSION  = NP_055731 
DEFINITION = lemur tyrosine kinase 2   
 
ACCESSION  = NP_004800 
DEFINITION = stomatin (EPB72)-like 1   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_006819 
DEFINITION = activating signal cointegrator 1 complex subunit 3 isoform a   
 
ACCESSION  = NP_955452 NP_054844 
DEFINITION = DNA polymerase theta   
 
ACCESSION  = XP_062872 
DEFINITION = PREDICTED: similar to RIKEN cDNA 4832428D23   
 
ACCESSION  = NP_079446 
DEFINITION = DEP domain containing 2 isoform b   
 
ACCESSION  = NP_937762 
DEFINITION = laminin alpha 3 subunit isoform 1   
 
ACCESSION  = NP_001724 
DEFINITION = complement component 1, r subcomponent   
 
ACCESSION  = NP_060921 
DEFINITION = centromere protein J   
 
ACCESSION  = XP_945854 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATR (Ataxia 
telangiectasia and Rad3-related protein) (FRAP-related protein 1)   
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ACCESSION  = NP_001814 
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ACCESSION  = NP_001017372 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = NP_005622 
DEFINITION = smoothened   
 
ACCESSION  = NP_757343 
DEFINITION = calcium/calmodulin-dependent protein kinase 1 alpha isoform a   
 
ACCESSION  = NP_065997 XP_497076 
DEFINITION = hypothetical protein LOC57706 isoform 1   
 
ACCESSION  = NP_115643 
DEFINITION = regulator of G-protein signalling like 2   
 
ACCESSION  = NP_004643 
DEFINITION = ubiquitin specific protease 9, X-linked isoform 1   
 
ACCESSION  = NP_004341 
DEFINITION = runt-related transcription factor 3 isoform 2   
 
ACCESSION  = NP_000042 
DEFINITION = ataxia telangiectasia mutated protein isoform 1   
 
ACCESSION  = NP_002412 
DEFINITION = matrix metalloproteinase 1 preproprotein   
 
ACCESSION  = NP_757344 
DEFINITION = calcium/calmodulin-dependent protein kinase 1 alpha isoform b   
 
ACCESSION  = NP_652761 
DEFINITION = A-kinase anchor protein 11 isoform 2   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_056372 
DEFINITION = chromodomain helicase DNA binding protein 5   
 
ACCESSION  = XP_943674 
DEFINITION = PREDICTED: similar to pleckstrin homology domain containing, 
family M (with RUN domain) member 1   
 
ACCESSION  = NP_036586 
DEFINITION = T-cell lymphoma invasion and metastasis 2 isoform a   
 
ACCESSION  = NP_001226 NP_004344 
DEFINITION = serine (or cysteine) proteinase inhibitor, clade H, member 1 precursor   
 
ACCESSION  = NP_005860 
DEFINITION = serologically defined colon cancer antigen 10   
 
ACCESSION  = NP_001018047 
DEFINITION = vacuolar protein sorting 13A isoform C   
 
ACCESSION  = NP_054750 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = NP_056001 
DEFINITION = vacuolar protein sorting 13A isoform B   
 
ACCESSION  = NP_006785 
DEFINITION = G protein-coupled receptor 75   
 
ACCESSION  = NP_001026850 
DEFINITION = runt-related transcription factor 3 isoform 1   
 
ACCESSION  = NP_000523 
DEFINITION = propionyl Coenzyme A carboxylase, beta polypeptide   
 
ACCESSION  = NP_001438 
DEFINITION = FAT tumor suppressor 2 precursor   
 
ACCESSION  = NP_002539 
DEFINITION = olfactory receptor, family 1, subfamily D, member 2   
 
ACCESSION  = NP_005586 
DEFINITION = nuclear factor I/A   
 
ACCESSION  = NP_056090 XP_035313 
DEFINITION = hypothetical protein LOC23325   
 
ACCESSION  = NP_004659 
DEFINITION = maltase-glucoamylase   
 
ACCESSION  = XP_944522 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_002967 
DEFINITION = sodium channel, voltage-gated, type VII, alpha   
 
ACCESSION  = NP_060142 
DEFINITION = transient receptor potential cation channel, subfamily M, member 7   
 
ACCESSION  = NP_001101 
DEFINITION = ADAM metallopeptidase domain 10   
 
ACCESSION  = NP_003256 
DEFINITION = toll-like receptor 3   
 
ACCESSION  = NP_004645 
DEFINITION = ubiquitin specific protease 9, Y-linked   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_071881 
DEFINITION = sterolin 1   
 
ACCESSION  = NP_001018048 
DEFINITION = vacuolar protein sorting 13A isoform D   
 
ACCESSION  = NP_055921 
DEFINITION = RAD54-like 2   
 
ACCESSION  = NP_001017970 XP_090844 
DEFINITION = transmembrane protein 30B   
 
ACCESSION  = NP_612409 XP_049384 XP_374590 
DEFINITION = nucleolar protein with MIF4G domain 1   
 
ACCESSION  = NP_150648 
DEFINITION = vacuolar protein sorting 13A isoform A   
 
ACCESSION  = NP_955452 NP_054844 
DEFINITION = DNA polymerase theta   
 
ACCESSION  = NP_000341 
DEFINITION = ATP-binding cassette, sub-family A member 4   
 
ACCESSION  = NP_057332 
DEFINITION = A-kinase anchor protein 11 isoform 1   
 
ACCESSION  = NP_068706 
DEFINITION = ubiquitin specific protease 9, X-linked isoform 2   
 
ACCESSION  = NP_060676 
DEFINITION = vacuolar protein sorting 35   
 
ACCESSION  = NP_056028 XP_290550 
DEFINITION = RAB6 interacting protein 1   
 
ACCESSION  = XP_290944 
DEFINITION = PREDICTED: pleckstrin homology domain containing, family M 
(with RUN domain) member 2   
 
ACCESSION  = NP_115670 
DEFINITION = calcium/calmodulin-dependent protein kinase 1 alpha isoform a   
 
ACCESSION  = NP_003543 XP_375390 
DEFINITION = olfactory receptor, family 1, subfamily D, member 4   
 
ACCESSION  = XP_945884 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATM (Ataxia 
telangiectasia mutated) (A-T, mutated)   
 
ACCESSION  = NP_057665 
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ACCESSION  = XP_055481 
DEFINITION = PREDICTED: myb-like, SWIRM and MPN domains 1   
 
ACCESSION  = NP_006142 XP_042207 
DEFINITION = lactoperoxidase   
 
ACCESSION  = XP_945719 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 1   
 
ACCESSION  = NP_055680 
DEFINITION = chromosome condensation-related SMC-associated protein 1   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_543148 
DEFINITION = netrin receptor Unc5h4   
 
ACCESSION  = XP_941069 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 8   
 
ACCESSION  = NP_065816 
DEFINITION = retinoblastoma-associated factor 600   
 
ACCESSION  = NP_573570 
DEFINITION = PGC-1-related estrogen receptor alpha coactivator   
 
ACCESSION  = XP_946889 
DEFINITION = PREDICTED: similar to myb-like, SWIRM and MPN domains 1   
 
ACCESSION  = XP_935639 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 1   
 
ACCESSION  = NP_001026971 
DEFINITION = LIM domain kinase 2 isoform 1   
 
ACCESSION  = NP_056076 XP_166201 
DEFINITION = KIAA0056 protein   
 
ACCESSION  = XP_373030 
DEFINITION = PREDICTED: hypothetical protein XP_373030   
 
ACCESSION  = NP_005560 
DEFINITION = LIM domain kinase 2 isoform 2a   
 
ACCESSION  = XP_940464 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 3   
 
ACCESSION  = NP_055726 
DEFINITION = AP2 associated kinase 1   
 
ACCESSION  = NP_061888 XP_376724 XP_379974 
DEFINITION = chondroitin sulfate glucuronyltransferase   
 
ACCESSION  = NP_004545 
DEFINITION = cytoplasmic nuclear factor of activated T-cells 4   
 
ACCESSION  = NP_942595 
DEFINITION = BMP-2 inducible kinase isoform a   
 
ACCESSION  = NP_054860 
DEFINITION = cell recognition molecule Caspr2 precursor   
 
ACCESSION  = NP_005916 
DEFINITION = meprin A, beta   
 
ACCESSION  = XP_933562 
DEFINITION = PREDICTED: hypothetical protein XP_933562   
 
ACCESSION  = XP_940790 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 3   
 
ACCESSION  = NP_064569 
DEFINITION = cyclin M4   
 
ACCESSION  = NP_115971 XP_496236 
DEFINITION = ubiquitin specific protease 32   
 
ACCESSION  = XP_949797 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 6   
 
ACCESSION  = NP_056534 
DEFINITION = collagen, type V, alpha 3 preproprotein   
 
ACCESSION  = NP_689914 
DEFINITION = ATP binding cassette, sub-family A (ABC1), member 13   
 
ACCESSION  = NP_690867 
DEFINITION = kelch repeat and BTB (POZ) domain-containing 6   
 
ACCESSION  = NP_697043 
DEFINITION = retinoblastoma binding protein 9   
 
ACCESSION  = NP_065928 XP_209041 
DEFINITION = protein similar to dynein   
 
ACCESSION  = NP_689522 
DEFINITION = phosphoinositide-3-kinase adaptor protein 1   
 
ACCESSION  = NP_002410 
DEFINITION = mitogen-activated protein kinase kinase kinase 11   
 
ACCESSION  = NP_113584 NP_005694 NP_060097 XP_497119 
DEFINITION = HECT, UBA and WWE domain containing 1   
 
ACCESSION  = XP_949782 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 3   
 
ACCESSION  = NP_060753 
DEFINITION = nudix-type motif 15   
 
ACCESSION  = NP_001395 
DEFINITION = eukaryotic translation elongation factor 1 gamma   
 
ACCESSION  = NP_004066 
DEFINITION = cryptochrome 1 (photolyase-like)   
 
ACCESSION  = NP_689494 
DEFINITION = NTKL-binding protein 1   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_114128 
DEFINITION = RALBP1 associated Eps domain containing 1   
 
ACCESSION  = NP_065870 XP_371832 
DEFINITION = hypothetical protein LOC57579   
 
ACCESSION  = NP_000183 
DEFINITION = T-box 5 isoform 1   
 
ACCESSION  = XP_940468 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 6   
 
ACCESSION  = NP_061897 XP_042685 
DEFINITION = hypothetical protein LOC54497   
 
ACCESSION  = XP_933588 
DEFINITION = PREDICTED: similar to vasoactive intestinal peptide receptor 2   
 
ACCESSION  = NP_006597 
DEFINITION = retinoblastoma binding protein 9   
 
ACCESSION  = NP_741996 
DEFINITION = sal-like 3   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = XP_941064 
DEFINITION = PREDICTED: similar to Elongation factor 1-gamma (EF-1-gamma) 
(eEF-1B gamma) isoform 5   
 
ACCESSION  = NP_542448 
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DEFINITION = T-box 5 isoform 3   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
 
ACCESSION  = NP_542449 
DEFINITION = T-box 5 isoform 2   
 
ACCESSION  = NP_002323 
DEFINITION = low density lipoprotein-related protein 1   
 
ACCESSION  = NP_060958 
DEFINITION = T-box 4   
 
ACCESSION  = NP_060414 
DEFINITION = ubiquitin specific protease 47   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = NP_060225 
DEFINITION = NOL1/NOP2/Sun domain family 2 protein   
 
ACCESSION  = NP_005246 
DEFINITION = cyclin G associated kinase   
 
ACCESSION  = NP_057952 
DEFINITION = LIM domain kinase 2 isoform 2b   
 
ACCESSION  = NP_061027 
DEFINITION = low density lipoprotein-related protein 1B   
 
ACCESSION  = NP_066267 
DEFINITION = ankyrin 3 isoform 1   
 
ACCESSION  = XP_944598 
DEFINITION = PREDICTED: hypothetical protein XP_944598   
 
ACCESSION  = NP_115514 
DEFINITION = kelch repeat and BTB (POZ) domain containing 7   
 
ACCESSION  = NP_852259 
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ACCESSION  = NP_004232 XP_495826 
DEFINITION = jumonji domain containing 1C   
 
ACCESSION  = NP_005466 
DEFINITION = lymphocyte adaptor protein   
 
ACCESSION  = NP_003997 
DEFINITION = dystrophin Dp427m isoform   
 
ACCESSION  = XP_947086 
DEFINITION = PREDICTED: similar to stereocilin   
 
ACCESSION  = NP_065816 
DEFINITION = retinoblastoma-associated factor 600   
 
ACCESSION  = NP_055993 
DEFINITION = Rho-related BTB domain containing 2   
 
ACCESSION  = NP_597812 
DEFINITION = sodium bicarbonate transporter 4 isoform c   
 
ACCESSION  = NP_055595 
DEFINITION = cullin 7   
 
ACCESSION  = NP_060009 
DEFINITION = dynein, axonemal, heavy polypeptide 3   
 
ACCESSION  = NP_001260 
DEFINITION = regulator of chromosome condensation 1   
 
ACCESSION  = NP_002213 
DEFINITION = inositol 1,4,5-triphosphate receptor, type 1   
 
ACCESSION  = NP_001377 
DEFINITION = dihydropyrimidinase-like 2   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_055869 XP_045423 
DEFINITION = hypothetical protein LOC23074 isoform a   
 
ACCESSION  = NP_477513 
DEFINITION = monoacylglycerol O-acyltransferase 1   
 
ACCESSION  = NP_055995 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform a   
 
ACCESSION  = NP_067019 
DEFINITION = sodium bicarbonate transporter 4 isoform a   
 
ACCESSION  = NP_066189 
DEFINITION = adaptor protein with pleckstrin homology and src homology 2 
domains   
 
ACCESSION  = NP_006606 
DEFINITION = calpain 9 isoform 1   
 
ACCESSION  = NP_631905 
DEFINITION = striated muscle activator of Rho-dependent signaling   
 
ACCESSION  = NP_055651 
DEFINITION = Rho-related BTB domain containing 1   
 
ACCESSION  = NP_597813 
DEFINITION = sodium bicarbonate transporter 4 isoform d   
 
ACCESSION  = NP_001027552 
DEFINITION = Rho-related BTB domain containing 1   
 
ACCESSION  = XP_947633 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 2   
 
ACCESSION  = NP_055051 
DEFINITION = glyceronephosphate O-acyltransferase   
 
ACCESSION  = NP_004001 
DEFINITION = dystrophin Dp427p2 isoform   
 
ACCESSION  = NP_001026849 
DEFINITION = methionine sulfoxide reductase B3 isoform 2   
 
ACCESSION  = NP_000100 
DEFINITION = dystrophin Dp427c isoform   
 
ACCESSION  = NP_056466 XP_045308 
DEFINITION = PHD finger protein 19 isoform a   
 
ACCESSION  = NP_004659 
DEFINITION = maltase-glucoamylase   
 
ACCESSION  = NP_004000 
DEFINITION = dystrophin Dp427p1 isoform   
 
ACCESSION  = NP_001032 
DEFINITION = sucrase-isomaltase (alpha-glucosidase)   
 
ACCESSION  = XP_951179 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 3   
 
ACCESSION  = NP_115536 
DEFINITION = hypothetical protein LOC92126   
 
ACCESSION  = NP_057688 
DEFINITION = jumonji domain containing 1B   
 
ACCESSION  = NP_006589 
DEFINITION = solute carrier family 12 (potassium/chloride transporters), member 7   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_061720 
DEFINITION = axonemal dynein heavy chain 7   
 
ACCESSION  = NP_201580 
DEFINITION = sodium bicarbonate transporter 4 isoform b   
 
ACCESSION  = XP_951188 
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DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 9   
 
ACCESSION  = NP_071341 
DEFINITION = solute carrier family 4, sodium bicarbonate transporter-like, member 
10   
 
ACCESSION  = NP_612152 
DEFINITION = polycystin-1L1   
 
ACCESSION  = NP_002290 
DEFINITION = lactase-phlorizin hydrolase preproprotein   
 
ACCESSION  = NP_055493 
DEFINITION = hypothetical protein LOC9701   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = NP_060903 
DEFINITION = jumonji domain containing 1A   
 
ACCESSION  = NP_055904 
DEFINITION = p53-associated parkin-like cytoplasmic protein   
 
ACCESSION  = NP_937868 
DEFINITION = Rho-related BTB domain containing 1   
 
ACCESSION  = NP_055178 
DEFINITION = sacsin   
 
ACCESSION  = NP_714544 
DEFINITION = stereocilin   
 
ACCESSION  = NP_003989 
DEFINITION = nuclear factor kappa-B, subunit 1   
 
ACCESSION  = NP_932346 
DEFINITION = methionine sulfoxide reductase B3 isoform 1   
 
ACCESSION  = NP_003998 
DEFINITION = dystrophin Dp427l isoform   
 
ACCESSION  = NP_031384 
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ACCESSION  = NP_004232 XP_495826 
DEFINITION = jumonji domain containing 1C   
 
ACCESSION  = NP_079021 
DEFINITION = SHC SH2-domain binding protein 1   
 
ACCESSION  = XP_940910 
DEFINITION = PREDICTED: similar to radical S-adenosyl methionine and 
flavodoxin domains 1 isoform 6   
 
ACCESSION  = XP_940913 
DEFINITION = PREDICTED: similar to radical S-adenosyl methionine and 
flavodoxin domains 1 isoform 7   
 
ACCESSION  = NP_543148 
DEFINITION = netrin receptor Unc5h4   
 
ACCESSION  = NP_006286 
DEFINITION = valyl-tRNA synthetase   
 
ACCESSION  = NP_149062 
DEFINITION = nesprin 1 isoform longer   
 
ACCESSION  = NP_079406 
DEFINITION = hexokinase domain containing 1   
 
ACCESSION  = NP_055595 
DEFINITION = cullin 7   
 
ACCESSION  = XP_942900 
DEFINITION = PREDICTED: similar to dynein, cytoplasmic, heavy chain 2 isoform 
3   
 
ACCESSION  = NP_056327 
DEFINITION = dynein, axonemal, heavy polypeptide 1   
 
ACCESSION  = NP_001363 
DEFINITION = dynein, axonemal, heavy polypeptide 9 isoform 2   
 
ACCESSION  = NP_842565 
DEFINITION = spectrin, beta, non-erythrocytic 1 isoform 2   
 
ACCESSION  = XP_937109 
DEFINITION = PREDICTED: hypothetical protein LOC441250 isoform 3   
 
ACCESSION  = NP_277033 
DEFINITION = hexokinase 1 isoform HKI-ta/tb   
 
ACCESSION  = NP_065779 
DEFINITION = family with sequence similarity 62 (C2 domain containing) member 
B   
 
ACCESSION  = NP_878918 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform e   
 
ACCESSION  = NP_149992 XP_372210 
DEFINITION = protein phosphatase 1, regulatory (inhibitor) subunit 3F   
 
ACCESSION  = NP_006030 
DEFINITION = mannose receptor, C type 2   
 
ACCESSION  = NP_064616 
DEFINITION = hypothetical protein LOC56983   
 
ACCESSION  = NP_003768 
DEFINITION = dynein, axonemal, heavy polypeptide 11   
 
ACCESSION  = XP_950850 
DEFINITION = PREDICTED: similar to subcommissural organ spondin isoform 16   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_056108 
DEFINITION = nesprin 1 isoform beta   
 
ACCESSION  = NP_060127 
DEFINITION = aftiphilin protein isoform b   
 
ACCESSION  = XP_942394 
DEFINITION = PREDICTED: similar to CG7400-PA, isoform A isoform 2   
 
ACCESSION  = NP_055995 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform a   
 
ACCESSION  = NP_000329 
DEFINITION = sodium potassium chloride cotransporter 2   
 
ACCESSION  = NP_277031 
DEFINITION = hexokinase 1 isoform HKI-R   
 
ACCESSION  = NP_277035 
DEFINITION = hexokinase 1 isoform HKI-td   
 
ACCESSION  = NP_003322 
DEFINITION = tyrosine kinase 2   
 
ACCESSION  = XP_933562 
DEFINITION = PREDICTED: hypothetical protein XP_933562   
 
ACCESSION  = NP_612815 
DEFINITION = BCL2-like 1 isoform 1   
 
ACCESSION  = NP_689518 
DEFINITION = hypothetical protein LOC56983   
 
ACCESSION  = NP_689914 
DEFINITION = ATP binding cassette, sub-family A (ABC1), member 13   
 
ACCESSION  = NP_003096 
DEFINITION = sortilin-related receptor containing LDLR class A repeats 
preproprotein   
 
ACCESSION  = NP_001007468 XP_038520 
DEFINITION = spindle assembly associated Sfi1 homolog isoform a   
 
ACCESSION  = NP_065928 XP_209041 
DEFINITION = protein similar to dynein   
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ACCESSION  = NP_001367 
DEFINITION = dynein, cytoplasmic, heavy polypeptide 1   
 
ACCESSION  = NP_055433 
DEFINITION = deleted in bladder cancer 1   
 
ACCESSION  = NP_062548 
DEFINITION = butyrophilin-like 2   
 
ACCESSION  = NP_060734 
DEFINITION = radical S-adenosyl methionine and flavodoxin domains 1   
 
ACCESSION  = XP_947633 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 2   
 
ACCESSION  = NP_001362 
DEFINITION = dynein, axonemal, heavy polypeptide 8   
 
ACCESSION  = NP_149095 
DEFINITION = stonin 2   
 
ACCESSION  = NP_000180 
DEFINITION = hexokinase 2   
 
ACCESSION  = NP_982261 
DEFINITION = aftiphilin protein isoform a   
 
ACCESSION  = XP_940855 
DEFINITION = PREDICTED: similar to subcommissural organ spondin isoform 7   
 
ACCESSION  = NP_000118 
DEFINITION = exostosin 1   
 
ACCESSION  = NP_055051 
DEFINITION = glyceronephosphate O-acyltransferase   
 
ACCESSION  = NP_872372 
DEFINITION = secretory protein LOC284013   
 
ACCESSION  = XP_371164 
DEFINITION = PREDICTED: NYD-SP11 protein   
 
ACCESSION  = NP_004659 
DEFINITION = maltase-glucoamylase   
 
ACCESSION  = XP_937099 
DEFINITION = PREDICTED: hypothetical protein LOC441250 isoform 2   
 
ACCESSION  = NP_001032 
DEFINITION = sucrase-isomaltase (alpha-glucosidase)   
 
ACCESSION  = XP_951179 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 3   
 
ACCESSION  = NP_002325 XP_035037 
DEFINITION = low density lipoprotein receptor-related protein 4   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_001945 
DEFINITION = discoidin domain receptor family, member 1 isoform b   
 
ACCESSION  = NP_114128 
DEFINITION = RALBP1 associated Eps domain containing 1   
 
ACCESSION  = NP_005145 
DEFINITION = ubiquitin specific protease 8   
 
ACCESSION  = XP_039877 
DEFINITION = PREDICTED: mucin 5, subtype B, tracheobronchial   
 
ACCESSION  = NP_057736 
DEFINITION = crooked neck-like 1 protein   
 
ACCESSION  = NP_002327 
DEFINITION = low density lipoprotein receptor-related protein 6   
 
ACCESSION  = NP_006099 NP_116109 
DEFINITION = spondin 1, extracellular matrix protein   
 
ACCESSION  = NP_071375 
DEFINITION = CTF18, chromosome transmission fidelity factor 18 homolog   
 
ACCESSION  = NP_001360 
DEFINITION = dynein, axonemal, heavy polypeptide 5   
 
ACCESSION  = XP_951188 
DEFINITION = PREDICTED: similar to Protein KIAA0685 isoform 9   
 
ACCESSION  = NP_071341 
DEFINITION = solute carrier family 4, sodium bicarbonate transporter-like, member 
10   
 
ACCESSION  = XP_933588 
DEFINITION = PREDICTED: similar to vasoactive intestinal peptide receptor 2   
 
ACCESSION  = NP_000179 
DEFINITION = hexokinase 1 isoform HKI   
 
ACCESSION  = NP_001002243 
DEFINITION = aftiphilin protein isoform c   
 
ACCESSION  = XP_943930 
DEFINITION = PREDICTED: similar to Mucin-5B precursor (Mucin 5 subtype B, 
tracheobronchial) (High molecular weight salivary mucin MG1) (Sublingual gland 
mucin)   
 
ACCESSION  = NP_002326 
DEFINITION = low density lipoprotein receptor-related protein 5   
 
ACCESSION  = NP_776297 
DEFINITION = chloride channel 3 isoform e   
 
ACCESSION  = XP_937111 
DEFINITION = PREDICTED: hypothetical protein LOC441250 isoform 4   
 
ACCESSION  = XP_940915 
DEFINITION = PREDICTED: similar to radical S-adenosyl methionine and 
flavodoxin domains 1 isoform 8   
 
ACCESSION  = XP_371850 
DEFINITION = PREDICTED: similar to CaLPain family member (clp-2)   
 
ACCESSION  = NP_002323 
DEFINITION = low density lipoprotein-related protein 1   
 
ACCESSION  = XP_940626 
DEFINITION = PREDICTED: similar to radical S-adenosyl methionine and 
flavodoxin domains 1 isoform 5   
 
ACCESSION  = NP_002290 
DEFINITION = lactase-phlorizin hydrolase preproprotein   
 
ACCESSION  = NP_055907 NP_054725 
DEFINITION = PI-3-kinase-related kinase SMG-1   
 
ACCESSION  = NP_892006 
DEFINITION = nesprin 1 longest   
 
ACCESSION  = NP_000780 
DEFINITION = angiotensin I converting enzyme isoform 1 precursor   
 
ACCESSION  = NP_060414 
DEFINITION = ubiquitin specific protease 47   
 
ACCESSION  = NP_055493 
DEFINITION = hypothetical protein LOC9701   
 
ACCESSION  = NP_056483 
DEFINITION = regulator of G-protein signalling 22   
 
ACCESSION  = NP_060903 
DEFINITION = jumonji domain containing 1A   
 
ACCESSION  = XP_370652 
DEFINITION = PREDICTED: dynein, cytoplasmic, heavy polypeptide 2 isoform 1   
 
ACCESSION  = NP_055590 XP_038520 
DEFINITION = spindle assembly associated Sfi1 homolog isoform b   
 
ACCESSION  = NP_001820 
DEFINITION = chloride channel 3 isoform b   
 
ACCESSION  = XP_946413 
DEFINITION = PREDICTED: similar to CaLPain family member (clp-2)   
 
ACCESSION  = NP_061027 
DEFINITION = low density lipoprotein-related protein 1B   
 
ACCESSION  = XP_932438 
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DEFINITION = PREDICTED: hypothetical protein LOC441250 isoform 1   
 
ACCESSION  = NP_277032 
DEFINITION = hexokinase 1 isoform HKI-ta/tb   
 
ACCESSION  = NP_003119 
DEFINITION = spectrin, beta, non-erythrocytic 1 isoform 1   
 
ACCESSION  = NP_004446 
DEFINITION = exostoses (multiple)-like 1   
 
ACCESSION  = NP_003461 





The pattern being searched is W..[FW].[DE].*DDGLDEAFSRLAQSRT 
 









47 matches found in protein 
############################## 
ACCESSION  = NP_078946 
DEFINITION = suppressor of variegation 3-9 homolog 2   
 
ACCESSION  = NP_149062 
DEFINITION = nesprin 1 isoform longer   
 
ACCESSION  = NP_597812 
DEFINITION = sodium bicarbonate transporter 4 isoform c   
 
ACCESSION  = NP_060392 
DEFINITION = PRP39 pre-mRNA processing factor 39 homolog   
 
ACCESSION  = NP_001363 
DEFINITION = dynein, axonemal, heavy polypeptide 9 isoform 2   
 
ACCESSION  = NP_001026971 
DEFINITION = LIM domain kinase 2 isoform 1   
 
ACCESSION  = NP_065779 
DEFINITION = family with sequence similarity 62 (C2 domain containing) member 
B   
 
ACCESSION  = NP_877435 XP_170760 
DEFINITION = hypothetical protein LOC256764   
 
ACCESSION  = XP_043739 
DEFINITION = PREDICTED: dual specificity phosphatase 27 (putative) isoform 1   
 
ACCESSION  = NP_937879 
DEFINITION = Rho guanine nucleotide exchange factor (GEF) 11 isoform 2   
 
ACCESSION  = NP_002232 
DEFINITION = potassium inwardly-rectifying channel J10   
 
ACCESSION  = NP_003772 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_055995 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform a   
 
ACCESSION  = NP_788276 
DEFINITION = CDK5 regulatory subunit associated protein 3 isoform b   
 
ACCESSION  = NP_067019 
DEFINITION = sodium bicarbonate transporter 4 isoform a   
 
ACCESSION  = NP_000553 
DEFINITION = complement component 8, alpha polypeptide precursor   
 
ACCESSION  = NP_056107 
DEFINITION = family with sequence similarity 62 (C2 domain containing), member 
A   
 
ACCESSION  = NP_003031 
DEFINITION = solute carrier family 4, anion exchanger, member 2 (erythrocyte 
membrane protein band 3-like 1)   
 
ACCESSION  = NP_065928 XP_209041 
DEFINITION = protein similar to dynein   
 
ACCESSION  = XP_947521 
DEFINITION = PREDICTED: similar to Dual specificity protein phosphatase 13 
(Testis- and skeletal-muscle-specific DSP) isoform 4   
 
ACCESSION  = NP_057123 
DEFINITION = chromosome 14 open reading frame 166   
 
ACCESSION  = NP_597813 
DEFINITION = sodium bicarbonate transporter 4 isoform d   
 
ACCESSION  = NP_963868 
DEFINITION = solute carrier family 4, anion exchanger, member 3 isoform 2   
 
ACCESSION  = NP_149358 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_001362 
DEFINITION = dynein, axonemal, heavy polypeptide 8   
 
ACCESSION  = NP_982261 
DEFINITION = aftiphilin protein isoform a   
 
ACCESSION  = NP_057733 
DEFINITION = ABT1-associated protein   
 
ACCESSION  = NP_149359 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_055599 
DEFINITION = Rho guanine nucleotide exchange factor (GEF) 11 isoform 1   
 
ACCESSION  = NP_004644 
DEFINITION = Smcy homolog, Y-linked   
 
ACCESSION  = NP_001175 
DEFINITION = ataxia telangiectasia and Rad3 related protein   
 
ACCESSION  = NP_006210 
DEFINITION = phosphoinositide-3-kinase, catalytic, beta polypeptide   
 
ACCESSION  = NP_004178 
DEFINITION = Smcx homolog, X chromosome   
 
ACCESSION  = NP_149115 
DEFINITION = hypothetical protein LOC85478   
 
ACCESSION  = NP_114128 
DEFINITION = RALBP1 associated Eps domain containing 1   
 
ACCESSION  = NP_201580 
DEFINITION = sodium bicarbonate transporter 4 isoform b   
 
ACCESSION  = NP_006835 
DEFINITION = ilvB (bacterial acetolactate synthase)-like isoform 1   
 
ACCESSION  = NP_005061 
DEFINITION = solute carrier family 4, anion exchanger, member 3 isoform 1   
 
ACCESSION  = NP_006819 
DEFINITION = activating signal cointegrator 1 complex subunit 3 isoform a   
 
ACCESSION  = NP_699187 
DEFINITION = TBC1 domain family, member 21   
 
ACCESSION  = NP_149357 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_892006 
DEFINITION = nesprin 1 longest   
 
ACCESSION  = NP_000780 
DEFINITION = angiotensin I converting enzyme isoform 1 precursor   
 
ACCESSION  = NP_777576 
DEFINITION = ubiquitin protein ligase E3 component n-recognin 1   
 
ACCESSION  = NP_004228 
DEFINITION = thyroid hormone receptor interactor 13   
 
ACCESSION  = XP_945854 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATR (Ataxia 
telangiectasia and Rad3-related protein) (FRAP-related protein 1)   
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ACCESSION  = NP_061159 XP_051860 









62 matches found in protein 
############################## 
ACCESSION  = NP_058650 
DEFINITION = T-box 22   
 
ACCESSION  = XP_943361 
DEFINITION = PREDICTED: similar to T-box transcription factor TBX18 (T-box 
protein 18) isoform 2   
 
ACCESSION  = NP_001017372 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = NP_065855 
DEFINITION = protein kinase C and casein kinase substrate in neurons 1   
 
ACCESSION  = NP_056120 
DEFINITION = angel homolog 1   
 
ACCESSION  = XP_942900 
DEFINITION = PREDICTED: similar to dynein, cytoplasmic, heavy chain 2 isoform 
3   
 
ACCESSION  = NP_689593 XP_371284 
DEFINITION = T-box 15   
 
ACCESSION  = NP_115643 
DEFINITION = regulator of G-protein signalling like 2   
 
ACCESSION  = NP_004643 
DEFINITION = ubiquitin specific protease 9, X-linked isoform 1   
 
ACCESSION  = NP_065872 
DEFINITION = vacuolar protein sorting 13C protein isoform 2A   
 
ACCESSION  = NP_001018098 
DEFINITION = vacuolar protein sorting 13C protein isoform 2B   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_003990 
DEFINITION = oncostatin M receptor   
 
ACCESSION  = NP_003585 
DEFINITION = transcription termination factor, RNA polymerase II   
 
ACCESSION  = NP_006436 
DEFINITION = U5 snRNP-specific protein   
 
ACCESSION  = NP_003772 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_009160 
DEFINITION = protein kinase C and casein kinase substrate in neurons 2   
 
ACCESSION  = NP_114119 XP_291067 
DEFINITION = family with sequence similarity 62 (C2 domain containing), member 
C   
 
ACCESSION  = NP_631905 
DEFINITION = striated muscle activator of Rho-dependent signaling   
 
ACCESSION  = NP_054750 
DEFINITION = solute carrier family 27 (fatty acid transporter), member 6   
 
ACCESSION  = NP_005140 
DEFINITION = T-box 19   
 
ACCESSION  = NP_079170 
DEFINITION = nucleolar protein 10   
 
ACCESSION  = NP_055433 
DEFINITION = deleted in bladder cancer 1   
 
ACCESSION  = NP_002410 
DEFINITION = mitogen-activated protein kinase kinase kinase 11   
 
ACCESSION  = NP_149358 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_149095 
DEFINITION = stonin 2   
 
ACCESSION  = NP_149359 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_060550 
DEFINITION = vacuolar protein sorting 13C protein isoform 1B   
 
ACCESSION  = NP_036546 
DEFINITION = rab3 GTPase-activating protein, non-catalytic subunit   
 
ACCESSION  = NP_055797 
DEFINITION = pecanex homolog   
 
ACCESSION  = NP_115597 
DEFINITION = chromodomain helicase DNA binding protein 6   
 
ACCESSION  = NP_036578 
DEFINITION = single-stranded DNA binding protein 2   
 
ACCESSION  = NP_057323 
DEFINITION = myosin XV   
 
ACCESSION  = NP_001032 
DEFINITION = sucrase-isomaltase (alpha-glucosidase)   
 
ACCESSION  = NP_060142 
DEFINITION = transient receptor potential cation channel, subfamily M, member 7   
 
ACCESSION  = NP_003172 
DEFINITION = transcription factor T   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_078922 XP_038291 
DEFINITION = hypothetical protein LOC79699   
 
ACCESSION  = NP_004645 
DEFINITION = ubiquitin specific protease 9, Y-linked   
 
ACCESSION  = NP_000183 
DEFINITION = T-box 5 isoform 1   
 
ACCESSION  = NP_065150 
DEFINITION = T-box transcription factor TBX20   
 
ACCESSION  = NP_001009944 
DEFINITION = polycystin 1 isoform 1 precursor   
 
ACCESSION  = NP_542448 
DEFINITION = T-box 5 isoform 3   
 
ACCESSION  = NP_776297 
DEFINITION = chloride channel 3 isoform e   
 
ACCESSION  = NP_060154 
DEFINITION = vacuolar protein sorting 13C protein isoform 1A   
 
ACCESSION  = XP_496819 
DEFINITION = PREDICTED: T-box 18 isoform 1   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
 
ACCESSION  = NP_001821 
DEFINITION = chloride channel 4   
 
ACCESSION  = NP_542449 
DEFINITION = T-box 5 isoform 2   
 
ACCESSION  = NP_060958 
DEFINITION = T-box 4   
 
ACCESSION  = NP_149357 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_060250 XP_098762 
DEFINITION = chromodomain helicase DNA binding protein 7   
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ACCESSION  = NP_068706 
DEFINITION = ubiquitin specific protease 9, X-linked isoform 2   
 
ACCESSION  = NP_000287 
DEFINITION = polycystin 1 isoform 2 precursor   
 
ACCESSION  = XP_370652 
DEFINITION = PREDICTED: dynein, cytoplasmic, heavy polypeptide 2 isoform 1   
 
ACCESSION  = NP_060225 
DEFINITION = NOL1/NOP2/Sun domain family 2 protein   
 
ACCESSION  = NP_001820 
DEFINITION = chloride channel 3 isoform b   
 
ACCESSION  = NP_066267 
DEFINITION = ankyrin 3 isoform 1   
 
ACCESSION  = NP_055524 XP_291018 
DEFINITION = ubiquitin specific protease 34   
 
ACCESSION  = NP_061903 
DEFINITION = DEAH (Asp-Glu-Ala-His) box polypeptide 29   
 
ACCESSION  = NP_852259 
DEFINITION = T-box 5 isoform 1   
 
ACCESSION  = NP_001262 





The pattern being searched is DDGLDEAFSRLAQSRT.*dp[fw] 
 





The pattern being searched is DDGLDEAFSRLAQSRT.*f.d.f 
 





The pattern being searched is DDGLDEAFSRLAQSRT.*W..[FW].[DE] 
 





The pattern being searched is DDGLDEAFSRLAQSRT.*DDGLDEAFSRLAQSRT 
 





The pattern being searched is 
DDGLDEAFSRLAQSRT.*L[LMIF][DEN][LMIF][DEN] 
 





The pattern being searched is DDGLDEAFSRLAQSRT.*npf 
 









85 matches found in protein 
############################## 
ACCESSION  = NP_079146 
DEFINITION = DEP domain containing 2 isoform a   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_057318 
DEFINITION = acyl-CoA synthetase long-chain family member 5 isoform a   
 
ACCESSION  = NP_001626 
DEFINITION = amphiphysin isoform 1   
 
ACCESSION  = NP_057368 
DEFINITION = CCR4-NOT transcription complex, subunit 1 isoform a   
 
ACCESSION  = NP_001028927 
DEFINITION = copine-like protein   
 
ACCESSION  = NP_065916 
DEFINITION = DEAH (Asp-Glu-Ala-His) box polypeptide 36   
 
ACCESSION  = XP_945898 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 12   
 
ACCESSION  = NP_110403 
DEFINITION = tumor stroma and activated macrophage protein DLM-1   
 
ACCESSION  = NP_976313 
DEFINITION = acyl-CoA synthetase long-chain family member 5 isoform b   
 
ACCESSION  = NP_071451 
DEFINITION = melanoma differentiation associated protein-5   
 
ACCESSION  = NP_071407 
DEFINITION = cadherin related 23 isoform 1 precursor   
 
ACCESSION  = XP_941081 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 11   
 
ACCESSION  = XP_941078 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 8   
 
ACCESSION  = NP_060653 
DEFINITION = sno, strawberry notch homolog 1   
 
ACCESSION  = NP_005329 
DEFINITION = huntingtin interacting protein 1   
 
ACCESSION  = NP_001008536 XP_060104 
DEFINITION = trichohyalin-like 1   
 
ACCESSION  = XP_949896 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 14   
 
ACCESSION  = NP_085124 
DEFINITION = dicer1   
 
ACCESSION  = XP_942343 
DEFINITION = PREDICTED: similar to purinergic receptor P2X3   
 
ACCESSION  = NP_149045 
DEFINITION = protocadherin 15 precursor   
 
ACCESSION  = XP_946300 
DEFINITION = PREDICTED: similar to FRAS1-related extracellular matrix protein 
2 precursor (ECM3 homolog)   
 
ACCESSION  = XP_934977 
DEFINITION = PREDICTED: FRAS1 related extracellular matrix protein 2   
 
ACCESSION  = XP_941079 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 9   
 
ACCESSION  = NP_001005336 
DEFINITION = dynamin 1 isoform 2   
 
ACCESSION  = NP_443715 
DEFINITION = WD repeat domain 10 isoform 2   
 
ACCESSION  = XP_943674 
DEFINITION = PREDICTED: similar to pleckstrin homology domain containing, 
family M (with RUN domain) member 1   
 
ACCESSION  = NP_065901 XP_043069 
DEFINITION = RAN binding protein 10   
 
ACCESSION  = XP_939215 
DEFINITION = PREDICTED: piccolo isoform 6   
 
ACCESSION  = NP_004406 
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DEFINITION = desmoplakin isoform I   
 
ACCESSION  = NP_003889 
DEFINITION = synaptojanin 2   
 
ACCESSION  = NP_003725 
DEFINITION = amine oxidase, copper containing 3 precursor   
 
ACCESSION  = NP_776152 
DEFINITION = PDZ domain containing 8   
 
ACCESSION  = NP_689914 
DEFINITION = ATP binding cassette, sub-family A (ABC1), member 13   
 
ACCESSION  = NP_002550 
DEFINITION = purinergic receptor P2X3   
 
ACCESSION  = NP_149132 XP_027237 
DEFINITION = mitogen-activated protein kinase kinase kinase 9   
 
ACCESSION  = NP_065928 XP_209041 
DEFINITION = protein similar to dynein   
 
ACCESSION  = NP_877439 XP_294213 XP_353565 
DEFINITION = putative binding protein 7a5   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = XP_949903 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 16   
 
ACCESSION  = NP_004942 
DEFINITION = EBV-induced G protein-coupled receptor 2   
 
ACCESSION  = NP_758424 
DEFINITION = ATP-binding cassette, sub-family A , member 5   
 
ACCESSION  = NP_647477 
DEFINITION = amphiphysin isoform 2   
 
ACCESSION  = NP_060779 
DEFINITION = hypothetical protein LOC55773   
 
ACCESSION  = NP_009097 
DEFINITION = phosphatidylinositol-binding clathrin assembly protein isoform 1   
 
ACCESSION  = NP_003728 
DEFINITION = dachsous 1 precursor   
 
ACCESSION  = XP_939207 
DEFINITION = PREDICTED: piccolo isoform 4   
 
ACCESSION  = NP_525023 
DEFINITION = ATP-binding cassette, sub-family A, member 6   
 
ACCESSION  = NP_055968 
DEFINITION = PHD finger protein 3   
 
ACCESSION  = XP_942238 
DEFINITION = PREDICTED: similar to myoferlin isoform b   
 
ACCESSION  = NP_055811 XP_042635 
DEFINITION = phospholipase C-like 3   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = NP_149072 
DEFINITION = death inducer-obliterator 1 isoform c   
 
ACCESSION  = NP_002709 
DEFINITION = protein phosphatase 2, regulatory subunit B'', alpha isoform 1   
 
ACCESSION  = XP_949889 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 13   
 
ACCESSION  = NP_003924 
DEFINITION = BAI1-associated protein 3   
 
ACCESSION  = NP_803187 
DEFINITION = dicer1   
 
ACCESSION  = NP_055434 
DEFINITION = glutamate receptor KA1 precursor   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_065870 XP_371832 
DEFINITION = hypothetical protein LOC57579   
 
ACCESSION  = NP_001010855 XP_375404 
DEFINITION = hypothetical protein LOC146850   
 
ACCESSION  = NP_055656 XP_498116 
DEFINITION = synaptosomal-associated protein, 91kDa homolog   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = NP_055919 XP_290517 
DEFINITION = hypothetical protein LOC23130   
 
ACCESSION  = NP_078858 
DEFINITION = FAT tumor suppressor homolog 4   
 
ACCESSION  = NP_443716 
DEFINITION = WD repeat domain 10 isoform 4   
 
ACCESSION  = XP_935039 
DEFINITION = PREDICTED: piccolo isoform 2   
 
ACCESSION  = NP_055731 
DEFINITION = lemur tyrosine kinase 2   
 
ACCESSION  = XP_939204 
DEFINITION = PREDICTED: piccolo isoform 3   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_976314 
DEFINITION = acyl-CoA synthetase long-chain family member 5 isoform b   
 
ACCESSION  = NP_061142 
DEFINITION = ATP-binding cassette, sub-family A , member 5   
 
ACCESSION  = NP_005679 
DEFINITION = ATP-binding cassette, sub-family C, member 5 isoform 1   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
 
ACCESSION  = NP_060732 
DEFINITION = WD repeat domain 10 isoform 3   
 
ACCESSION  = NP_002323 
DEFINITION = low density lipoprotein-related protein 1   
 
ACCESSION  = NP_001008844 
DEFINITION = desmoplakin isoform II   
 
ACCESSION  = NP_006488 
DEFINITION = hypermethylated in cancer 1   
 
ACCESSION  = NP_004399 
DEFINITION = dynamin 1 isoform 1   
 
ACCESSION  = XP_290944 
DEFINITION = PREDICTED: pleckstrin homology domain containing, family M 
(with RUN domain) member 2   
 
ACCESSION  = NP_061027 
DEFINITION = low density lipoprotein-related protein 1B   
 
ACCESSION  = NP_443711 
DEFINITION = WD repeat domain 10 isoform 1   
 
ACCESSION  = NP_003905 
DEFINITION = cyclin A1   
 
ACCESSION  = XP_940803 










73 matches found in protein 
############################## 
ACCESSION  = NP_060808 
DEFINITION = WD repeat domain 52   
 
ACCESSION  = NP_065965 XP_290768 
DEFINITION = chromosome 17 open reading frame 27   
 
ACCESSION  = NP_002700 
DEFINITION = protein phosphatase 1, catalytic subunit, beta isoform 1   
 
ACCESSION  = XP_939177 
DEFINITION = PREDICTED: hypothetical protein LOC84162 isoform 5   
 
ACCESSION  = NP_065916 
DEFINITION = DEAH (Asp-Glu-Ala-His) box polypeptide 36   
 
ACCESSION  = NP_597812 
DEFINITION = sodium bicarbonate transporter 4 isoform c   
 
ACCESSION  = NP_055595 
DEFINITION = cullin 7   
 
ACCESSION  = NP_055872 
DEFINITION = MYC binding protein 2   
 
ACCESSION  = XP_948165 
DEFINITION = PREDICTED: similar to CG4841-PA isoform 15   
 
ACCESSION  = NP_057373 
DEFINITION = calcium binding protein 39   
 
ACCESSION  = NP_005329 
DEFINITION = huntingtin interacting protein 1   
 
ACCESSION  = XP_941990 
DEFINITION = PREDICTED: similar to CG4841-PA isoform 10   
 
ACCESSION  = NP_001061 
DEFINITION = tubulin, gamma 1   
 
ACCESSION  = XP_939180 
DEFINITION = PREDICTED: hypothetical protein LOC84162 isoform 6   
 
ACCESSION  = NP_085124 
DEFINITION = dicer1   
 
ACCESSION  = XP_949034 
DEFINITION = PREDICTED: similar to epidermal growth factor receptor pathway 
substrate 8-like protein 2 isoform 3   
 
ACCESSION  = XP_371706 
DEFINITION = PREDICTED: hypothetical protein LOC84162 isoform 1   
 
ACCESSION  = NP_060024 XP_291055 
DEFINITION = poly (ADP-ribose) polymerase family, member 14   
 
ACCESSION  = NP_149045 
DEFINITION = protocadherin 15 precursor   
 
ACCESSION  = NP_002281 
DEFINITION = laminin, alpha 4 precursor   
 
ACCESSION  = NP_002701 
DEFINITION = protein phosphatase 1, catalytic subunit, gamma isoform   
 
ACCESSION  = NP_001026894 
DEFINITION = calcium binding protein 39-like isoform 1   
 
ACCESSION  = NP_000935 
DEFINITION = protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform 
(calcineurin A alpha)   
 
ACCESSION  = NP_003741 
DEFINITION = eukaryotic translation initiation factor 3, subunit 10 theta, 
150/170kDa   
 
ACCESSION  = XP_943674 
DEFINITION = PREDICTED: similar to pleckstrin homology domain containing, 
family M (with RUN domain) member 1   
 
ACCESSION  = NP_004406 
DEFINITION = desmoplakin isoform I   
 
ACCESSION  = NP_067019 
DEFINITION = sodium bicarbonate transporter 4 isoform a   
 
ACCESSION  = NP_776152 
DEFINITION = PDZ domain containing 8   
 
ACCESSION  = NP_003162 
DEFINITION = suppressor of var1, 3-like 1   
 
ACCESSION  = NP_005752 
DEFINITION = plexin C1   
 
ACCESSION  = NP_597813 
DEFINITION = sodium bicarbonate transporter 4 isoform d   
 
ACCESSION  = NP_057346 
DEFINITION = tubulin, epsilon 1   
 
ACCESSION  = NP_078898 
DEFINITION = hypothetical protein LOC79675   
 
ACCESSION  = NP_525023 
DEFINITION = ATP-binding cassette, sub-family A, member 6   
 
ACCESSION  = NP_996759 
DEFINITION = protein phosphatase 1, catalytic subunit, beta isoform 1   
 
ACCESSION  = NP_004229 XP_376178 
DEFINITION = thyroid hormone receptor interactor 12   
 
ACCESSION  = XP_949047 
DEFINITION = PREDICTED: similar to epidermal growth factor receptor pathway 
substrate 8-like protein 2 isoform 6   
 
ACCESSION  = NP_001412 
DEFINITION = E74-like factor 4 (ets domain transcription factor)   
 
ACCESSION  = NP_004438 
DEFINITION = epidermal growth factor receptor pathway substrate 8   
 
ACCESSION  = NP_002709 
DEFINITION = protein phosphatase 2, regulatory subunit B'', alpha isoform 1   
 
ACCESSION  = NP_056029 XP_291291 
DEFINITION = DDHD domain containing 2   
 
ACCESSION  = XP_948169 
DEFINITION = PREDICTED: similar to CG4841-PA isoform 16   
 
ACCESSION  = NP_056109 
DEFINITION = tripartite motif-containing 37 protein   
 
ACCESSION  = NP_803187 
DEFINITION = dicer1   
 
ACCESSION  = NP_055434 
DEFINITION = glutamate receptor KA1 precursor   
 
ACCESSION  = NP_057521 
DEFINITION = tubulin, gamma 2   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_002699 
DEFINITION = protein phosphatase 1, catalytic subunit, alpha isoform 1   
 
ACCESSION  = NP_201580 
DEFINITION = sodium bicarbonate transporter 4 isoform b   
 
ACCESSION  = NP_055656 XP_498116 
DEFINITION = synaptosomal-associated protein, 91kDa homolog   
 
ACCESSION  = NP_055071 
DEFINITION = beta-1,3-N-acetylglucosaminyltransferase bGnT-3   
 
ACCESSION  = XP_949059 
DEFINITION = PREDICTED: similar to epidermal growth factor receptor pathway 
substrate 8-like protein 2 isoform 10   
 
ACCESSION  = XP_948155 
DEFINITION = PREDICTED: similar to CG4841-PA isoform 13   
 
ACCESSION  = NP_061908 
DEFINITION = protocadherin 18 precursor   
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ACCESSION  = NP_001005207 
DEFINITION = tripartite motif-containing 37 protein   
 
ACCESSION  = XP_371474 
DEFINITION = PREDICTED: plexin B2   
 
ACCESSION  = XP_943993 
DEFINITION = PREDICTED: similar to epidermal growth factor receptor pathway 
substrate 8-like protein 2 isoform 2   
 
ACCESSION  = NP_055259 
DEFINITION = gamma tubulin ring complex protein (76p gene)   
 
ACCESSION  = NP_001020948 
DEFINITION = UDP-glucose ceramide glucosyltransferase-like 1 isoform 2   
 
ACCESSION  = XP_943338 
DEFINITION = PREDICTED: similar to Plexin B2 precursor (MM1)   
 
ACCESSION  = NP_073609 
DEFINITION = epidermal growth factor receptor pathway substrate 8-like protein 2   
 
ACCESSION  = NP_001008844 
DEFINITION = desmoplakin isoform II   
 
ACCESSION  = NP_055904 
DEFINITION = p53-associated parkin-like cytoplasmic protein   
 
ACCESSION  = NP_112187 
DEFINITION = calcium binding protein 39-like isoform 2   
 
ACCESSION  = NP_064505 
DEFINITION = UDP-glucose ceramide glucosyltransferase-like 1 isoform 1   
 
ACCESSION  = XP_290944 
DEFINITION = PREDICTED: pleckstrin homology domain containing, family M 
(with RUN domain) member 2   
 
ACCESSION  = XP_939185 
DEFINITION = PREDICTED: hypothetical protein LOC84162 isoform 7   
 
ACCESSION  = NP_001008709 
DEFINITION = protein phosphatase 1, catalytic subunit, alpha isoform 3   
 
ACCESSION  = NP_443179 
DEFINITION = heart alpha-kinase   
 
ACCESSION  = NP_003905 
DEFINITION = cyclin A1   
 
ACCESSION  = NP_004949 
DEFINITION = FK506 binding protein 12-rapamycin associated protein 1   
 
ACCESSION  = NP_031373 
DEFINITION = adaptor-related protein complex 4, epsilon 1 subunit   
 
ACCESSION  = NP_005642 









63 matches found in protein 
############################## 
ACCESSION  = NP_065164 XP_041116 
DEFINITION = transmembrane protein 63C   
 
ACCESSION  = NP_056193 XP_044546 
DEFINITION = vacuolar protein sorting 13D isoform 1   
 
ACCESSION  = NP_149033 
DEFINITION = microfilament and actin filament cross-linker protein isoform b   
 
ACCESSION  = NP_149062 
DEFINITION = nesprin 1 isoform longer   
 
ACCESSION  = NP_000338 
DEFINITION = spectrin beta isoform b   
 
ACCESSION  = NP_002700 
DEFINITION = protein phosphatase 1, catalytic subunit, beta isoform 1   
 
ACCESSION  = NP_055595 
DEFINITION = cullin 7   
 
ACCESSION  = XP_942900 
DEFINITION = PREDICTED: similar to dynein, cytoplasmic, heavy chain 2 isoform 
3   
 
ACCESSION  = NP_001363 
DEFINITION = dynein, axonemal, heavy polypeptide 9 isoform 2   
 
ACCESSION  = NP_842565 
DEFINITION = spectrin, beta, non-erythrocytic 1 isoform 2   
 
ACCESSION  = NP_065779 
DEFINITION = family with sequence similarity 62 (C2 domain containing) member 
B   
 
ACCESSION  = NP_690043 
DEFINITION = angiotensin I converting enzyme isoform 2 precursor   
 
ACCESSION  = NP_536724 
DEFINITION = cell division cycle 91-like 1 protein   
 
ACCESSION  = NP_065872 
DEFINITION = vacuolar protein sorting 13C protein isoform 2A   
 
ACCESSION  = NP_001018098 
DEFINITION = vacuolar protein sorting 13C protein isoform 2B   
 
ACCESSION  = NP_002701 
DEFINITION = protein phosphatase 1, catalytic subunit, gamma isoform   
 
ACCESSION  = XP_166254 
DEFINITION = PREDICTED: odz, odd Oz/ten-m homolog 4   
 
ACCESSION  = NP_078962 
DEFINITION = tubulin tyrosine ligase-like family, member 7   
 
ACCESSION  = NP_055995 
DEFINITION = spectrin repeat containing, nuclear envelope 2 isoform a   
 
ACCESSION  = XP_943080 
DEFINITION = PREDICTED: similar to kinesin family member 27 isoform 2   
 
ACCESSION  = NP_690044 
DEFINITION = angiotensin I converting enzyme isoform 3 precursor   
 
ACCESSION  = NP_689914 
DEFINITION = ATP binding cassette, sub-family A (ABC1), member 13   
 
ACCESSION  = NP_065928 XP_209041 
DEFINITION = protein similar to dynein   
 
ACCESSION  = XP_377696 
DEFINITION = PREDICTED: similar to carbonic anhydrase 15   
 
ACCESSION  = XP_943924 
DEFINITION = PREDICTED: similar to Mucin-5B precursor (Mucin 5 subtype B, 
tracheobronchial) (High molecular weight salivary mucin MG1) (Sublingual gland 
mucin)   
 
ACCESSION  = NP_057645 
DEFINITION = apoptosis regulator   
 
ACCESSION  = NP_001362 
DEFINITION = dynein, axonemal, heavy polypeptide 8   
 
ACCESSION  = XP_945556 
DEFINITION = PREDICTED: similar to odd Oz/ten-m homolog 4   
 
ACCESSION  = NP_996759 
DEFINITION = protein phosphatase 1, catalytic subunit, beta isoform 1   
 
ACCESSION  = NP_057733 
DEFINITION = ABT1-associated protein   
 
ACCESSION  = NP_060550 
DEFINITION = vacuolar protein sorting 13C protein isoform 1B   
 
ACCESSION  = NP_002215 
DEFINITION = inositol 1,4,5-triphosphate receptor, type 3   
 
ACCESSION  = NP_006210 
DEFINITION = phosphoinositide-3-kinase, catalytic, beta polypeptide   
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ACCESSION  = NP_002214 
DEFINITION = inositol 1,4,5-triphosphate receptor, type 2   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_114128 
DEFINITION = RALBP1 associated Eps domain containing 1   
 
ACCESSION  = NP_065870 XP_371832 
DEFINITION = hypothetical protein LOC57579   
 
ACCESSION  = XP_039877 
DEFINITION = PREDICTED: mucin 5, subtype B, tracheobronchial   
 
ACCESSION  = NP_899236 
DEFINITION = dystonin isoform 1   
 
ACCESSION  = NP_002699 
DEFINITION = protein phosphatase 1, catalytic subunit, alpha isoform 1   
 
ACCESSION  = NP_005090 
DEFINITION = ADAM metallopeptidase with thrombospondin type 1 motif, 4 
preproprotein   
 
ACCESSION  = NP_001360 
DEFINITION = dynein, axonemal, heavy polypeptide 5   
 
ACCESSION  = XP_948598 
DEFINITION = PREDICTED: similar to kinesin family member 27 isoform 4   
 
ACCESSION  = NP_060626 
DEFINITION = vacuolar protein sorting 13D isoform 2   
 
ACCESSION  = NP_001020029 
DEFINITION = spectrin beta isoform a   
 
ACCESSION  = XP_948603 
DEFINITION = PREDICTED: similar to kinesin family member 27 isoform 5   
 
ACCESSION  = NP_079410 
DEFINITION = chromodomain helicase DNA binding protein 9   
 
ACCESSION  = NP_065077 
DEFINITION = solute carrier family 24 (sodium/potassium/calcium exchanger), 
member 2   
 
ACCESSION  = NP_060154 
DEFINITION = vacuolar protein sorting 13C protein isoform 1A   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
 
ACCESSION  = NP_002323 
DEFINITION = low density lipoprotein-related protein 1   
 
ACCESSION  = NP_892006 
DEFINITION = nesprin 1 longest   
 
ACCESSION  = NP_000780 
DEFINITION = angiotensin I converting enzyme isoform 1 precursor   
 
ACCESSION  = XP_370652 
DEFINITION = PREDICTED: dynein, cytoplasmic, heavy polypeptide 2 isoform 1   
 
ACCESSION  = NP_982271 
DEFINITION = synaptojanin 1 isoform b   
 
ACCESSION  = XP_942832 
DEFINITION = PREDICTED: similar to carbonic anhydrase 15   
 
ACCESSION  = NP_055904 
DEFINITION = p53-associated parkin-like cytoplasmic protein   
 
ACCESSION  = NP_689829 
DEFINITION = tripartite motif-containing 42   
 
ACCESSION  = NP_061027 
DEFINITION = low density lipoprotein-related protein 1B   
 
ACCESSION  = NP_055524 XP_291018 
DEFINITION = ubiquitin specific protease 34   
 
ACCESSION  = NP_001008709 
DEFINITION = protein phosphatase 1, catalytic subunit, alpha isoform 3   
 
ACCESSION  = NP_114141 
DEFINITION = hemicentin 1   
 
ACCESSION  = NP_003119 
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ACCESSION  = NP_008877 
DEFINITION = spectrin, beta, non-erythrocytic 2   
 
ACCESSION  = XP_949035 
DEFINITION = PREDICTED: similar to ral guanine nucleotide dissociation 
stimulator-like 3 isoform 14   
 
ACCESSION  = NP_060808 
DEFINITION = WD repeat domain 52   
 
ACCESSION  = NP_079146 
DEFINITION = DEP domain containing 2 isoform a   
 
ACCESSION  = NP_065965 XP_290768 
DEFINITION = chromosome 17 open reading frame 27   
 
ACCESSION  = XP_939711 
DEFINITION = PREDICTED: ral guanine nucleotide dissociation stimulator-like 3 
isoform 9   
 
ACCESSION  = NP_742093 
DEFINITION = sperm-associated cation channel 2 isoform 2   
 
ACCESSION  = XP_939708 
DEFINITION = PREDICTED: ral guanine nucleotide dissociation stimulator-like 3 
isoform 6   
 
ACCESSION  = NP_058633 
DEFINITION = polymerase (DNA-directed), alpha   
 
ACCESSION  = NP_055872 
DEFINITION = MYC binding protein 2   
 
ACCESSION  = NP_071407 
DEFINITION = cadherin related 23 isoform 1 precursor   
 
ACCESSION  = NP_004696 
DEFINITION = protein-kinase, interferon-inducible double stranded RNA dependent 
inhibitor, repressor of (P58 repressor)   
 
ACCESSION  = NP_573444 
DEFINITION = epidermal growth factor receptor pathway substrate 8-like protein 3 
isoform b   
 
ACCESSION  = NP_002171 
DEFINITION = immunoglobulin mu binding protein 2   
 
ACCESSION  = NP_059447 
DEFINITION = major vault protein   
 
ACCESSION  = XP_939707 
DEFINITION = PREDICTED: ral guanine nucleotide dissociation stimulator-like 3 
isoform 5   
 
ACCESSION  = NP_085124 
DEFINITION = dicer1   
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ACCESSION  = NP_006297 
DEFINITION = SMC1 structural maintenance of chromosomes 1-like 1   
 
ACCESSION  = NP_877496 
DEFINITION = engulfment and cell motility 2   
 
ACCESSION  = NP_060914 
DEFINITION = pyruvate dehydrogenase phosphatase precursor   
 
ACCESSION  = NP_757367 
DEFINITION = sperm associated antigen 1   
 
ACCESSION  = NP_065872 
DEFINITION = vacuolar protein sorting 13C protein isoform 2A   
 
ACCESSION  = XP_946300 
DEFINITION = PREDICTED: similar to FRAS1-related extracellular matrix protein 
2 precursor (ECM3 homolog)   
 
ACCESSION  = NP_001018098 
DEFINITION = vacuolar protein sorting 13C protein isoform 2B   
 
ACCESSION  = XP_949050 
DEFINITION = PREDICTED: similar to ral guanine nucleotide dissociation 
stimulator-like 3 isoform 18   
 
ACCESSION  = XP_934977 
DEFINITION = PREDICTED: FRAS1 related extracellular matrix protein 2   
 
ACCESSION  = NP_005210 
DEFINITION = diaphanous 1   
 
ACCESSION  = NP_005106 
DEFINITION = major vault protein   
 
ACCESSION  = NP_071373 XP_371779 
DEFINITION = transposon-derived Buster3 transposase-like   
 
ACCESSION  = NP_065789 XP_291015 
DEFINITION = kinase D-interacting substance of 220 kDa   
 
ACCESSION  = NP_776152 
DEFINITION = PDZ domain containing 8   
 
ACCESSION  = NP_003162 
DEFINITION = suppressor of var1, 3-like 1   
 
ACCESSION  = NP_733468 
DEFINITION = cancer susceptibility candidate 5 isoform 1   
 
ACCESSION  = XP_939709 
DEFINITION = PREDICTED: ral guanine nucleotide dissociation stimulator-like 3 
isoform 7   
 
ACCESSION  = NP_004923 
DEFINITION = cadherin 6, type 2 preproprotein   
 
ACCESSION  = NP_149132 XP_027237 
DEFINITION = mitogen-activated protein kinase kinase kinase 9   
 
ACCESSION  = NP_065928 XP_209041 
DEFINITION = protein similar to dynein   
 
ACCESSION  = NP_001118 
DEFINITION = adaptor-related protein complex 1 beta 1 subunit isoform a   
 
ACCESSION  = NP_078953 
DEFINITION = hypothetical protein LOC79730   
 
ACCESSION  = XP_949040 
DEFINITION = PREDICTED: similar to ral guanine nucleotide dissociation 
stimulator-like 3 isoform 15   
 
ACCESSION  = NP_060387 
DEFINITION = chromosome 14 open reading frame 10   
 
ACCESSION  = NP_055684 
DEFINITION = IQ motif and Sec7 domain 1   
 
ACCESSION  = NP_003728 
DEFINITION = dachsous 1 precursor   
 
ACCESSION  = XP_944006 
DEFINITION = PREDICTED: similar to ral guanine nucleotide dissociation 
stimulator-like 3 isoform 10   
 
ACCESSION  = NP_620641 
DEFINITION = epidermal growth factor receptor pathway substrate 8-like protein 3 
isoform a   
 
ACCESSION  = NP_057733 
DEFINITION = ABT1-associated protein   
 
ACCESSION  = XP_949019 
DEFINITION = PREDICTED: similar to ral guanine nucleotide dissociation 
stimulator-like 3 isoform 11   
 
ACCESSION  = NP_078802 
DEFINITION = epidermal growth factor receptor pathway substrate 8-like protein 3 
isoform c   
 
ACCESSION  = NP_060550 
DEFINITION = vacuolar protein sorting 13C protein isoform 1B   
 
ACCESSION  = NP_037523 
DEFINITION = dimethylglycine dehydrogenase precursor   
 
ACCESSION  = NP_733792 
DEFINITION = mitochondrial elongation factor G2 isoform 2   
 
ACCESSION  = NP_005503 
DEFINITION = leucine rich repeat containing 32 precursor   
 
ACCESSION  = XP_939703 
DEFINITION = PREDICTED: ral guanine nucleotide dissociation stimulator-like 3 
isoform 2   
 
ACCESSION  = NP_006210 
DEFINITION = phosphoinositide-3-kinase, catalytic, beta polypeptide   
 
ACCESSION  = XP_935400 
DEFINITION = PREDICTED: ral guanine nucleotide dissociation stimulator-like 3 
isoform 1   
 
ACCESSION  = NP_803187 
DEFINITION = dicer1   
 
ACCESSION  = NP_003105 
DEFINITION = sperm associated antigen 1   
 
ACCESSION  = NP_071369 
DEFINITION = engulfment and cell motility 2   
 
ACCESSION  = NP_075463 
DEFINITION = hypothetical protein CG003   
 
ACCESSION  = NP_003117 
DEFINITION = spectrin, alpha, erythrocytic 1 (elliptocytosis 2)   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = XP_949027 
DEFINITION = PREDICTED: similar to ral guanine nucleotide dissociation 
stimulator-like 3 isoform 13   
 
ACCESSION  = NP_055615 
DEFINITION = engulfment and cell motility 1 isoform 1   
 
ACCESSION  = NP_065801 
DEFINITION = exportin 5   
 
ACCESSION  = NP_056371 
DEFINITION = signal-induced proliferation-associated 1 like 1   
 
ACCESSION  = XP_949042 
DEFINITION = PREDICTED: similar to ral guanine nucleotide dissociation 
stimulator-like 3 isoform 16   
 
ACCESSION  = NP_060154 
DEFINITION = vacuolar protein sorting 13C protein isoform 1A   
 
ACCESSION  = NP_036273 
DEFINITION = DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26   
 
ACCESSION  = XP_093839 
DEFINITION = PREDICTED: hypothetical protein LOC23045 isoform 1   
 
ACCESSION  = XP_939706 
DEFINITION = PREDICTED: ral guanine nucleotide dissociation stimulator-like 3 
isoform 4   
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ACCESSION  = NP_004265 
DEFINITION = A-kinase anchor protein 6   
 
ACCESSION  = NP_001273 
DEFINITION = adaptor-related protein complex 2, beta 1 subunit isoform b   
 
ACCESSION  = NP_473361 
DEFINITION = sperm-associated cation channel 2 isoform 1   
 
ACCESSION  = NP_001025177 
DEFINITION = adaptor-related protein complex 2, beta 1 subunit isoform a   
 
ACCESSION  = NP_663782 
DEFINITION = adaptor-related protein complex 1 beta 1 subunit isoform b   
 
ACCESSION  = NP_653091 
DEFINITION = cancer susceptibility candidate 5 isoform 2   
 
ACCESSION  = XP_946679 
DEFINITION = PREDICTED: similar to CG32045-PB, isoform B isoform 5   
 
ACCESSION  = NP_115756 
DEFINITION = mitochondrial elongation factor G2 isoform 1   
 
ACCESSION  = NP_060395 
DEFINITION = hypothetical protein LOC55667   
 
ACCESSION  = NP_573403 
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ACCESSION  = NP_060109 
DEFINITION = dachsous 2 isoform 1   
 
ACCESSION  = NP_872346 XP_498462 XP_499592 
DEFINITION = hypothetical protein LOC203522   
 
ACCESSION  = NP_000149 
DEFINITION = glucan (1,4-alpha-), branching enzyme 1 (glycogen branching 
enzyme)   
 
ACCESSION  = XP_942900 
DEFINITION = PREDICTED: similar to dynein, cytoplasmic, heavy chain 2 isoform 
3   
 
ACCESSION  = NP_689488 
DEFINITION = hypothetical protein LOC92104   
 
ACCESSION  = NP_620309 
DEFINITION = B-cell lymphoma 6 protein   
 
ACCESSION  = NP_065791 
DEFINITION = ankyrin repeat and FYVE domain containing 1 isoform 2   
 
ACCESSION  = NP_060653 
DEFINITION = sno, strawberry notch homolog 1   
 
ACCESSION  = NP_057336 
DEFINITION = baculoviral IAP repeat-containing 6   
 
ACCESSION  = NP_001008660 
DEFINITION = phosphatidylinositol-binding clathrin assembly protein isoform 2   
 
ACCESSION  = NP_065872 
DEFINITION = vacuolar protein sorting 13C protein isoform 2A   
 
ACCESSION  = XP_941767 
DEFINITION = PREDICTED: similar to Suppressor Of Clr family member (soc-2)   
 
ACCESSION  = NP_001018098 
DEFINITION = vacuolar protein sorting 13C protein isoform 2B   
 
ACCESSION  = NP_056081 XP_030524 
DEFINITION = Na+/H+ exchanger isoform 8   
 
ACCESSION  = XP_166254 
DEFINITION = PREDICTED: odz, odd Oz/ten-m homolog 4   
 
ACCESSION  = XP_943674 
DEFINITION = PREDICTED: similar to pleckstrin homology domain containing, 
family M (with RUN domain) member 1   
 
ACCESSION  = XP_931283 
DEFINITION = PREDICTED: similar to Leucine-rich repeat-containing protein 1 
(LAP and no PDZ protein) (LANO adapter protein)   
 
ACCESSION  = NP_001697 
DEFINITION = B-cell lymphoma 6 protein   
 
ACCESSION  = NP_079039 
DEFINITION = WD repeat domain 78 isoform 1   
 
ACCESSION  = NP_005348 
DEFINITION = hormone-sensitive lipase   
 
ACCESSION  = NP_057460 
DEFINITION = ankyrin repeat and FYVE domain containing 1 isoform 1   
 
ACCESSION  = NP_877439 XP_294213 XP_353565 
DEFINITION = putative binding protein 7a5   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = XP_943924 
DEFINITION = PREDICTED: similar to Mucin-5B precursor (Mucin 5 subtype B, 
tracheobronchial) (High molecular weight salivary mucin MG1) (Sublingual gland 
mucin)   
 
ACCESSION  = NP_009097 
DEFINITION = phosphatidylinositol-binding clathrin assembly protein isoform 1   
 
ACCESSION  = XP_945556 
DEFINITION = PREDICTED: similar to odd Oz/ten-m homolog 4   
 
ACCESSION  = NP_058632 
DEFINITION = ubinuclein 1   
 
ACCESSION  = NP_055811 XP_042635 
DEFINITION = phospholipase C-like 3   
 
ACCESSION  = NP_060550 
DEFINITION = vacuolar protein sorting 13C protein isoform 1B   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = NP_006210 
DEFINITION = phosphoinositide-3-kinase, catalytic, beta polypeptide   
 
ACCESSION  = NP_056986 
DEFINITION = E3 ubiquitin protein ligase, HECT domain containing, 1   
 
ACCESSION  = XP_941327 
DEFINITION = PREDICTED: similar to E3 ubiquitin protein ligase, HECT domain 
containing, 1   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = XP_039877 
DEFINITION = PREDICTED: mucin 5, subtype B, tracheobronchial   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = XP_949600 
DEFINITION = PREDICTED: similar to Tubulin gamma-1 chain (Gamma-1 tubulin) 
(Gamma-tubulin complex component 1) (GCP-1) isoform 3   
 
ACCESSION  = NP_203744 
DEFINITION = molecule interacting with Rab13   
 
ACCESSION  = NP_689730 
DEFINITION = hypothetical protein LOC150737   
 
ACCESSION  = NP_060154 
DEFINITION = vacuolar protein sorting 13C protein isoform 1A   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
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ACCESSION  = NP_036273 
DEFINITION = DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26   
 
ACCESSION  = NP_955452 NP_054844 
DEFINITION = DNA polymerase theta   
 
ACCESSION  = XP_370652 
DEFINITION = PREDICTED: dynein, cytoplasmic, heavy polypeptide 2 isoform 1   
 
ACCESSION  = XP_290944 
DEFINITION = PREDICTED: pleckstrin homology domain containing, family M 
(with RUN domain) member 2   
 
ACCESSION  = NP_055524 XP_291018 
DEFINITION = ubiquitin specific protease 34   
 
ACCESSION  = NP_005305 
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ACCESSION  = NP_055963 
DEFINITION = PAS domain containing serine/threonine kinase   
 
ACCESSION  = NP_579899 
DEFINITION = myoferlin isoform b   
 
ACCESSION  = NP_115515 
DEFINITION = ankyrin repeat domain 27 (VPS9 domain)   
 
ACCESSION  = NP_055680 
DEFINITION = chromosome condensation-related SMC-associated protein 1   
 
ACCESSION  = NP_005622 
DEFINITION = smoothened   
 
ACCESSION  = NP_006274 
DEFINITION = transforming, acidic coiled-coil containing protein 1   
 
ACCESSION  = NP_008928 
DEFINITION = transforming, acidic coiled-coil containing protein 2 isoform d   
 
ACCESSION  = XP_943656 
DEFINITION = PREDICTED: similar to Zinc finger protein 292 isoform 4   
 
ACCESSION  = NP_000009 
DEFINITION = acyl-Coenzyme A dehydrogenase, very long chain isoform 1 
precursor   
 
ACCESSION  = NP_055483 
DEFINITION = GREB1 protein isoform a   
 
ACCESSION  = NP_066921 
DEFINITION = calcium channel, voltage-dependent, alpha 1H subunit isoform a   
 
ACCESSION  = NP_065997 XP_497076 
DEFINITION = hypothetical protein LOC57706 isoform 1   
 
ACCESSION  = XP_945898 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 12   
 
ACCESSION  = NP_006136 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 1   
 
ACCESSION  = NP_003595 
DEFINITION = insulin receptor substrate 4   
 
ACCESSION  = NP_055927 
DEFINITION = microtubule associated serine/threonine kinase 2   
 
ACCESSION  = XP_941081 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 11   
 
ACCESSION  = XP_941078 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 8   
 
ACCESSION  = NP_060653 
DEFINITION = sno, strawberry notch homolog 1   
 
ACCESSION  = NP_001008220 
DEFINITION = amylase, alpha 1C; salivary precursor   
 
ACCESSION  = XP_048070 
DEFINITION = PREDICTED: zinc finger protein 292 isoform 1   
 
ACCESSION  = XP_945671 
DEFINITION = PREDICTED: hypothetical protein XP_945671   
 
ACCESSION  = XP_942211 
DEFINITION = PREDICTED: similar to double homeobox 4c   
 
ACCESSION  = NP_004029 
DEFINITION = amylase, alpha 1A; salivary precursor   
 
ACCESSION  = NP_612563 
DEFINITION = B-cell CLL/lymphoma 11A isoform 5   
 
ACCESSION  = NP_075049 
DEFINITION = B-cell CLL/lymphoma 11B isoform 2   
 
ACCESSION  = NP_652761 
DEFINITION = A-kinase anchor protein 11 isoform 2   
 
ACCESSION  = XP_086287 
DEFINITION = PREDICTED: similar to protein tyrosine phosphatase, receptor type, 
V   
 
ACCESSION  = NP_851607 
DEFINITION = SCY1-like 3 isoform 2   
 
ACCESSION  = NP_065710 
DEFINITION = tweety 1 isoform 1   
 
ACCESSION  = NP_055726 
DEFINITION = AP2 associated kinase 1   
 
ACCESSION  = NP_002963 XP_037447 
DEFINITION = SET binding factor 1 isoform a   
 
ACCESSION  = NP_942595 
DEFINITION = BMP-2 inducible kinase isoform a   
 
ACCESSION  = NP_004227 
DEFINITION = COP9 constitutive photomorphogenic homolog subunit 2   
 
ACCESSION  = XP_943674 
DEFINITION = PREDICTED: similar to pleckstrin homology domain containing, 
family M (with RUN domain) member 1   
 
ACCESSION  = NP_996742 
DEFINITION = transforming, acidic coiled-coil containing protein 2 isoform c   
 
ACCESSION  = NP_036586 
DEFINITION = T-cell lymphoma invasion and metastasis 2 isoform a   
 
ACCESSION  = XP_939215 
DEFINITION = PREDICTED: piccolo isoform 6   
 
ACCESSION  = NP_001501 
DEFINITION = glutamate receptor, ionotropic, delta 2   
 
ACCESSION  = XP_946113 
DEFINITION = PREDICTED: similar to protein tyrosine phosphatase, receptor type, 
V   
 
ACCESSION  = NP_996743 
DEFINITION = transforming, acidic coiled-coil containing protein 2 isoform b   
 
ACCESSION  = NP_055621 XP_048462 
DEFINITION = RUN and SH3 domain containing 2   
 
ACCESSION  = NP_001029031 
DEFINITION = acyl-Coenzyme A dehydrogenase, very long chain isoform 2 
precursor   
 
ACCESSION  = XP_932914 
DEFINITION = PREDICTED: similar to Gamma-tubulin complex component 3 
(GCP-3) (Spindle pole body protein Spc98 homolog) (hSpc98) (hGCP3) (h104p)   
 
ACCESSION  = NP_001010972 
DEFINITION = zyxin   
 
ACCESSION  = XP_377445 
DEFINITION = PREDICTED: similar to double homeobox 4c   
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ACCESSION  = NP_006039 
DEFINITION = ubiquitination factor E4B   
 
ACCESSION  = NP_877439 XP_294213 XP_353565 
DEFINITION = putative binding protein 7a5   
 
ACCESSION  = NP_001010927 
DEFINITION = T-cell lymphoma invasion and metastasis 2 isoform b   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = NP_996744 
DEFINITION = transforming, acidic coiled-coil containing protein 2 isoform a   
 
ACCESSION  = XP_949903 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 16   
 
ACCESSION  = NP_612808 
DEFINITION = B-cell CLL/lymphoma 11B isoform 1   
 
ACCESSION  = NP_001004051 
DEFINITION = G protein-coupled receptor associated sorting protein 2   
 
ACCESSION  = NP_001005407 
DEFINITION = calcium channel, voltage-dependent, alpha 1H subunit isoform b   
 
ACCESSION  = NP_060466 
DEFINITION = de-etiolated 1   
 
ACCESSION  = NP_004749 
DEFINITION = peripheral benzodiazepine receptor-associated protein 1   
 
ACCESSION  = XP_495939 
DEFINITION = PREDICTED: hypothetical protein LOC57666   
 
ACCESSION  = NP_001008222 
DEFINITION = amylase, alpha 1A; salivary precursor   
 
ACCESSION  = XP_942238 
DEFINITION = PREDICTED: similar to myoferlin isoform b   
 
ACCESSION  = NP_055811 XP_042635 
DEFINITION = phospholipase C-like 3   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = NP_001008219 
DEFINITION = amylase, alpha 1B; salivary precursor   
 
ACCESSION  = NP_005586 
DEFINITION = nuclear factor I/A   
 
ACCESSION  = XP_949889 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 13   
 
ACCESSION  = XP_097977 
DEFINITION = PREDICTED: hypothetical protein XP_097977   
 
ACCESSION  = NP_001010870 XP_166443 
DEFINITION = tudor domain containing 6   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_116250 
DEFINITION = serine active site containing 1   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_689804 
DEFINITION = hypothetical protein LOC160762   
 
ACCESSION  = XP_094074 
DEFINITION = PREDICTED: similar to FRAS1-related extracellular matrix protein 
3 precursor   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = NP_036547 
DEFINITION = RAD54 homolog B   
 
ACCESSION  = XP_941521 
DEFINITION = PREDICTED: similar to autism susceptibility candidate 2   
 
ACCESSION  = XP_935039 
DEFINITION = PREDICTED: piccolo isoform 2   
 
ACCESSION  = NP_075044 
DEFINITION = B-cell CLL/lymphoma 11A isoform 1   
 
ACCESSION  = NP_653308 
DEFINITION = prominin 2   
 
ACCESSION  = NP_079097 XP_496529 
DEFINITION = hypothetical protein LOC79879   
 
ACCESSION  = NP_056018 XP_371309 
DEFINITION = hypothetical protein LOC23248   
 
ACCESSION  = XP_291671 
DEFINITION = PREDICTED: similar to Matrin-3   
 
ACCESSION  = XP_939204 
DEFINITION = PREDICTED: piccolo isoform 3   
 
ACCESSION  = XP_946603 
DEFINITION = PREDICTED: similar to DnaJ homolog subfamily B member 5 (Heat 
shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40) (Hsp40-2) isoform 2   
 
ACCESSION  = NP_038479 
DEFINITION = myoferlin isoform a   
 
ACCESSION  = NP_060484 NP_612562 
DEFINITION = B-cell CLL/lymphoma 11A isoform 2   
 
ACCESSION  = NP_056040 XP_041018 
DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
 
ACCESSION  = NP_000690 
DEFINITION = amylase, alpha 2A; pancreatic precursor   
 
ACCESSION  = NP_057332 
DEFINITION = A-kinase anchor protein 11 isoform 1   
 
ACCESSION  = NP_612446 
DEFINITION = G protein-coupled receptor associated sorting protein 2   
 
ACCESSION  = XP_290944 
DEFINITION = PREDICTED: pleckstrin homology domain containing, family M 
(with RUN domain) member 2   
 
ACCESSION  = XP_944430 
DEFINITION = PREDICTED: similar to Matrin-3   
 
ACCESSION  = NP_036398 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 5   
 
ACCESSION  = NP_066188 
DEFINITION = amylase, alpha 2B; pancreatic precursor   
 
ACCESSION  = NP_004779 
DEFINITION = ubiquitination factor E4A   
 
ACCESSION  = NP_003452 
DEFINITION = zyxin   
 
ACCESSION  = XP_940803 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 7   
 
ACCESSION  = NP_008965 
DEFINITION = DnaJ (Hsp40) homolog, subfamily B, member 4   
 
ACCESSION  = NP_071897 
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ACCESSION  = NP_579899 
DEFINITION = myoferlin isoform b   
 
ACCESSION  = NP_612149 
DEFINITION = ataxia telangiectasia mutated protein isoform 2   
 
ACCESSION  = NP_473454 
DEFINITION = DNA-dependent protein kinase catalytic subunit-interacting protein 3   
 
ACCESSION  = NP_058633 
DEFINITION = polymerase (DNA-directed), alpha   
 
ACCESSION  = NP_787072 
DEFINITION = exocyst complex 84-kDa subunit   
 
ACCESSION  = NP_000042 
DEFINITION = ataxia telangiectasia mutated protein isoform 1   
 
ACCESSION  = NP_055950 XP_371954 XP_374530 
DEFINITION = nucleoporin 205kDa   
 
ACCESSION  = NP_004295 
DEFINITION = anaplastic lymphoma kinase Ki-1   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_997404 
DEFINITION = reticulon 4 isoform E   
 
ACCESSION  = NP_001030 
DEFINITION = sodium channel, nonvoltage-gated 1, gamma   
 
ACCESSION  = NP_055621 XP_048462 
DEFINITION = RUN and SH3 domain containing 2   
 
ACCESSION  = NP_631905 
DEFINITION = striated muscle activator of Rho-dependent signaling   
 
ACCESSION  = NP_060647 
DEFINITION = Nedd4 binding protein 2   
 
ACCESSION  = NP_006039 
DEFINITION = ubiquitination factor E4B   
 
ACCESSION  = NP_055426 
DEFINITION = MDN1, midasin homolog   
 
ACCESSION  = NP_060466 
DEFINITION = de-etiolated 1   
 
ACCESSION  = XP_941345 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = XP_940697 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_004659 
DEFINITION = maltase-glucoamylase   
 
ACCESSION  = NP_001032 
DEFINITION = sucrase-isomaltase (alpha-glucosidase)   
 
ACCESSION  = XP_944522 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_057688 
DEFINITION = jumonji domain containing 1B   
 
ACCESSION  = NP_006589 
DEFINITION = solute carrier family 12 (potassium/chloride transporters), member 7   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_003256 
DEFINITION = toll-like receptor 3   
 
ACCESSION  = NP_006827 XP_045792 
DEFINITION = GCN1 general control of amino-acid synthesis 1-like 1   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_006374 
DEFINITION = DNA-dependent protein kinase catalytic subunit-interacting protein 2   
 
ACCESSION  = NP_065393 
DEFINITION = reticulon 4 isoform A   
 
ACCESSION  = NP_056167 
DEFINITION = protein O-fucosyltransferase 1 isoform 1 precursor   
 
ACCESSION  = NP_038479 
DEFINITION = myoferlin isoform a   
 
ACCESSION  = NP_689483 
DEFINITION = hypothetical protein FLJ34922   
 
ACCESSION  = NP_758436 
DEFINITION = protein O-fucosyltransferase 1 isoform 2 precursor   
 
ACCESSION  = XP_931230 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_056031 
DEFINITION = hypothetical protein LOC23262   
 
ACCESSION  = XP_945884 
DEFINITION = PREDICTED: similar to Serine-protein kinase ATM (Ataxia 
telangiectasia mutated) (A-T, mutated)   
 
ACCESSION  = NP_056099 
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ACCESSION  = NP_055111 
DEFINITION = calpain 7   
 
ACCESSION  = NP_055680 
DEFINITION = chromosome condensation-related SMC-associated protein 1   
 
ACCESSION  = NP_112219 
DEFINITION = ADAM metallopeptidase with thrombospondin type 1 motif, 10 
preproprotein   
 
ACCESSION  = NP_891555 
DEFINITION = fms-related tyrosine kinase 4 isoform 1   
 
ACCESSION  = NP_597705 XP_062545 
DEFINITION = hypothetical protein LOC121256   
 
ACCESSION  = XP_942900 
DEFINITION = PREDICTED: similar to dynein, cytoplasmic, heavy chain 2 isoform 
3   
 
ACCESSION  = NP_001019980 
DEFINITION = retinoic acid receptor, alpha isoform b   
 
ACCESSION  = NP_002011 
DEFINITION = fms-related tyrosine kinase 4 isoform 2   
 
ACCESSION  = NP_079426 
DEFINITION = threonyl-tRNA synthetase-like 1   
 
ACCESSION  = NP_005457 
DEFINITION = mediator of RNA polymerase II transcription, subunit 6 homolog   
 
ACCESSION  = XP_941326 
DEFINITION = PREDICTED: similar to Maltase-glucoamylase, intestinal   
 
ACCESSION  = NP_851607 
DEFINITION = SCY1-like 3 isoform 2   
 
ACCESSION  = NP_003585 
DEFINITION = transcription termination factor, RNA polymerase II   
 
ACCESSION  = NP_066988 
DEFINITION = BMP/retinoic acid-inducible neural-specific protein 2   
 
ACCESSION  = XP_166254 
DEFINITION = PREDICTED: odz, odd Oz/ten-m homolog 4   
 
ACCESSION  = XP_936549 
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DEFINITION = PREDICTED: odz, odd Oz/ten-m homolog 2 isoform 3   
 
ACCESSION  = XP_047995 
DEFINITION = PREDICTED: odz, odd Oz/ten-m homolog 2 isoform 1   
 
ACCESSION  = NP_055336 
DEFINITION = SH3-domain binding protein 4   
 
ACCESSION  = NP_004823 
DEFINITION = glutathione-S-transferase omega 1   
 
ACCESSION  = NP_851320 
DEFINITION = intimal thickness-related receptor   
 
ACCESSION  = NP_055433 
DEFINITION = deleted in bladder cancer 1   
 
ACCESSION  = XP_943924 
DEFINITION = PREDICTED: similar to Mucin-5B precursor (Mucin 5 subtype B, 
tracheobronchial) (High molecular weight salivary mucin MG1) (Sublingual gland 
mucin)   
 
ACCESSION  = NP_950252 XP_290915 
DEFINITION = family with sequence similarity 5, member C   
 
ACCESSION  = NP_922932 NP_055088 XP_293904 
DEFINITION = ADAM metallopeptidase with thrombospondin type 1 motif, 6 
preproprotein   
 
ACCESSION  = XP_945556 
DEFINITION = PREDICTED: similar to odd Oz/ten-m homolog 4   
 
ACCESSION  = XP_948728 
DEFINITION = PREDICTED: hypothetical protein XP_948728   
 
ACCESSION  = NP_006210 
DEFINITION = phosphoinositide-3-kinase, catalytic, beta polypeptide   
 
ACCESSION  = NP_001010870 XP_166443 
DEFINITION = tudor domain containing 6   
 
ACCESSION  = NP_004659 
DEFINITION = maltase-glucoamylase   
 
ACCESSION  = NP_057688 
DEFINITION = jumonji domain containing 1B   
 
ACCESSION  = NP_006589 
DEFINITION = solute carrier family 12 (potassium/chloride transporters), member 7   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = NP_937784 XP_370857 
DEFINITION = glucosidase, alpha; neutral C   
 
ACCESSION  = XP_039877 
DEFINITION = PREDICTED: mucin 5, subtype B, tracheobronchial   
 
ACCESSION  = XP_947301 
DEFINITION = PREDICTED: similar to odd Oz/ten-m homolog 2 isoform 4   
 
ACCESSION  = NP_001009944 
DEFINITION = polycystin 1 isoform 1 precursor   
 
ACCESSION  = NP_776297 
DEFINITION = chloride channel 3 isoform e   
 
ACCESSION  = NP_612409 XP_049384 XP_374590 
DEFINITION = nucleolar protein with MIF4G domain 1   
 
ACCESSION  = NP_060250 XP_098762 
DEFINITION = chromodomain helicase DNA binding protein 7   
 
ACCESSION  = XP_950881 
DEFINITION = PREDICTED: similar to odd Oz/ten-m homolog 2 isoform 6   
 
ACCESSION  = NP_000287 
DEFINITION = polycystin 1 isoform 2 precursor   
 
ACCESSION  = XP_370652 
DEFINITION = PREDICTED: dynein, cytoplasmic, heavy polypeptide 2 isoform 1   
 
ACCESSION  = NP_001820 
DEFINITION = chloride channel 3 isoform b   
 
ACCESSION  = NP_038474 
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ACCESSION  = NP_060109 
DEFINITION = dachsous 2 isoform 1   
 
ACCESSION  = NP_055477 XP_376007 
DEFINITION = DEP domain containing 5 isoform 1   
 
ACCESSION  = XP_945898 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 12   
 
ACCESSION  = NP_058633 
DEFINITION = polymerase (DNA-directed), alpha   
 
ACCESSION  = XP_941081 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 11   
 
ACCESSION  = XP_941078 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 8   
 
ACCESSION  = XP_944389 
DEFINITION = PREDICTED: similar to MAX-interacting protein isoform 5   
 
ACCESSION  = NP_055950 XP_371954 XP_374530 
DEFINITION = nucleoporin 205kDa   
 
ACCESSION  = XP_940748 
DEFINITION = PREDICTED: similar to Rap guanine nucleotide exchange factor 5 
(Guanine nucleotide exchange factor for Rap1) (Related to Epac) (Repac) (M-Ras-
regulated Rap GEF) (MR-GEF) isoform 6   
 
ACCESSION  = NP_115832 
DEFINITION = protocadherin 7 isoform b precursor   
 
ACCESSION  = NP_003820 
DEFINITION = multiple PDZ domain protein   
 
ACCESSION  = NP_055558 XP_291106 
DEFINITION = hypothetical protein LOC9778   
 
ACCESSION  = NP_114072 
DEFINITION = frizzled 8   
 
ACCESSION  = NP_004227 
DEFINITION = COP9 constitutive photomorphogenic homolog subunit 2   
 
ACCESSION  = NP_003772 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = XP_939215 
DEFINITION = PREDICTED: piccolo isoform 6   
 
ACCESSION  = NP_060434 
DEFINITION = solute carrier family 30 (zinc transporter), member 6   
 
ACCESSION  = NP_055416 
DEFINITION = EH-domain containing 2   
 
ACCESSION  = NP_775792 
DEFINITION = hypothetical protein LOC158401   
 
ACCESSION  = XP_933695 
DEFINITION = PREDICTED: Rap guanine nucleotide exchange factor (GEF) 5 
isoform 1   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = XP_949903 
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DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 16   
 
ACCESSION  = NP_001004051 
DEFINITION = G protein-coupled receptor associated sorting protein 2   
 
ACCESSION  = NP_055426 
DEFINITION = MDN1, midasin homolog   
 
ACCESSION  = NP_149358 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = XP_937813 
DEFINITION = PREDICTED: MAX dimerization protein 5 isoform 2   
 
ACCESSION  = NP_060137 
DEFINITION = hypothetical protein LOC55610 isoform a   
 
ACCESSION  = NP_149359 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = XP_942238 
DEFINITION = PREDICTED: similar to myoferlin isoform b   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = XP_031689 
DEFINITION = PREDICTED: MAX dimerization protein 5 isoform 1   
 
ACCESSION  = XP_942937 
DEFINITION = PREDICTED: similar to Rap guanine nucleotide exchange factor 5 
(Guanine nucleotide exchange factor for Rap1) (Related to Epac) (Repac) (M-Ras-
regulated Rap GEF) (MR-GEF) isoform 11   
 
ACCESSION  = NP_006210 
DEFINITION = phosphoinositide-3-kinase, catalytic, beta polypeptide   
 
ACCESSION  = XP_949889 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 13   
 
ACCESSION  = NP_115833 
DEFINITION = protocadherin 7 isoform c precursor   
 
ACCESSION  = XP_949185 
DEFINITION = PREDICTED: similar to MAX-interacting protein isoform 6   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_733751 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 3 isoform 2   
 
ACCESSION  = NP_059129 
DEFINITION = myosin IIIA   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = NP_612449 
DEFINITION = slit-like 2   
 
ACCESSION  = XP_935039 
DEFINITION = PREDICTED: piccolo isoform 2   
 
ACCESSION  = XP_939204 
DEFINITION = PREDICTED: piccolo isoform 3   
 
ACCESSION  = NP_000495 
DEFINITION = coagulation factor X precursor   
 
ACCESSION  = NP_036273 
DEFINITION = DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26   
 
ACCESSION  = NP_067053 
DEFINITION = myeloid/lymphoid or mixed-lineage leukemia 3 isoform 1   
 
ACCESSION  = XP_931818 
DEFINITION = PREDICTED: similar to myoferlin isoform b   
 
ACCESSION  = NP_149357 
DEFINITION = UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 3   
 
ACCESSION  = NP_612446 
DEFINITION = G protein-coupled receptor associated sorting protein 2   
 
ACCESSION  = NP_005834 
DEFINITION = signal transducing adaptor molecule 2   
 
ACCESSION  = NP_002580 
DEFINITION = protocadherin 7 isoform a precursor   
 
ACCESSION  = NP_055495 XP_371036 
DEFINITION = hypothetical protein LOC9703   
 
ACCESSION  = XP_940803 
DEFINITION = PREDICTED: similar to Piccolo protein (Aczonin) isoform 7   
 
ACCESSION  = NP_872395 
DEFINITION = 5-hydroxytryptamine receptor 3 subunit E   
 
ACCESSION  = NP_008965 
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ACCESSION  = NP_060139 
DEFINITION = hypothetical protein LOC54821 isoform a   
 
ACCESSION  = NP_438173 
DEFINITION = secretory carrier membrane protein 1 isoform 2   
 
ACCESSION  = NP_060109 
DEFINITION = dachsous 2 isoform 1   
 
ACCESSION  = XP_946431 
DEFINITION = PREDICTED: similar to Nucleoporin-like protein RIP (HIV-1 Rev-
binding protein) (Rev interacting protein) (Rev/Rex activation domain-binding 
protein) isoform 1   
 
ACCESSION  = NP_065855 
DEFINITION = protein kinase C and casein kinase substrate in neurons 1   
 
ACCESSION  = NP_037465 
DEFINITION = epsin 1   
 
ACCESSION  = NP_004778 
DEFINITION = slit homolog 2   
 
ACCESSION  = NP_891555 
DEFINITION = fms-related tyrosine kinase 4 isoform 1   
 
ACCESSION  = NP_550434 
DEFINITION = asialoglycoprotein receptor 2 isoform a   
 
ACCESSION  = NP_683723 
DEFINITION = epsin 2 isoform a   
 
ACCESSION  = NP_003052 
DEFINITION = slit homolog 1   
 
ACCESSION  = NP_002011 
DEFINITION = fms-related tyrosine kinase 4 isoform 2   
 
ACCESSION  = NP_001007793 
DEFINITION = neurotrophic tyrosine kinase, receptor, type 1 isoform 3   
 
ACCESSION  = XP_950234 
DEFINITION = PREDICTED: similar to Nucleoporin-like protein RIP (HIV-1 Rev-
binding protein) (Rev interacting protein) (Rev/Rex activation domain-binding 
protein) isoform 3   
 
ACCESSION  = NP_060650 
DEFINITION = DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 32   
 
ACCESSION  = NP_004161 
DEFINITION = solute carrier family 1, member 1   
 
ACCESSION  = NP_001009954 
DEFINITION = hypothetical protein LOC54821 isoform b   
 
ACCESSION  = NP_005689 
DEFINITION = secretory carrier membrane protein 3 isoform 1   
 
ACCESSION  = NP_075049 
DEFINITION = B-cell CLL/lymphoma 11B isoform 2   
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ACCESSION  = NP_038472 
DEFINITION = ubiquilin 2   
 
ACCESSION  = NP_006140 
DEFINITION = galectin 4   
 
ACCESSION  = XP_086287 
DEFINITION = PREDICTED: similar to protein tyrosine phosphatase, receptor type, 
V   
 
ACCESSION  = NP_060759 
DEFINITION = VPS53 protein   
 
ACCESSION  = NP_001008938 
DEFINITION = colonic and hepatic tumor over-expressed protein isoform a   
 
ACCESSION  = NP_003585 
DEFINITION = transcription termination factor, RNA polymerase II   
 
ACCESSION  = NP_006067 
DEFINITION = HIV-1 Rev-binding protein-like protein   
 
ACCESSION  = NP_001005736 
DEFINITION = lysosomal trafficking regulator isoform 2   
 
ACCESSION  = NP_115892 
DEFINITION = G protein-coupled receptor 145   
 
ACCESSION  = NP_001501 
DEFINITION = glutamate receptor, ionotropic, delta 2   
 
ACCESSION  = NP_009160 
DEFINITION = protein kinase C and casein kinase substrate in neurons 2   
 
ACCESSION  = NP_689992 
DEFINITION = hypothetical protein LOC256710   
 
ACCESSION  = XP_946113 
DEFINITION = PREDICTED: similar to protein tyrosine phosphatase, receptor type, 
V   
 
ACCESSION  = NP_055621 XP_048462 
DEFINITION = RUN and SH3 domain containing 2   
 
ACCESSION  = NP_055336 
DEFINITION = SH3-domain binding protein 4   
 
ACCESSION  = NP_056067 
DEFINITION = EH domain binding protein 1   
 
ACCESSION  = NP_116561 
DEFINITION = synaptotagmin-like 2 isoform a   
 
ACCESSION  = NP_851782 
DEFINITION = WD repeat domain 17 isoform 2   
 
ACCESSION  = NP_061937 
DEFINITION = sidekick 2   
 
ACCESSION  = NP_877439 XP_294213 XP_353565 
DEFINITION = putative binding protein 7a5   
 
ACCESSION  = NP_002520 NP_001007205 
DEFINITION = neurotrophic tyrosine kinase, receptor, type 1 isoform 2   
 
ACCESSION  = NP_597676 
DEFINITION = titin isoform novex-1   
 
ACCESSION  = XP_947084 
DEFINITION = PREDICTED: similar to ataxin-1 ubiquitin-like interacting protein 
isoform 1   
 
ACCESSION  = NP_612808 
DEFINITION = B-cell CLL/lymphoma 11B isoform 1   
 
ACCESSION  = NP_057340 
DEFINITION = N-acetylglucosamine-1-phosphodiester alpha-N-
acetylglucosaminidase precursor   
 
ACCESSION  = NP_003053 
DEFINITION = slit homolog 3   
 
ACCESSION  = NP_009097 
DEFINITION = phosphatidylinositol-binding clathrin assembly protein isoform 1   
 
ACCESSION  = NP_149095 
DEFINITION = stonin 2   
 
ACCESSION  = NP_078997 
DEFINITION = zinc finger homeodomain 4   
 
ACCESSION  = NP_055474 
DEFINITION = hypothetical protein LOC9677 isoform 2   
 
ACCESSION  = NP_597681 
DEFINITION = titin isoform novex-2   
 
ACCESSION  = NP_055779 
DEFINITION = epsin 2 isoform b   
 
ACCESSION  = NP_733828 
DEFINITION = WD repeat domain 17 isoform 1   
 
ACCESSION  = NP_001012331 
DEFINITION = neurotrophic tyrosine kinase, receptor, type 1 isoform 1   
 
ACCESSION  = NP_443069 
DEFINITION = secretory carrier membrane protein 3 isoform 2   
 
ACCESSION  = NP_060427 
DEFINITION = epsin 3   
 
ACCESSION  = NP_005688 
DEFINITION = secretory carrier membrane protein 2   
 
ACCESSION  = NP_001032 
DEFINITION = sucrase-isomaltase (alpha-glucosidase)   
 
ACCESSION  = NP_055571 
DEFINITION = colonic and hepatic tumor over-expressed protein isoform b   
 
ACCESSION  = NP_079199 
DEFINITION = nucleoporin 210   
 
ACCESSION  = NP_003310 
DEFINITION = titin isoform N2-B   
 
ACCESSION  = NP_003886 
DEFINITION = synaptojanin 1 isoform a   
 
ACCESSION  = XP_950699 
DEFINITION = PREDICTED: similar to ataxin-1 ubiquitin-like interacting protein 
isoform 2   
 
ACCESSION  = NP_003256 
DEFINITION = toll-like receptor 3   
 
ACCESSION  = NP_001334 
DEFINITION = disabled homolog 2   
 
ACCESSION  = NP_596869 
DEFINITION = titin isoform N2-A   
 
ACCESSION  = NP_055719 
DEFINITION = RAB11 family interacting protein 2 (class I)   
 
ACCESSION  = NP_001005236 
DEFINITION = olfactory receptor, family 1, subfamily L, member 1   
 
ACCESSION  = NP_055061 
DEFINITION = cadherin EGF LAG seven-pass G-type receptor 1   
 
ACCESSION  = NP_203744 
DEFINITION = molecule interacting with Rab13   
 
ACCESSION  = NP_004495 
DEFINITION = HIV-1 Rev binding protein   
 
ACCESSION  = NP_000072 
DEFINITION = lysosomal trafficking regulator isoform 1   
 
ACCESSION  = NP_001009944 
DEFINITION = polycystin 1 isoform 1 precursor   
 
ACCESSION  = NP_085058 NP_078949 XP_290704 
DEFINITION = WD repeat domain 59   
 
ACCESSION  = NP_444295 
DEFINITION = ubiquilin 1 isoform 2   
 
ACCESSION  = NP_056040 XP_041018 
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ACCESSION  = NP_038466 DEFINITION = BNIP2 motif containing molecule at the carboxyl terminal region 1   
DEFINITION = ubiquilin 1 isoform 1    
 ACCESSION  = NP_036273 
ACCESSION  = NP_004857 DEFINITION = DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26   
DEFINITION = secretory carrier membrane protein 1 isoform 1    
 ACCESSION  = NP_001005234 
ACCESSION  = NP_064516 DEFINITION = olfactory receptor, family 1, subfamily L, member 3   
DEFINITION = ataxin-1 ubiquitin-like interacting protein    
 ACCESSION  = NP_006251 
ACCESSION  = NP_038478 DEFINITION = DnaJ (Hsp40) homolog, subfamily C, member 3   
DEFINITION = bromodomain adjacent to zinc finger domain, 2B    
 ACCESSION  = XP_943327 
ACCESSION  = NP_001172 DEFINITION = PREDICTED: similar to Zinc finger protein 486   
DEFINITION = asialoglycoprotein receptor 2 isoform a    
 ACCESSION  = NP_060250 XP_098762 
ACCESSION  = XP_950232 DEFINITION = chromodomain helicase DNA binding protein 7   
DEFINITION = PREDICTED: similar to Nucleoporin-like protein RIP (HIV-1 Rev-
binding protein) (Rev interacting protein) (Rev/Rex activation domain-binding 
protein) isoform 2   
 
ACCESSION  = NP_071735 
DEFINITION = FYVE-finger-containing Rab5 effector protein rabenosyn-5   
  
ACCESSION  = NP_002368 ACCESSION  = NP_000287 
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